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ABSTRACT 
 
ABSTRACT 
First in order to explore the possibilities of building a synthetic artificial cell following a 
biomimetic approach, we engineered synthetic polymer-based giant unilamellar vesicles 
(GUVs) with selective membrane permeability. Since the membranes of polymeric GUVs 
present a high impermeability compared to natural lipid membranes, membranes are 
selectively permeabilized in a biomimetic approach by the insertion of the small pore-
forming peptide gramicidin (gA) as gA biopores are known to allow the transport of protons 
and monovalent ions. Whilst gA has been inserted in lipid membranes in numerous research 
studies, the challenge of inserting the bacterial pore into polymer membranes is greater 
because of the significant difference between the pore length and the thickness of the 
polymer membrane (more than 3.5 times). Confocal laser scanning microscopy (CLSM) was 
used to show that neither the size, nor the morphology of the GUVs was affected by 
successful insertion of gA and further to visualize the pH change inside the cavity of GUVs 
in real-time by recording videos. In order to demonstrate the successful insertion of gA, a pH-
sensitive dye is encapsulated inside the cavity of GUVs and proton gradients between the 
environment of GUVs and their inner cavity serves to assess the exchange of protons across 
the membrane upon gA insertion. The results showed that gA was successfully inserted and 
remained functional in polymer membranes with thickness of 9.2–12.1 nm. Larger membrane 
thicknesses did not allow gA insertion, and 12.1 nm represents a limit for the mismatch 
between the pore length and the membrane thickness. Our gA-GUVs are therefore pH-
regulating and maintain their integrity in different pH conditions in a cell-like manner. This 
bio-mimetic approach to use ion channels with specific selectivity for insertion in polymer 
membranes is an elegant strategy to develop mimics of biomembranes or for supporting the 
design of bioreactors.  
Next, a functional cell mimetic compartment is developed by the insertion of the bacterial 
membrane protein (OmpF) in thick synthetic polymer membranes of an artificial GUV 
compartment that encloses the oxidative enzyme horseradish peroxidase. In this manner a 
simple and robust cell mimic is designed, that supports a rudimental form of metabolism. The 
biopore serves as a gate, which allows substrates to enter the cavities of the GUVs, where 
they are converted into the resorufin-like products by the encapsulated enzyme, and then 
released in the environments of GUVs. 
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Our bio-equipped GUVs facilitate the control of specific catalytic reactions in confined 
micro-scale spaces mimicking cell size and architecture and thus provide a straightforward 
approach serving to obtain deeper insights in the real-time of biological processes inside 
cells.  
This elegant strategy of equipping both GUV membranes and GUV cavities with 
biomolecules, opens the way towards cell-like compartments as novel materials with bio-
functionality is the combination of synthetic micrometer-sized giant unilamellar vesicles 
(GUVs) with biomolecules because it enables studying the behavior of biomolecules and 
processes within confined cavities. 
Finally a visionary strategy for creating the first bioinspired molecular factory with 
functionality as a real cell-mimic based on micrometer-sized giant plasma membrane vesicles 
(GPMVs) is addressed. GPMVs are cell-derived giant vesicles consisting of an outer 
compartment architecture (membrane) and an inner composition, which both directly mirror 
the composition of cells from which they originate except the larger organelles like for 
example nuclei and Golgi apparatus making measurements easier and are the closest cell-
mimic available on the market up to now. In a step towards the development of bioinspired 
molecular factories with functionality as cell mimics, we generate the next generation of cell 
mimics by the production of sophisticated hybrid molecular factories based on GPMVs, 
which are equipped with a synthetic molecular machinery inside their cavities that provides 
functionality. Such a hierarchical approach in compartmentalization allows the lower-level 
synthetic functional compartments encapsulated within the cavity of the GPMV to act as 
independent anatomically discreet units that specialize in their own function, making them 
nanoscale versions of nature own organelles. 
Towards the first bioinspired molecular factory enzyme-equipped polymersomes with a 
reconstituted membrane protein (OmpF) are encapsulated inside the GPMVs as enzymatic 
nanocompartment spaces, where they retain their structure and functionality. When substrates 
were added to the outer solution of the GPMVs, it was shown that they could penetrate both 
the membrane of the GPMVs and the inner compartment membranes of the synthetic 
nanoreactors equipped with OmpF pores. In this respect the equipment of the catalytic 
nanocompartment spaces with OmpF was essential as it allowed the enzyme to perform in the 
inner cavities. Successful substrate conversion was visualized by following the fluorescent 
product of the enzymatic reaction (resorufin-like product), which could leave the 
polymersome and diffuse inside the GPMV cavity. Finally we demonstrate that equipped 
GPMVs can act as artificial cell mimics – retaining their membrane and inner composition if 
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they are injected into multicellular organisms – Zebrafish embryos. To the best of our 
knowledge, this is the first time that a molecular factory functioning as a cell-like mimic has 
been be constructed by using a top down-bottom up approach and has been tested in vivo by 
taking advantage of the fundamental nature of GPMVs. 
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Chapter 1 
FUNCTIONAL BIOMIMETIC DESIGN OF GIANT 
UNILAMELLAR VESICLES (GUVS) 
 
The first chapter of this thesis serves to familiarize the reader with the fundamental 
principles and the scientific interest of building synthetic cell-mimics. The reader is 
introduced to native cell membranes and the current state of the art of synthetic cell 
membrane mimics. Therefore, amphiphilic lipids and polymers, which are the central 
building blocks of synthetic membranes are explained first. Further the thermodynamically 
driven self-assembly and characterization methods of spherical membrane-based micro-sized 
vesicles -lipid, polymer and cell-derived GUVs are discussed, which are the basis/fundament 
used in the later chapters of this work, when designing different kinds of bioinspired cell 
mimics. Due to their size, cell-sized GUVs can give a deeper insight into biological processes 
and are therefore ideal candidates for biomimics. Finally, the approach of building 
molecular hybrids of cell membrane mimics by equipping them with biomolecules is 
presented.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This chapter is partially reprinted and has been published:  
M. Garni, T. Einfalt, M. Lomora, A. Car, W. Meier*, C. G. Palivan*, Artificial Organelles: Reactions inside 
Protein–Polymer Supramolecular Assemblies, CHIMIA International Journal for Chemistry, Volume 70, 
Number 6, 2016, 424-427. 
M. Garni, S. Thamboo, C. A. Schoenenberger, C. G. Palivan*, Biopores/membrane proteins in synthetic 
polymer membranes, Biochimica et Biophysica Acta (BBA) - Biomembranes, Volume 1859, Issue 4, 2017, 619-
638.   
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ARTIFICIAL CELLS / CELL MIMICS 
Since the discovery in 1838 that cells represent the basic structural and biological/ functional 
units of all known living organisms, the so called “building blocks of life” which contain the 
hereditary information have the necessary molecular machinery to support metabolism and 
are able to replicate independently, researchers had the dream to create a synthetic/artificial 
cell with all kinds of imaginable specific functionalities. Behind that dream, the fundamental 
motivation is that being able to create an artificial cell would help to answer essential 
questions of how non-living systems progressed from simple molecular organizational 
systems to living systems. Artificial cell mimics could ideally bring deeper insight into many 
fields such as cell biology, biochemistry, molecular biology, and systems biology1 by 
studying cellular processes in an artificially created micro-environment that represents a real 
cell (Figure 1).  
 
Figure 1. Artificial cell mimics – A versatile platform that allows studying biological 
phenomena in a simplified manner. Adapted from Salehi-Rehyani with permission.1 
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This technique is perceived as an ’understanding by building’ approach. In a science-fiction 
scenario, the acquired knowledge could even lead to artificial cells, capable of producing 
synthetic biomacromolecules (i.e. genes, proteins), supporting independent metabolism, 
replication and differentiation – making them indistinguishable from cells found in living 
organisms. By appropriate vision and execution, researchers could build whole tissues, 
organs or organisms that could be later transplanted in our body as treatments for diseases 
and open the way towards longer lifespans. Two centuries after the discovery of living cells 
numerous achievements have step by step brought us closer towards the ambitious aim of 
designing an artificial cell mimic, becoming a rapidly growing area of research in the 21st 
century.1 
 
Building an artificial cell – where to start? 
Up to this point there are two established conceptual approaches that dominate the field of 
artificial cell mimics.  
The first is based on genetic engineering techniques that allow reengineering and 
manipulation of an existing organism (i.e. stem-cell) with the help of well-developed tools 
and technologies in biotechnology. Currently this approach is more advanced, as it does not 
rely heavily on assembling the entire cellular machinery from scratch, but rather uses pre-
existing organisms and modifies them. Top down designed cells embody the same 
complexity (i.e. intricate metabolic pathways) as the living cells they originate from. This 
complexity is advantageous when designing fully functional cells but hinders the use of top 
down cell-mimics to gain insight into singular processes within cells. As this thesis will focus 
primarily on cell-mimics as platforms for visualization of cellular processes, this approach is 
beyond the scope of this thesis and is discussed in detail elsewhere.2 
The second approach is based on designing an artificial cell from the bottom up. In this way 
cell mimics are constructed on the molecular level by combining either synthetic, biological 
molecular building blocks or a combination thereof in vitro. The vast libraries of synthetic 
and biological molecules that have been discovered, isolated and studied in the previous 
century, give researchers an unprecedented freedom in choosing the material from which the 
artificial cell mimics are built. Specific molecular building blocks (i.e. lipids, polymers, 
DNA, proteins etc.) can be picked and combined in order to support a specific function (i.e. 
structural integrity or a specific chemical reaction), giving bottom up artificial cell systems an 
innate versatility. By using this approach, bottom up designed artificial cells are starting to 
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gain ground in applied sciences, for example as biosensing micromachines, and molecular 
systems that perform defined tasks, function / navigate autonomously and support a 
rudimental form of metabolism in the form of basic chemical synthesis.3–7 Unquestionably, 
the most important application of bottom up designed cell mimics is in research areas where 
they are used as simplified mimics of real biological cells, giving insight into the complex 
cellular metabolism and the progression of non-living systems to living cells.  
Finally, an unprecedented combination of bottom up and top down approaches is possible, 
where biological systems (i.e. eukaryotic cells) are used as a tool, to assemble individual 
molecular building blocks and produce artificial stand-alone systems on demand. To the best 
of my knowledge, this approach remains predominantly untapped and has not been used for 
the construction of a cell mimic by any other research group. The first proof of concept of a 
bottom up/top down designed cell-mimic is discussed in great detail in the last chapter of this 
thesis.   
 
Building an artificial cell – the advantage 
Both eukaryotic and prokaryotic cells are complex structures with well-organized molecular 
machineries that work with high precision and efficiency.8 In order to develop artificial 
molecular systems with similar complexity and multifunctionality as is found in biological 
systems, it is necessary to understand and mimic at the molecular level the various reactions 
involved in cell metabolism.  
The discovery of cell-free enzymatic reactions by Eduard Buchner in 18979 demonstrated that 
not all chemical reactions of biological systems require organized, living cells. In principle 
bottom up synthetic biology, is a contemporary application of this principle. In a bottom up 
approach of designing micro-sized vesicle-based cell mimics equipped with biomolecules, 
the latter have been shown capable of hosting a wide array of confined reactions10 catalyzed 
by either inorganic catalysts or biomolecules. Examples of such reactions include the 
polymerase chain reaction11, RNA polymerization12, protein synthesis13 and even coupled 
transcription and translation.14 
Taking into consideration the fundamental complexity of the proteome found in eukaryotic 
cells, which covers over 20,000 protein coding genes in human DNA, the design of an ideal 
cell-mimic is still out of reach and demonstrates the enormous challenge bottom up synthetic 
biology faces.15 In living cells there are various interactions between proteins and also 
between proteins and other biomolecules (i.e. DNA, lipids) that result in a complex network 
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capable of supporting all kinds of molecular interactions and signaling pathways. The 
challenge is to understand this complexity and to determine all the possible molecular 
parameters that play a role in supporting cellular metabolism in a quantitative manner. 
However, due to the overwhelming complexity a significant potential for redundancy is 
required, when studying cellular processes. Isolating the exact role that individual 
components play in cellular metabolism in a systematic way appears as a nearly impossible 
task when studying whole cells. Herein lies the key attraction of using bottom up designed 
artificial cells as models of their biological counterparts. Lab-created artificial cells come 
with a key advantage: simplicity. On the one hand, artificial cells are simple enough to 
experimentally give insight into fundamental processes of cell biology, and on the other hand 
they can still estimate aspects of biological processes, which otherwise only appear in more 
complex systems. Whereas biological cells require cell specific cultivation (i.e. temperature 
and CO2 atmosphere) and essential nutrients, the designed artificial cells are independent of 
their external environment unless specified otherwise. By increasing the complexity of a 
simple artificial cell systematically using more and more components in a controlled manner, 
the construction of a cell mimic that represents almost a real cell could be realized in a not so 
far away future (Figure 2). Cell mimics previously arose in the form of biomolecule-loaded 
lipid- and polymer-based giant unilamellar vesicles (GUVs)5,7,16–18 lipid coated porous silica 
nanoparticles19, layer-by-layer capsules20, membrane free microdroplets, and micro scaled 
proteinosomes.21 This thesis will focus on giant unilamellar vesicles (GUVs) as their 
membranous hollow sphere structure makes them the closest cell mimics up to date.  
 
11 
FUNCTIONAL BIOMIMETIC DESIGN OF GIANT UNILAMELLAR VESICLES (GUVS) 
 
Figure 2. Increasing complexity of artificial cell mimics, giving insight into the progression 
of non-living systems to living systems. Current artificial cell systems heavily rely on a 
bottom up or top down approach in design. Adapted from Salehi-Reyhani et al. with 
permission.1 
 
Previously, the most common approaches to produce membranous cell mimics were based on 
bulk self-assembly of molecular building blocks and emulsion-based techniques.22,23 
Contemporary approaches rely on the established microfluidics technologies, which allow a 
high degree of control with respect to size (micro- or nanoscale) and architecture (i.e. 
compartmentalization, connectivity within the mimic or membrane composition).24–29 Due to 
the flexibility of the experimental approach, new ways are being opened in combining 
artificial cells with synthetic parts and therefore creating new hybrid materials. The above-
mentioned techniques enable the controlled creation of artificial cells with defined 
functionalities working as complex self-organized systems and discussed along with the 
different types of molecular building blocks, later on in the subsequent chapters of the thesis.  
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ESSENTIAL BUILDING BLOCKS FOR CELL-LIKE 
MEMBRANE MIMICS: LIPIDS, POLYMERS AND          
CELL-DERIVED MATERIALS 
Since many years, researchers study and mimic native biological cell membranes and further 
use them as a model to study various biological processes. When mimicking a cellular 
membrane in a laboratory environment many different factors have to be taken into account, 
such as lipid/polymer composition of the membrane30–32, membrane asymmetry33, degree of 
confinement and compartmentalization34, as well as their intrinsic mechanical properties.35,36  
 
Biomembranes  
Analyzing native biological cell membranes resulted in a technological progress towards the 
generation of artificial membrane systems, which serve as the fundamental architecture of 
cell mimics. Biological membranes composed of a phospholipid bilayer are complex matrices 
which serve as a border between the inner cavity of a cell and the outside environment to 
protect the cell from its surroundings. The main components of cell membranes are 
phospholipids. Broken down, the phospholipid structure is composed of a hydrophilic head 
group (neutral, charged or zwitterionic) and a hydrophobic tail (saturated or unsaturated 
carbon chain).37 Once in solution this leads to the molecular arrangement of phospholipid 
molecules into a thin two-dimensional double layer (bilayer), with hydrophilic head groups 
facing the water interfaces in order to reduce the total entropy.  
The cell membrane controls the transport of substances through selective permeability 
towards ions and/or molecules and is involved in a variety of active cellular processes as for 
example cell adhesion, ion conductivity and cell signaling.38 However, lipids alone cannot 
support complex function required from a cell. Biological cell membranes have a wide 
variety of different kinds of membrane proteins embedded within the lipid matrix in order to 
support cellular metabolism. In fact, membrane proteins are so important that they can 
contribute to 15-80% of the plasma membrane’s dry weight and represent around 30% of the 
human cell genome, highlighting their importance.39–41 Depending on their type, membrane 
proteins contribute to vital cellular functions or are involved in cell-to-cell communication. 
One of the major roles of membrane proteins is the translocation of substrates from the 
cellular environment across the plasma membrane into the cytoplasm and the excretion of 
metabolites or signaling molecules into the cellular environment. For this purpose biological 
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systems have evolved specific and non-specific membrane protein channels, which allow 
translocation of substrates or solvents across the phospholipid membrane with exceptional 
selectivity and at high transport rates.30,41 In addition to membrane proteins relatively small 
molecular weight amphiphilic molecules, such as steroles (i.e. cholesterol) enhance 
membrane tensile strength and maintain membrane fluidity.43 Once self-assembled, cellular 
membranes represent a dynamic mosaic of molecules where membrane proteins and lipids 
can diffuse freely in the two-dimensional space. The wide range of components found in 
eukaryotic and prokaryotic membranes, makes creating artificial membrane systems a great 
challenge. Simplifying membrane composition by narrowing down the components is the 
first step in obtaining a control over the self-assembly of the fundamental architecture of the 
cell mimic. 
 
Lipid-based artificial membranes  
With regard to composition, most cell mimics are composed of phospholipids, as they are 
readily available, well characterized and represent membranes that closely imitate the 
composition of the natural plasma membrane of cells. Phospholipids are abundant molecules 
in all biological membranes and at first seem to be the most suitable building blocks for the 
construction of membrane-based cell mimics. By definition, phospholipids are built of four 
components: a.) fatty acids (i.e. C18, C16, C12), b.) a platform to which the fatty acids are 
attached (i.e. glycerol or sphingosine), c.) a phosphate, and d.) an alcohol attached to the 
phosphate (i.e. serine, choline, ethanolamine).44 This flexibility in phospholipid composition 
already gives us an idea into the variety of phospholipids that can exist by varying the 
different sub components of a phospholipid. In aqueous environments phospholipids can 
form many kinds of assemblies, such as micelles, vesicles and hexagonal phases, which are a 
result of the molecular conformations the phospholipids adopt (Figure 3).44 The molecular 
shapes are a result of the individual phospholipid components. For example, non-bilayer 
forming lipids, such as the unsaturated phosphatidylethanolamine (PE) can be stabilized in a 
bilayer forming structure by the presence of a bilayer preferring lipid, such as 
phosphatidylserine (PS). A rule of thumb is that 20-50% of bilayer preferring lipids are 
required to maintain a stable bilayer. Further, the structural properties of lipid mixtures can 
be modulated by a range of parameters, like head group size, temperature, hydrocarbon 
saturation, ionic strength, pH or even the presence of divalent cations (i.e. Ca2+).44 
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Figure 3. Polymorphic phases and corresponding dynamic molecular shapes of component 
phosphoplipids. Modified from Li et al. with permission.44 
 
Ideally, by observing the composition of the plasma membrane – composed mainly of 
phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylinositol (PI) 
phosphatidylserine (PS), sphingomyeline (SM) and steroles (i.e. cholesterol) – a formulation 
could be achieved in a laboratory environment, which would mimic the natural plasma 
membrane.30  
Intuitively, phospholipids should represent an ideal platform for the reconstitution of 
membrane proteins45, as the composition of the cell mimic membrane can be achieved close 
to that of cell membrane and various parameters of the membrane changed on demand by 
changing the lipid composition. The power to methodically change membrane lipid 
composition of the cell mimics has allowed researchers to study the effects of geometric 
membrane curvature on protein binding, activity, and function46,47, in addition to protein-
induced membrane deformation that is implicated in trafficking48 and lipid and protein 
distribution.49  
An important factor to consider when working with lipid-based artificial cell mimics is that 
amphiphilic molecules (i.e detergents) used in membrane protein isolation and purification 
might influence the GUV self-assembly. The task of membrane protein reconstitution is not 
trivial, as amphiphiles stabilizing membrane proteins outside their native environment 
heavily influence the self-assembly of the lipid bilayer.45 Despite the recent advances, using 
lipid-based membranes to form artificial cell mimics comes with various disadvantages, such 
as a relatively high membrane permeability and low stability, which are both a direct result of 
the fluidity of the phospholipid bilayer.  
 
Polymer-based artificial membranes  
Amphiphilic block copolymers represent an alternative to lipids as building blocks for 
generating artificial cellular membranes. Due to their synthetic and rationally designed origin, 
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amphiphilic block copolymers offer a new dimension of bioinspired supramolecular 
assemblies. The large variety of chemical structures found in synthetic copolymers allows 
formation of membranes with tailored properties, which have several advantages over those 
of liposomes, especially in their mechanical and chemical stability.  
The essential building blocks of synthetic membranes - synthetic polymers - most commonly 
categorized into homopolymers, copolymers and polyelectrolytes and can be obtained in a 
laboratory environment via different polymerization procedures.50 Polyelectrolytes are a 
special group of polymers that present characteristic charged functional groups, which leads 
to the assembly of structures based on the opposite charges of the polyelectrolyte multilayers, 
however these are beyond the scope of this thesis.51 As the name implies, homopolymers are 
composed of repeating units of relatively low molecular weight monomers connected by 
covalent bonds. Block-copolymers are composed of two, three or more different blocks of 
covalently linked homopolymers. Once homopolymeric blocks are synthetized, two, three or 
more different homopolymeric blocks are linked together in a final step in order to yield the 
desired block-copolymer. Amphiphilicity is an essential consideration when designing a 
membrane forming polymer. In this respect, the amphiphilic properties of the final polymer 
chain are the result of different hydrophilic and hydrophobic ratio of individual types of 
homopolymeric blocks composing the polymer. During self-assembly the amphiphilic 
properties of the block-copolymers alongside with the respective lengths of polymer chains 
and the method used in preparation of nanoarchitectures determine if the polymer will form a 
membrane. The molecular properties of individual blocks as well as of the entire copolymer 
chain, such as the specific molar mass and polydispersity, lead to the formation of various 
self-assembled structures in water, including spherical, cylindrical, gyroidal and lamellar 
structures.52–54 The resulting morphology of self-assembling structures in solutions is dictated 
by the relative fraction of hydrophobic and hydrophilic block volumes, whereas the thickness 
of the membrane is controlled by the overall molecular weight of the amphiphilic block 
copolymer. In order to favor formation of spherical structures, called polymer nano-sized 
vesicles (polymersomes) or GUVs (Figure 4.), the hydrophilic to whole mass balance (f-
value), the packing parameter (p = v/a0lc), and the polydispersity index (PDI) of the 
amphiphilic block-copolymer are essential parameters, which determine how the self-
assembly process will take place (v = volume of hydrophobic part, a0 = contact area of head 
group, lc = length of hydrophobic part).55,56. f-ratios in a range of 25 - 45% and p parameters 
between 0.5 and 1 and a PDI around 1 favor formation of hollow sphere vesicles (Figure 4). 
The chemical nature of the amphiphilic copolymers plays an essential role in providing the 
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artificial membrane with properties that are conducive to the integration of functional 
biomolecules. The most commonly used amphiphilic block copolymers consist of hydrophilic 
blocks such as poly(acrylic acid) (PAA), poly(ethylene oxide) (PEO), poly(ethylene glycol) 
(PEG), poly(2-methyl-2-oxazoline) (PMOXA), or poly[L-isocyanoalanine(2-thiophen-3-yl-
ethyl)amide] (PIAT), in combination with a hydrophobic block, such as polystyrene (poly(1-
phenylene-1,2-diyl), polybutadiene (PB; buta-1,3-diene), or poly(dimethylsiloxane) 
(PDMS).57–59  
 
Figure 4. Polymersome formation and membrane properties. A) Polymersome formation 
from a rehydrated thin polymer film. B) Schematic representation of membrane properties 
versus amphiphile molecular weight of polymers and lipids. Adapted from Discher et al. with 
permission.56 
 
General preparation methods of GUVs 
Vesicular structures of sizes up to 1 µm self-assembled from amphiphilic phospholipids or 
polymers are termed liposomes or polymersomes, whereas larger cell-sized structures are 
termed giant unilamellar vesicles (GUVs). Because the architecture of supramolecular 
assemblies varies significantly with the method of formation, appropriate procedures need to 
be selected in order to obtain the desired structure. There are several different methods for the 
preparation of lipid or polymer-based GUVs (Figure 5).60  
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Figure 5. Commonly used lipid GUV formation methods. 1a. Hydration of a dried thin lipid 
film deposited on a surface, or (1b) hydration in the presence of an electric field 
(electroformation), 2. Conversion of a lipid-stabilized water in oil double emulsion or a 
surfactant-stabilized water in oil emulsion into giant vesicles, 3. Transformation of a lipid-
stabilized water/oil/water double emulsion into giant vesicles. 4. Fusion of smaller, nano-
sized liposomes into larger GUVs, 5. Jet blowing onto a planar lipid bilayer kept between 
separate aqueous solutions, 6. Mixing lipids in an organic solvent into water, 7. Micelle 
formation method, 8. Bilayer forming lipids that are present in a w/o two phase system. 
(Figure x). Figure and text adapted from Peter Walde et al. Chem Bio chem.60  
 
Here, the aim is to provide a general overview of the different GUV formation techniques. 
The conventional procedures for the formation of lipid GUVs can be easily adapted to 
polymer GUV formation. Although many of the methods for polymer GUV formation 
resemble those used for the preparation lipid GUVs, they need to be carefully adapted for 
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each amphiphilic block copolymer, as the thermodynamic self-assembly of polymers differs 
to that of lipids. Depending on the procedure and the amphiphiles (lipids / polymers), it is 
possible to obtain micrometer-sized GUVs that encapsulate small volumes of about ten 
picoliters.55,61,62 Among other methods GUVs can be formed by the conversion of a lipid-
stabilized water in oil double emulsion or a surfactant-stabilized water in oil emulsion into 
GUVs. More recently, microfluidic double emulsions have proven to be versatile for 
generating highly monodisperse GUVs.63,64 Another emulsion-based technique is the 
transformation of a lipid-stabilized water/oil/water double emulsion into GUVs. Further, it is 
possible to fuse smaller nano-sized vesicles (liposomes / polymersomes) into larger GUVs.60  
A more straightforward approach is mixing lipids/polymers dissolved in an organic solvent 
into water and finally by assembly of amphiphile-based micelles into GUVs, when the co-
solvent or solvent is removed or diluted.65  
However, the two most widely used techniques that result in GUV formation involve 
swelling of the amphiphilic film in an electrical field (electroformation) or spontaneous 
swelling (film hydration). In the electroformation approach, dry polymer films (such as 
PMOXA–PDMS diblock copolymer and PMOXA–PDMS–PMOXA triblock copolymer 
films) deposited on conductive indium tin oxide glass slides form GUVs when rehydrated 
with 300 mM sucrose solution in an alternating sine-wave current.66,67 If charged amphiphiles 
are used this method is not favorable due to the electrostatic interactions. A more suitable 
technique to circumvent this problem is film rehydration, where the amphiphile is first 
dissolved in an organic solvent, which is subsequently removed by using a rotary evaporator 
or high vacuum pump to yield a dry thin polymer film. Rehydration takes place by adding an 
aqueous solution to the dried film that leads to the detachment of the film from the substrate. 
Because self-assembly does not have a strong size selection regarding GUV radius, a mixture 
of GUVs in the size range from 1 to 40 µm is formed. 
Based on their size, GUVs closely reflect cellular membrane properties and behavior, 
particularly with respect to membrane curvature. Similar to lipid-based GUVs, block 
copolymer GUVs are well suited for characterizing the mechanical and rheological properties 
of single- or multi-component membranes, as well as for investigating bilayer interactions. 
They are also easily visible under an optical microscope, and offer the possibility of directly 
visualizing certain interactions of encapsulated solutes and/or structures in real-time. Hybrid 
phospholipid/block copolymer vesicles,67,68 in which the polymeric membrane is blended 
with phospholipids, combine the robustness and chemical versatility of polymersomes with 
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the softness and biocompatibility of liposomes. Such structures can be conveniently 
characterized by preparing hybrid GUVs.69  
 
Cell-derived architectures  
Maybe the most innovative option in constructing an artificial cell mimic is exploiting nature 
itself to build the cell mimic. Cell-derived vesicles (CVs) are lipid-based hollow sphere 
structures, shed by cells under both physiological and pathological circumstances. CVs can 
also be referred to as natural liposomes, consisting of a bilayer membrane that is derived 
directly from the cell. In this respect, various different kinds of CVs exist and range from 
nanometer-sized exosomes - derived from endosomal membranes of donor cells, and larger 
micrometer-sized giant plasma membrane vesicles (GPMVs) – derived from the plasma 
membrane cells.70  
GPMVs present a particularly interesting platform, whose potential has surprisingly been left 
predominantly untouched.71,71 These cell-derived micro vesicles can be produced and isolated 
in high quantities by chemical, salt or laser treatment of donor cells71–73 and are formed by a 
local delamination of the plasma membrane from the underlying cytoskeleton, which leads to 
filling of the expanding area within the GPMV via a passive flow of  the cytoplasm74 (Figure 
6).  
 
Figure 6. GPMV visualization. (a,b) GPMVs are visualized by bright-field microscopy 
directly after formation (a) or after isolation (b). (c) Fluorescence microscopy allows direct 
visualization of GPMVs after labeling the membranes with a fluorescent amphiphilic dye 
(FAST-DiO). Scale bars, 20 µm. Adapted from Sezgin et al. with permission.74 
 
Hence, both the outer membrane architecture and the inner composition of GPMVs directly 
mirror the composition of the cells from which they originate, but without the larger cellular 
organelles (i.e. nuclei, Golgi apparatus) making them the closest cell-mimic available on the 
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market up-to now.75 Previously these characteristics made GPMVs improved membrane 
models to study the lipid composition of the plasma membrane, the behavior of functional 
membrane proteins within the GPMV membrane, and membrane interaction with external 
compounds.76 Even more recently GPMV applications have been extended from biophysical 
model77,78 to bioinspired drug delivery agents by making use of the host-cell membrane 
functionality.79,80 However, up to date there no reports of studies that take advantage of the 
complexity of the GMPVs membrane and its compartment architecture in order to create 
molecular factories that act as artificial mimics of cells.  
 
Subcompartmentalization within cell mimics  
In biological cells, evolution has developed the system of subcompartmentalization (cellular 
organelles) within individual cells in order to allow specific reactions to take place in a 
spatially defined manner. This is a powerful solution, as many reactions (i.e. protein lysis, 
electron transport) need very specific conditions (i.e. low pH, proton gradient) to take place. 
When designing an artificial cell mimic, this concept has been realized by constructing 
synthetic multicompartmentalized sytems. The most prominent examples were based on 
smaller nano-sized liposomes within a larger lipid-based GUV58, liposomes within a larger 
polymer-based GUV and finally smaller nano-sized polymersomes within a polymer-based 
GUV (Figure 7).  
 
Figure 7. Subcompartmentalization within artificial cells. Smaller polymersome sub-
compartments encapsulate enzymes and diffuse freely within the cavity of a larger polymer 
GUV. Adapted from Peters et al. with permission.16 
 
By applying the principle of multicompartmentalization in vitro an artificial cell mimic is 
created with artificial organelles – successive enzymes of an enzymatic cascade reaction are 
separated within different sub-compartments in a larger polymeric GUV. This facilitates the 
diffusion of reagents and products between the sub-compartments, while confining the 
enzymes to their individual subcompartments. However, for the creation of an artificial cell 
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mimic by multicompartmentalization, every membrane of the different compartments has to 
be selectively permeabilized. This would allow a higher control of the diffusion of substrates 
and products across all involved membranes. To realize this, the knowledge of membrane 
protein reconstitution in artificial membranes is required.   
 
Characterization of cell mimics  
Because of the great variability of structural materials used in the construction of cell mimics 
(amphiphilic block copolymers, lipids or cell-derived materials) careful characterization of 
the system is required with respect to membrane properties, size, structure and functionality. 
Membrane properties, such as permeability, elasticity, and surface charge, are especially 
important parameters in many applications. Several methods are commonly applied to 
characterize vesicular structures (liposomes, polymersomes, lipid/polymer GUVs and 
GPMVs)81,82 including various electron microscopy (EM) techniques, which allow direct 
visual inspection of these structures. In particular, cryo-EM, which avoids the drying and 
staining artifacts associated with conventional transmission or scanning EM, provides 
information on size, morphology, and membrane thickness of the vesicular assemblies.83 
Atomic force microscopy (AFM) measurements reveal mechanical characteristics in addition 
to morphology.84 Light/fluorescence/confocal laser scanning microscopy can be used to 
visualize GUVs and follow their integration in vivo. Fluorescence correlation spectroscopy 
(FCS) can be utilized to analyze fluorescently labeled structures (i.e. lipids, polymers or 
proteins), providing data on lateral diffusion coefficients and molecular organization in GUV 
membranes83, and on the number of antibodies coupled to artificial membranes.85 Due to their 
cell-like size, GUVs can be subjected to flow cytometry analysis and analyzed in terms of 
size and fluorescent properties.86 The whole-cell patch clamp technique also applies to GUVs 
and can be used to measure current and voltage of intact GUVs (Figure 8).87  
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Figure 8. Whole GUV Patch-clamp technique. A) GUV-Attached method: The adhesion 
between the GUV membrane and micropipette inner surface leads to an electrical seal (R> 
1GOhm). B) Whole-GUV method: To access the GUV interior while establishing the 
electrical seal resistance the pipette pressure is adjusted before breaking the membrane 
patch with a voltage pulse. A low molecular weight fluorescent dye (Carboxyfluorescein – 
Green) can enter the GUV from the pipette. The capacitance increases, since the 
micropipette now controls the transmembrane voltage, current and tension of the whole GUV 
membrane. Adapted from Garten et al. with permission.87  
 
Among the diverse scattering methods, static and dynamic light scattering (SLS, DLS) are 
predominantly employed to assess molecular mass and radius of gyration (SLS), and 
hydrodynamic radius and size distribution (DLS) of nano-sized polymersome samples, but 
are not suitable for GUVs, due to their size and subsequent sedimentation behavior. Zeta 
potential measurements provide information about the surface charge of artificial membranes 
under various conditions.88 Artificial cell mimics may be characterized with respect to their 
membrane permeability89–92, or responses to various external stimuli such as temperature, pH, 
redox potential, or the presence of biomolecules (e.g., saccharides, nucleotides).93–96 
Moreover, if endowed with biological functions by the insertion of membrane proteins, 
artificial cell mimics can be characterized by functional assays related to the embedded 
proteins.  
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HYBRID SYSTEMS – ARTIFICIAL CELLS EQUIPPED WITH 
BIOMOLECULES 
In order to increase the functionality of the cell mimic lipid- and polymer-based artificial 
membrane systems have previously combined with numerous different biomolecules 
(proteins, DNA, polysaccharides or their combinations.1,62  
 
Lipid-based biomimics  
Lipid-based systems have previously spearheaded the field of biomolecule equipped artificial 
cells, due to the relative accessibility of lipids to several research groups in the world and 
maybe even more significantly due to the proximity of lipid membranes to biological cell 
membranes. As this thesis focuses primarily on synthetic membranes equipped with 
biomolecules and cell-derived structures, only the most prominent examples of lipid 
structures equipped with biomolecules are presented here. The first report of a functionally 
reconstituted membrane protein in lipid membranes dates back to 1971 where the 
transmembrane ATP-Pi exchange was catalyzed by the mitochondrial proton translocating 
ATPase in artificial lipid membranes.97 Since then established techniques of membrane 
protein reconstitution have been improved and new, more sophisticated methods developed 
(Figure 9).98,99 
 
Figure 9. Schematic representation of the methods used for preparation of proteo-GUVs 
(not to scale). (1a) Spontaneous swelling: Dehydrated or partially dehydrated biological 
membranes, proteoliposomes or lipid/protein solutions are rehydrated. (1b) 
Electroformation: Dehydrated or partially dehydrated biological membranes, 
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proteoliposomes or lipid/protein solutions are rehydrated under the influence of an AC-
electrical field. (2) Peptide-induced fusion: Fusion of preformed GUVs and proteoliposomes 
are induced by a fusion peptide conjugated to the liposomes. (3) Direct (detergent-mediated) 
reconstitution: Purified and detergent solubilized protein is added to preformed GUVs 
prepared from lipids or lipids and detergent. (4) Spontaneous fusion: Preformed GUVs are 
incubated with proteoliposomes. (5) Droplet transfer method: Droplets coated with a lipid 
monolayer are formed and sedimented through a water phase lined with a lipid monolayer, 
resulting in bilayer GUVs. Protein is either added to the intra-vesicular or extra-vesicular 
solution depending on the desired protein orientation. (6) Microfluidic jetting: Two aqueous 
droplets are introduced in an oil-filled custom chamber divided by an acrylic spacer. Lipid 
monolayers form at the oil-water interfaces with protein and lipids deriving from 
proteoliposomes. When the spacer is removed, the monolayers merge into a planar lipid 
bilayer from which GUVs are blown using the nozzle of an ink-jet printer. Text and figure 
adapted from Jørgensen et al. with permission.99 
 
For the incorporation of transmembrane proteins in GUVs, main methods involve the 
assembly of GUVs from a dried film of lipid and proteins by spontaneous swelling or by 
electroformation.98 For this technique to work, relatively “robust” proteins are required that 
retain function and structure after drying. Further only membrane proteins, which do not need 
a specific orientation can be applied, because during the self-assembly process of GUVs the 
protein orientation is lost and likely symmetrical.   
A very promising approach towards the design of cell membrane mimics was shown by the 
direct incorporation of solubilized membrane proteins in preformed GUVs. GUVs containing 
complex, biologically relevant internal solutions are formed in the presence of a 
subsolubilizing concentration of detergent. Next, membrane proteins can be unidirectionally 
inserted in these GUVs, followed by the detergent removal step.100 Despite the higher success 
rates of the incorporation of proteins by this technique, there is the disadvantage that some of 
the proteins aggregate during the reconstitution process due to the low amount of detergent or 
more critically that the detergent molecules used in the reconstitution effect the GUV 
architecture. 
Applying the latest mentioned technique allowed the development of lipid GUVs with the 
reconstituted membrane protein bacteriorhodopsin (BR), a light-induced proton pump that 
produces a transmembrane-stable and light-switchable electrochemical gradient of 
protons.112,113 To visualize the functionality of BR, lipid GUVs with an encapsulated pH-
responsive dye (pyranine) were produced. After the incubation with fluorescently red-labeled 
BR micelles, the detergent was removed. The internal pH variation due to the proton transfer 
25 
FUNCTIONAL BIOMIMETIC DESIGN OF GIANT UNILAMELLAR VESICLES (GUVS) 
across the lipid membrane could be measured with the help of the pH sensitive pyranine dye 
(Figure 10).100  
 
Figure 10. Direct incorporation of solubilized transmembrane proteins in GUVs. 
Reconstitution of red-labeled bacteriorhodospin, a photoactivable proton pump, in DOTM 
destabilized EPC–EPA GUVs. (A and B) After detergent removal, light-induced proton 
pumping induces an internal acidification of GUVs. (C) Normalized pyranine fluorescence 
intensity and variance in the presence (black columns, n = 350) and in the absence (gray 
columns, n = 440) of valinomycin. (D) Schematic representation of the reconstitution of 
FhuA, a T5 phage receptor, in red-labeled EPC GUVs encapsulating YOPRO-1, a green 
fluorescent DNA probe. (E) After binding of T5 phage to FhuA, DNA is injected inside GUVs  
(Scale bars: 10 μm). Text and figure adapted from Dezi et al. with permission.100 
  
A more complex reconstitution example was shown with the Escherichia coli outer 
membrane protein FhuA. This receptor was functionally reconstituted into lipid GUVs even 
though there are several partners needed for the functional assay. Starting with the 
encapsulation of a green fluorescent probe, with enhanced fluorescence after binding to 
DNA, into lipid GUVs, followed with the incorporation of FhuA into the membrane, 
followed by the incubation with T5 phage, a large increase of the green fluorescence inside 
the cavity of GUVs could be observed. This proved the functional reconstitution with a 
defined orientation.100 
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Another strategy for the reconstitution of transmembrane proteins in GUVs was achieved by 
fusion of native membranes or proteoliposomes with lipid GUVs.100 This detergent-mediated 
fusion resulted in GUVs with incorporated membrane proteins (Figure 11). Interestingly the 
orientation of the membrane proteins reconstituted in the membrane of GUVs stays the same 
as in the native vesicles.101  
 
Figure 11. Incorporation of transmembrane proteins by fusion of native membranes with 
GUVs. Fusion of green-labeled inverted inner vesicles (IMVs) of E. coli containing 
overexpressed BmrC/BmrD, a multidrug resistance transporter to nonlabeled EPC–EPA 
GUVs in the absence (A) or the presence (B) of 300 μM Triton X-100. (C) Fusion of green-
labeled chromatophores to DOPC/DOPE GUVs containing Tx-red–labeled lipid. (D) Fusion 
of proteoliposomes containing red-labeled bacteriorhodopsin to unlabeled DOPC/DOPE 
GUVs in the presence of 300 μM Triton Xk00. (E and F) Fusion of green E. coli IMVs to red-
labeled GUVs containing lipid domains of DOPC/sphingomyelin/cholesterol, in the absence 
(E) or in the presence (F) of 300 μM Triton X-100 (Scale bars: 10 μm). Text and figure 
adapted from Dezi et al. with permission.100 
 
To prove the functionality of membrane proteins, which are reconstituted via this fusion 
technique, the bacterial heterodimetic ATP-binding cassette efflux transporter BmrC/BmrD 
was incorporated into membranes of GUVs after DNA was encapsulated in their cavities. 
The addition of ATP to the external solution induced the transport of ethidium bromide to the 
inner cavity of the GUVs, where it could bind to DNA resulting in an enhancement of its 
fluorescence (Figure 12).100  
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Figure 12. Drug transport by BmrC/BmrD, a bacterial ABC transporter in GUVs. 
EPC/EPA GUVs are grown encapsulating DNA before incorporation of BmrC/BmrD by 
fusion of green E. coli IMVs. Addition of ATP induces the translocation of ethidium bromide 
(EtBr) and its binding to DNA induces an enhancement of its fluorescence. The transport is 
inhibited by addition of orthovanadate (Vi), a specific inhibitor of BmrC/BmrD (Scale bars: 
10 μm). Text and figure adapted from Dezi et al. with permission.97 
 
Recent advances have lead towards GUV systems with complex lipid compositions and 
controlled lipid asymmetries that enabled detailed studies of membrane protein structure and 
function in cell-like model membranes.102 
The final example presented in the chapter of functional membrane protein reconstitution into 
GUVs deals with the ATP synthase (F1F0-ATPase), which is a rotating transmembrane 
protein complex. Reconstituted into lipid GUVs, it synthesizes ATP through proton-pumping 
activity across the lipid membrane. The proton outward translocation through F1F0-ATPases 
could be visualized by encapsulating a pH-sensitive fluorophore (pyranine) within the GUVs, 
which allows a change of pH to be detected as a change in fluorescence signal. Therefore, the 
insight of the GUV cavities shows an increased fluorescence when proton pumping takes 
place (Figure 13).103  
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Figure 13. Reconstitution of the E. coli F1F0-ATPase in GUVs. A) Schematic cartoon of 
F1F0-ATPase reconstitution into giant vesicles (Left). ATP synthesis is triggered on 
valinomycin incubation that creates a membrane potential, positive in the lumen of the 
vesicle. Proton outward translocation through F1F0-ATPases is monitored by the pH-
sensitive fluorophore pyranine (green). The lipid bilayer was doped with 0.5% mol RhPE 
(orange dye). B) Proton efflux kinetics of E. coli GUVs on valinomycin incubation as 
observed under fluorescence microcopy, in the presence (Top) and in the absence (Bottom) of 
F1F0-ATPases (Scale bar: 10 microns). Text and figure adapted from Almendo-Vedia et al. 
with permission.103 
 
In addition, it was obtained that ATP synthase rotates at a frequency of about 20 Hz. The 
rotation of F1F0-ATPase promotes fluctuations at certain parts of the GUV membranes. This 
phenomena was observed as a reduction in the bending stiffness and the associated lowering 
of its surface tension of the GUV membrane, establishing that there is a direct link between 
microscopy protein activity, supramolecular organization, and macroscopic mechanics of the 
GUV membrane.  
All these examples of the shown methods for the reconstitution of membrane proteins into 
the membranes of lipid GUVs should apply to a wide variety of membrane or peripheral 
proteins for producing more complex biomimetic GUVs.  
 
Polymer-based biomimics  
Using synthetic polymer membranes as a platform for the incorporation of biomolecular 
gateways has gained considerable interest since the first polymersomes were published in 
2000.104 Selective permeability of artificial membranes, most importantly the exchange of 
energy, solutes and molecules across the membrane, is a prerequisite for many technological, 
bioengineering, and biomedical applications. Although by themselves, polymer membranes 
exhibit lower permeability compared to lipid membranes, it is possible to modify molecule 
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transport through them by choosing appropriate polymers that favor porous membrane 
formation, or by chemical modification of the artificial membranes to induce pore formation. 
More significantly, functional insertion of ion-channels, transporters and pore-forming 
peptides and membrane proteins into synthetic polymer membranes presents a biomimetic 
strategy for membrane permeabilization.66  
Even though, numerous protein reconstitutions have been successfully implemented with 
lipid membranes of GUVs, these methods are not readily applicable to synthetic copolymer 
membranes. A reason for this is the different physicochemical properties of polymer 
membranes, such as flexibility and fluidity, strongly affect membrane-protein-detergent 
interactions.34,55 Polymer GUVs are more sensitive towards disruption by detergents used in 
membrane protein reconstitution methods. In addition, a key parameter for protein 
functionality is the lateral mobility within membranes, which largely depends on the 
flexibility and fluidity of the membrane.105 
Further, compared to lipid membranes, synthetic polymer membranes have a much higher 
molecular mass and therefore a considerably thicker membrane, which results in a mismatch 
in length between the hydrophobic domain of the copolymer membrane and the membrane-
spanning hydrophobic domain of the biomolecule.  
Smaller nano-sized polymersomes are the preferred nano-objects for the development of pilot 
polymer-based bio hybrids because they are significantly more stable than GUVs, due to their 
smaller size and resulting higher surface tension.  
Significant progress in understanding the mechanisms of reconstituting membrane proteins in 
nano-sized polymersome membranes and developing corresponding procedures have been 
reported recently, thus improving the success rate for preparing polymer membranes with 
functional protein entities.106 Nevertheless, optimal reconstitution procedures for GUVs still 
have to be established empirically for each membrane protein and polymer membrane, and 
this is often a painstaking endeavor. A substantial mismatch has been overcome in specific 
conditions of synthetic membranes, resulting in successful insertion of various biopores and 
membranes proteins.  
Interestingly, incorporation of biomolecules can influence the morphology of the synthetic 
supramolecular assembly. For example, increasing the concentration of the water channel 
Aquaporin 0 (Aqp0) leads to a change in morphology from spherical structures to planar 
membranes with PEO-PB or PMOXA-PDMS-PMOXA membranes, which can be 10 times 
thicker than lipid membranes (Figure 14). These functional Aqp0 molecules remained active 
up to a 1:1 protein to polymer ratio where initiation of crystallization was observed.107,108 
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Figure 14. A model illustrating the behavior of Aqp0 in PEO-PB polymer membranes. The 
concentration of Aqp0 (ABA42) affects the membrane morphology. (A) In the absence of 
ABA42, (B) 15.5 M ABA42, (C) 3.9 M ABA42, (D) 1.3 M ABA42. Increasing the amounts of 
protein in the polymer membrane (left to right) leads to changes in the structure from 
spherical (vesicle) to planar membranes, and ultimately to a crystalline structure. Adapted 
from Kumar et al. with permission.108  
 
In order to understand the molecular factors that affect the mobility of membrane proteins 
within synthetic membranes, the lateral diffusion of both the polymer chains and the 
membrane proteins have been investigated using a small library of diblock and triblock 
copolymer membranes based on PMOXA as hydrophilic block and PDMS as hydrophobic 
block (Figure 15).83,109 A number of fluorescently labeled membrane proteins (AqpZ, OmpF 
and prokaryotic K+ ion channel (KcsA)) were successfully reconstituted in PMOXA-PDMS 
and PMOXA-PDMS-PMOXA GUV membranes, where they exhibited a lateral diffusion 
similar to that of the polymer chains in the membrane, but an order of magnitude slower than 
in lipid membranes.83,109 This study revealed that a significant flexibility of the membrane is 
necessary to overcome the high hydrophobic mismatch between the membrane thickness (9–
13 nm) and the 3.5–5 times smaller proteins (3.3–7.1 nm) to allow successful insertion of 
membrane proteins. Owing to the PDMS flexibility, such synthetic polymer membranes 
provide a fluid environment that can adopt conformational changes in order to incorporate the 
proteins in a functional state.83,110 
Despite the proof that all these membrane proteins (KcsA, AqpZ and OmpF) were 
successfully reconstituted into triblock copolymer membranes of GUVs, the functionality of 
the reconstituted membrane proteins was not addressed in this study. 
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Figure 15. Log − log plots displaying the diffusion coefficient D relative to membrane 
thickness d. Lipids are shown as squares and triblock copolymers as circles. The membranes 
self-assembled from different triblock copolymer have different molecular weights and thus 
different membrane thicknesses. The dashed line represents the power law dependence of the 
diffusion coefficient in relation to the membrane thickness as D ∼ d− 1.25. The zoomed area 
illustrates diffusion coefficients for KcsA (green), AqpZ (red), and OmpF (blue) within the 
three different ABA membranes (ABA34, ABA49, ABA63). Text and figure adapted from Itel 
et al. with permission. 83,109 
 
Functional reconstitution of biomolecules in the membrane of GUVs  
Insertion of biopores into polymer membranes of GUVs induces permeability to specific 
ions/molecules, i.e. renders the GUVs selectively permeable. The first example of a 
PMOXA-PDMS-PMOXA-based GUV (1–2 μm dimensions) membrane that was 
permeabilized for Ca2+ ions was obtained by inserting an unselective ionophore, Lasalocid A, 
and the highly selective ionophore N,N-dicyclohexyl-N′,N″-dioctadecyl-3-oxapentane-1,5-
diamide.90 In addition, the channel forming peptide alamethicin that transports cations and 
anions unselectively was inserted into PMOXA-PDMS-PMOXA membranes of GUVs.90 The 
spontaneous insertion of these three ionophores was achieved by adding the ionophores in 
ethanol to the preformed GUVs, which led to ion carrier-assisted precipitation of calcium 
phosphate inside their cavities. This concept of combining synthetic membranes with natural 
membrane proteins can serve as a new platform for biomimetic mineralization. Calcium 
carbonate precipitation induced within polymer GUVs was triggered by the calcium-selective 
ionophore calcimycin, which induced a calcium influx into carbonate-containing GUVs and 
opened the way towards the development of efficient microreactors.111 However, systems 
based on GUVs in general cannot be used for medical applications because of the size and 
instability of these cell-sized polymer structures. 
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Functional reconstitution of membrane proteins in polymer membranes of 
nm-sized vesicles  
Despite the number of examples of lipid GUVs equipped with membrane proteins, there is no 
study regarding the functionality of a reconstituted membrane protein into polymer GUVs. 
However, it was possible to reconstitute membrane proteins with preserved functionality in 
the polymer membranes of nanometer-sized vesicles. For example the 26 kDa alpha-helical 
model membrane protein bacteriorhodopsin (BR), a light-driven proton pump, that depends 
on a specific orientation for functionality. It generates an electrochemical proton gradient by 
converting the potential energy of incident photons and is usually found in two-dimensional 
crystalline patches known as “purple membrane” (PM). Its functional reconstitution into 
PEtOz-b-PDMS-b-PEtOz (PEtOz, poly(2-ethyl-2-oxazoline) polymersome membranes, 
allowing transmembrane proton pumping, has been achieved during the polymer membrane 
self-assembly step.112,113 The simultaneous embedding of BR and F0F1-ATP synthase has 
been proposed to convert photon energy to chemical energy in response to external 
illumination.112 In a cascade of orchestrated reaction steps, BR generates a pH gradient across 
the membrane, and together with the molecular motor protein F0F1-ATP synthase, this 
proton gradient is used to drive the conversion of ADP and inorganic phosphate into ATP 
(Figure 16).113 Because of its high photochemical efficiency, thermal stability and cyclicity, 
BR is of great interest for the development of bioelectronics devices, such as photonic 
materials in optical memories, drug delivery, biocatalytic reactors, fuel cells, and 
nanomachines.114 
 
 
Figure 16. (A) Schematic representation of bacteriorhodopsin (BR) and F0F1-ATP synthase 
reconstituted in a proteopolymersome. (B) Photoresponsive behavior of BR-ATP synthase-
proteopolymersomes: pH change during and after illumination. Adapted from Choi et al. 
with permission.113 
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This example shows that in general the functional membrane protein reconstitution in 
polymer membranes can be realized. Even further, it was possible to create small 
nanoreactors, meaning membrane protein equipped polymersomes with ecapsulated enzymes. 
Substrates can enter their cavities, react with the enzyme and the product converted by the 
enzyme can be released afterwards.  
This concept was realized by building a tuneable catalytic compartment space, developed by 
the encapsulation of horseradish peroxidase (HRP) in PMOXA-PDMS-PMOXA 
polymersomes with a membrane containing a pore (OmpF) that was chemically modified 
with a pH-responsive molecular cap. Opening the OmpF “gate” by a change in pH led to the 
influx of Amplex UltraRed and induced peroxidase activity (Figure 17).115 Catalytic 
compartment spaces with trigger-based activity represent ideal candidates when a specific 
step in the flow of an artificial cell requires a reaction activated “on demand”, i.e. by the 
presence of a specific stimulus. 
 
 
Figure 17. A) Concept of a catalytic compartment space with activity triggered by a 
chemically engineered protein “gate” inserted in the synthetic membrane of a polymersome. 
A change in pH induces the release of the sensitive molecular cap (red dots) from the protein 
“gate”, allowing substrates (green dots) to enter, and the products of the enzymatic reaction 
(yellow dots) to be released. B) Substrate Amplex UltraRed conversion kinetics of catalytic 
compartment spaces equipped with different OmpFs: OmpF blocked with a pH-responsive 
molecular cap (blue), OmpF with pH-responsive molecular cap released (grey), Ompf-WT 
(black), and unpermeabilized catalytic compartment spaces (orange) at pH 5.5, at time 0 (a) 
and after 1 h (b). Text and figure adapted from Einfalt et al. with permission.115 
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GAP IN KNOWLEDGE 
The possibility to use GUVs with functional reconstituted membrane proteins as cell-mimics 
appears as a realizable vision considering the state of the art for reconstitution of membrane 
proteins into nano-sized polymer vesicles. Previous research demonstrated that the mismatch 
between the thick polymer membrane (di- or triblock) and the small membrane proteins, can 
be overcome if the polymer membrane has a high flexibility and fluidity. The latter allows 
entanglement, integration and protection of the membrane proteins within the synthetic 
membrane, while at the same time stretching and compressing in the area of a small 
biomolecule to preserve its active conformation should be possible. Unfortunately, 
reconstitution methods for membrane proteins used for polymer vesicles in the nanometer 
range (polymersomes) are not easy adapted to polymer GUVs, even if the same polymer is 
used. A reason for this are the GUV formation techniques. Whereas polymersome 
membranes can be stirred, disrupted, reassembled and further purified with the help of 
dialysis and filtration, these techniques are limited in the case of GUVs. The major cause for 
this is that their membrane thickness versus their total size ratio (keep in mind by using the 
same polymer the membrane thickness is not changing, only the size of the total compartment 
and therefore the inner cavity). This is also the reason why smaller compartments are always 
more stable than bigger ones and stirring (applying mechanical stress) rapidly decreases the 
amount of GUVs in solution. 
Another reason which makes the work with GUVs more complicated is that several 
measurements or treatments are not useful at all as for example extrusion to get a 
homogeneous size distribution, which is quite often used in the case of polymersomes, it 
would not make sense to use this technique for GUVs. GUVs with homogeneous sizes can 
only be achieved with the microfluidic technique for GUV formation, which is a very new 
and not so well-established method. Regarding purification methods, techniques that allow 
the separation of nano-sized polymersomes from GUVs are scarce and rudimental. Therefore, 
measurements and techniques used for cells are more useful when working with GUVs, due 
to the comparable sizes and morphologies of GUVs to cells. This brings us back to lipid 
GUVs, where a lot of membrane proteins could be functionally reconstituted into their 
membranes - the measurement techniques used in lipid GUV characterization can be directly 
applied on polymer GUVs. However, the lipid membranes are orders of magnitude thinner 
and more robust against detergents, used in membrane protein reconstitution, than 
membranes of polymer GUVs. Approaches of membrane protein reconstitution cannot be 
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easily adapted for polymer GUVs. Nevertheless, by combining the knowledge of membrane 
protein reconstitution into membranes of both, lipid GUVs and nanometer-sized 
polymersomes, the design of polymer GUVs with functional reconstituted membrane proteins 
or biopores may/could be realized. Finally, cell-derived giant plasma membrane vesicles 
(GPMVs) are promising candidates towards the design of artificial cells due to their native 
cell membrane and the cell plasma inside their cavities. By modifying membranes of GPMVs 
by genetic modification of donor cells we can equip them with specific functional membrane 
proteins and at the same time encapsulate functional nano-sized compartments (i.e. 
membrane protein equipped polymersomes with encapsulated enzymes) inside their cavities 
the design of the closest cell mimic up to now may/could be created.  
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AIM OF THE THESIS  
 
The aim of this thesis is to advance the state of the art in development of cell mimics, with 
the focus on designing giant unilamellar vesicles (GUVs and GPMVs) with inserted 
functional biomolecules or membrane proteins used as a platform to get a deeper insight into 
biological processes. Due to their size in the micrometer range, which corresponds to the size 
of native cells, GUVs have the unique advantage that they can be visualized and analyzed by 
microscopy techniques thereby allowing insight into compartmentalized processes in real-
time. Besides GUVs formed out of synthetic lipids there are only a few examples/studies 
done in the direction towards using synthetic polymer GUVs with reconstituted biomolecules 
inside their synthetic membrane. In Nature, biomolecules (transmembrane proteins, pores, 
etc.) are well adapted for the native cell membranes in which they are present with preserved 
functionality. An environment, which is only slightly different from the biological one can 
lead to the denaturation of the biomolecule or the disruption of the environment into which 
the biomolecule is inserted. This makes the insertion of biomolecules into artificial 
membranes so difficult. Nevertheless, a great scientific interest remains, as especially 
membrane proteins play a crucial role in fundamental cell processes, which are up to now 
unknown. However, there are many unanswered questions in this research field like: How do 
biomolecules (enzymes, proteins, substrates) behave inside confined compartments with sizes 
that mimic cells? Is there any interaction between encapsulated compounds and compartment 
membranes? Do encapsulated compounds diffuse freely inside the cavities, or are they 
attached to the membrane? If so, does this possible interaction affect the activity and stability 
of the encapsulated compounds? Development of advanced functional compartments requires 
detailed responses to such questions in order to understand the complexity and specificity of 
natural bio-compartments. These questions are addressed in this work by using cell-sized 
GUVs for the visualization of interactions and diffusion behavior of encapsulated 
compounds, further membrane interactions in real-time with the help of microscopy 
techniques. Therefore pores and membrane proteins are inserted into the membranes of 
polymer GUVs to visualize their functionalities. In addition cell-derived micrometer-sized 
giant plasma membrane vesicles (GPMVs) present a particularly interesting platform, 
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because both the outer compartment architecture of GPMVs (membrane) and the inner 
composition of GPMVs directly mirror the composition of cells from which they originate, 
but without the larger organelles like for example nuclei and Golgi apparatus making 
measurements easier and the closest cell mimic available up to now. By using these GPMVs, 
a strategy for creating the first bioinspired molecular factory with functionality as cell mimic 
is introduced and executed. 
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SYNTHETIC GUVS WITH ENGINEERED PROTON 
SELECTIVE PERMEABILITY AS STIMULI-
RESPONSIVE COMPARTMENTS 
 
Following a biomimetic approach, we present here in this first chapter synthetic giant 
unilamellar vesicles (GUVs) with proton selective permeability, achieved by inserting 
gramicidin (gA) biopores in their polymer membrane. Encapsulation of a pH-sensitive dye 
inside the cavity of GUVs was used to assess the proper insertion and functionality of gA 
inside the synthetic membrane. Confocal laser scanning microscopy (CLSM) was used to 
show that neither the size, nor the morphology of the GUVs was affected by successful 
insertion of gA. Interestingly, proper insertion and functionality of gA were demonstrated for 
membranes with thicknesses in the range 9.2–12.1 nm, which are significantly greater than 
membrane lipid counterparts. GUVs with inserted gA exhibited efficient time response to pH-
changes and therefore are ideal candidates for designing bioreactors or biosensors for a 
variety of applications in which changes in the environment, such as variations of ionic 
concentration or pH, are required. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This study has been published: Mihai Lomora, Martina Garni, Fabian Itel, Pascal Tanner, Mariana Spulber, 
Cornelia G. Palivan*. Polymersomes with engineered ion-selective permeability as stimuli-responsive 
nanocompartments with preserved architecture, Biomaterials, (2015), Volume 53, pages 406-414. 
DOI: 10.1016/j.biomaterials.2015.02.080 
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MOTIVATION AND PROBLEM DEFINITION  
Compartmentalization is crucial for biological systems as it allows spatial localization of 
molecules within defined spaces. Furthermore an eukaryotic cell has the majority of its 
volume retained by intracellular membranes in discrete compartments known as cell-
organelles, an essential feature for cellular metabolism.38 Compartmentalization through 
confinement of compounds can be achieved using nanoscale and microscale synthetic 
structures. These have previously been used to transport sensitive molecules in conventional 
drug delivery approaches93,116, function as nanoreactors117, biosensors118, or artificial 
organelles119. Synthetic nanocompartment spaces with encapsulated catalytically active 
compounds (i.e. enzymes) in their inner cavities have been shown to increase efficacy of 
polymerization reactions120  and catalysis121,122 offer protected space for consecutive 
enzymatic reactions16, serve as source of reactive oxygen species, or provide twofold 
functionality (oxygen storage and detoxification of peroxinitrites)117. Polymeric vesicles 
(polymersomes, polymer giant unilamellar vesicles) have spearheaded the field of artificial 
compartmentalization and have found numerous applications in different scientific fields, 
because they are more robust and versatile than their lipid analogs.123 An additional 
advantage of polymeric vesicles is the possibility to regulate their properties (size, 
morphology) by changing the polymer composition, functionalizing the polymer end groups 
for targeting approaches, or introducing stimuli-responsiveness. Especially GUVs are very 
appealing platforms for the construction of rudimental cell mimics due to their micrometer 
sizes, which allow us to visualize them by microscopy techniques. Therefore, they are a 
useful platform to get a deeper insight into biological processes in real-time.  
As described in the introduction of this thesis, most of the advances in designing custom-
made polymer vesicles have been made on assemblies in the nanometer ranges, due to their 
relatively high stability when compared to microscale systems. Among others, these have 
been designed to respond to specific stimuli, such as pH124, temperature, light125, enzyme16,126 
or a combination of thereof127,128. Responsive polymeric assemblies can be created by 
numerous approaches: (i) selection of responsive homopolymers, (ii) selection of copolymers 
with stimulus-responsive blocks (for example polydimethylaminoethyl methacrylate 
PDMAEMA129), and (iii) use of responsive groups on the main chain, on side chains of 
polymers, or as linkers between different blocks.130–132 For example, responsiveness of 
compartments towards pH-changes, because a pH-change is an essential signaling factor 
accompanying pathological conditions.133 pH-responsive assemblies have been designed by 
40 
SYNTHETIC GUVS WITH ENGINEERED PROTON SELECTIVE PERMEABILITY AS 
STIMULI-RESPONSIVE COMPARTMENTS 
using a pH-responsive polymer, such as PDMAEMA129  or 4-vinylbenzyl)-pentane-1,5-
diamine dihydrochloride (VBPDA)133, and introducing amino acids (histidine)134 or carboxyl 
groups in the polymer main- or side chains.128 Most of pH-responsive 3D polymer assemblies 
are aimed to dissociate or degrade into polymer chains or small molecules in order to 
discharge their molecular cargo.135–137 Although polymersomes and polymer GUVs have 
lower membrane permeability compared to their lipid counterparts.138,139 There are various 
possible approaches for increasing it, such as: (i) selection of polymers that intrinsically form 
porous membranes for example poly(styrene)-block-polyisocyanoalanine(2-thiophene-3-yl-
ethyl)amide118 or boronic acid-based block copolymers140, (ii) chemical modification of the 
membrane with a hydroxyalkylphenone141 and (iii) insertion of channel proteins.57,104,139 
There are only rare examples of pH-responsive 3D polymer assemblies capable of 
maintaining their structural integrity during their response to stimuli.142,143 Most of them are 
obtained by using a cross-linked homopolymer PDMAEMA but they have lack controlled 
permeability and limited stability.143 
One aspect that needs to be considered is that preservation of the compartment integrity is 
necessary if polymer vesicles are to serve as bioreactors, biosensors or artificial organelles. 
To the best of our knowledge, none of these examples were reported on polymer GUVs with 
selective membrane permeability, where pores could allow an exchange of small molecular 
weight molecules with a defined cut-off depending on the pore size. 
Here we describe the design of GUVs with membranes capable of permitting proton 
exchange without changing their hollow-sphere architecture (Figure 18). Selective 
permeability of GUV membranes was achieved by inserting biopores. We selected as a 
biopore model the bacterial ion channel gramicidin (gA), which allows a controlled passage 
of protons and ions.144 This biopore was selected, due to its simplicity (only 15 amino acids 
in its compositions), and versatility. In previous studies, gA has been well characterized in 
lipid membranes145–148, surfactants mimics of unsaturated lipids149,150, and liposomes150,151, in 
which a successful insertion was favored by a reduced thickness mismatch between gA size 
and the model membranes. However up till now, there is only one report on the insertion of 
gA in synthetic membrane arrays, which gave shallow insight into the influence of the 
membrane thickness, the number of inserted gA pores or their localization inside the 
membrane.152 
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Figure 18. Design of a GUV engineered for proton-selective permeability based on 
gramicidin (gA) biopore insertion. 
In order to study and understand the effect of membrane thickness on the functional insertion 
of the gA pore we have used a library of poly(2-methyloxazoline)-block-
poly(dimethylsiloxane)-block-poly(2-methyloxazoline) (PMOXAx-PDMSy-PMOXAx) 
triblock copolymers, capable of self-assembly into GUVs with membrane thickness ranging 
from 9.2 to 16.2 nm. Depending on the hydrophilic-to-hydrophobic ratio, this type of 
amphiphilic polymer self-assembles in dilute solutions, and generates vesicles with sizes in 
the micrometer range (GUVs), with high mechanical stability and flexibility.104 In previous 
studies, PMOXAx-PDMSy-PMOXAx membranes have been shown to be permeable only to 
reactive oxygen species and oxygen153, whereas presenting high impermeablity to ions, and 
low molecular mass molecules.138,139 Confocal laser scanning microscopy was used to 
analyze the functional insertion of gA in the polymer membrane of GUVs and if its insertion 
affects their architecture and size. GUVs without inserted gA were used for control 
experiments. The encapsulation of a pH-sensitive dye inside the cavities of the GUVs enables 
monitoring proton exchange across the GUV membranes due to the fluorescence intensity 
change as a result of pH.  
Therefore, gA was inserted in individual giant unilamellar vesicles (GUVs), and the change 
of fluorescence intensity of the encapsulated dye was visualized in real-time (gA insertion is 
described in detail in material and methods, chapter 3). The design of GUVs with membranes 
permeable to protons represents a new approach for creating compartments with specific 
responses, whilst preserving their morphology, and therefore the encapsulated active 
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compounds. They represent ideal candidates for developing applications in which specificity 
and responsiveness are key factors, as for example in biosensors.  
 
PROTON OUTFLUX THROUGH SYNTHETIC 
MEMBRANES OF GUVS  
Polymer membranes present characteristic bilayer thicknesses, which are significantly higher 
compared to lipid membranes. This leads to a higher degree of hydrophobic mismatch 
between the polymer membrane and the protein size, as compared to lipid bilayers with 
thicknesses of 3 to 5 nm. Especially for shorter membrane proteins or biopores, their 
incorporation into membranes with increased thicknesses is a challenging task.  
gA which has a length of ≈2.6 nm forms a pore with an inner diameter of 0.4 nm.154 It should 
be tested if gA can be functionally inserted into the membranes of GUVs with thicknesses 
ranging from 9.2 to 16.2 nm which are significantly larger than the biopore. 
A membrane thickness larger than the size of the gA has been reported to be correlated with a 
dimeric stretched active conformation of the biopore with preserved functionality in the case 
of lipid membranes.155 However, as polymer membranes have a significantly larger thickness 
than those formed from lipids, the difference between the polymer membrane and the size of 
the gA channel is large. Therefore, we were interested to see whether gA insertion is affected 
or even blocked as predicted by modeling the insertion of membrane proteins in polymer 
membranes.110  Triblock copolymers resulting in GUVs with membrane thickness between 
9.2 and 16.2 nm were chosen (Table 1). 
 
Table 1. gA reconstitution as a function of membrane thickness. 
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Owing to their large dimensions, we used giant unilamellar vesicles (GUVs) as a tool to 
visualize gA insertion and activity by testing all six triblock copolymers (Table 1). First, we 
verified the GUV membrane integrity by adding Bodipy 633, a fluorescent hydrophobic dye 
known to directly insert into the hydrophobic part of the membrane (Figure 19A, Figure S1). 
Then, a gA labeled with a green fluorophore (gA-OG488) was added to the GUVs (Figure 
19B). The similar fluorescence intensities of both components (Figure 19C) indicate that 
neither the insertion of gA nor the addition of the solvent affects the shape/architecture of the 
GUV membrane. 
 
Figure 19. CLSM images of a giant unilamellar vesicle (GUV) composed of A7B49A7 triblock 
copolymer in the presence of: (A) Bodipy (red), (B) labeled gA-OG488 (green), (C) Overlay 
of A and B (red and green).  
In order to verify the functionality of gA when inserted into GUV membranes, 5(6)-
carboxyfluorescein (CF), a pH-sensitive fluorescent dye with reduced fluorescence intensity 
at low pH, and high fluorescence intensity at high pH, was encapsulated in GUVs. 
GUVs were formed in presence of CF at pH = 5.5 (Figure 20). At this pH the fluorescence of 
the dye is quenched, therefore CLSM micrographs show low fluorescence intensity inside 
GUVs (Figure 20A, inset). It has to be noted that the CF concentration inside the GUVs is 
higher due to dilution of the GUV solution into the LSM observation chamber that is already 
filled with a CF-free buffer (see experimental section). Therefore, at the beginning of the 
experiments, the fluorescent intensity inside the GUVs was always higher than the outside 
solution. In order to prove that GUVs membranes are impermeable to protons, the pH of the 
outer solution was increased from 5.5 by the addition of NaOH. The higher pH increases the 
fluorescent intensity of the background solution significantly, but the fluorescent intensity of 
the inner cavity of the GUVs remained unchanged, indicating that the block copolymer 
membrane does not allow diffusion of protons (Figure 20A, inset). The change of 
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fluorescence intensity outside the cavities of GUVs upon gA insertion was also confirmed by 
plotting the fluorescent intensity over time (Figure 20A). Even after several additions of 
NaOH, no response of the fluorescent intensity inside the GUVs was observed until the 
particular GUV ruptured and released its encapsulated CF, shown as a sudden intensity 
increase (Figure 20A). GUVs tested in presence of pure solvent (DMSO:EtOH (1:1)) were 
observed to have a membrane still impermeable to protons (Figure S2) showing that the 
solvent affects neither the GUV membrane stability nor its permeability properties, which is 
an important fact when performing the experiments with gA. 
 
 
Figure 20. Fluorescent intensity change over time of 5(6)-carboxyfluorescein (CF) inside 
and outside of polymer GUVs (A7B42A7) in absence (A), and in upon insertion of gA (B). 
Insets: representative LSM images showing the principle of blocking the membrane to 
protons (A) and permeability of the membrane to protons by insertion of gA (B). 
Fluorescence intensity inside GUVs (dotted line), and outside GUVs (solid line). 
In contrast, when gA was added to the GUVs solution and the pH was increased, the 
fluorescent intensity inside the GUVs increased immediately after the higher pH reached the 
GUV membrane, shown by the higher fluorescent intensity of the outside solution. The 
increase in the fluorescence intensity inside GUVs clearly indicates permeability of the 
membrane because of a successful insertion and functionality of gA (Figure 20B). 
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INFLUENCE OF POLYMER MEMBRANE 
THICKNESS ON gA INSERTION 
Successful incorporation of gA with preserved functionality was achieved for GUV 
membranes based on A6B34A6, A6B44A6, A7B42A7, and A7B49A7 block copolymers with 
thicknesses ranging from 9.2 to 12.1 nm. These GUVs showed a significant fluorescence 
intensity increase inside their cavities whereas GUVs without incorporated gA showed no 
fluorescence change. The increase in fluorescence indicates that gA is functional 
incorporated into thick polymer membranes and proton outflux across the membrane takes 
place. The preserved functionality for gA inside membranes with thicknesses ranging from 
9.2 to 12.1 nm can be explained by a bilayer compression which exists due to an energetic 
balance between the surface tension at the hydrophobic/hydrophilic interface and the chain 
configurations to match the biopore length. Bilayer compression results in an increase of the 
surface tension energy and a decrease in stretching energy. Protein insertion reduces the 
system free energy compensating for thickness mismatches.110  
A modulation of membrane protein activity has been reported for Complex I when inserted in 
PMOXAx-PDMSy-PMOXAx membranes, the hydrophobic block being the key domain, 
which provided the necessary flexibility to accommodate the significantly smaller size of the 
hydrophobic part of the protein.156  
The functional insertion of gA in GUV membranes of A12B63A12 and A12B87A12 block 
copolymers with thicknesses ≥13.4 nm showed no fluorescent intensity change inside the 
cavity of GUVs (Table 1, Figures S3–S7) meaning there is no outflux of protons across the 
membrane taking place. This leads to the assumption that there is a limit regarding thickness 
mismatch for which the membrane perturbation energy becomes a barrier for protein 
insertion.110 In this case the thickness mismatches between the synthetic membrane and the 
biopore which is higher than 12.1 nm can not be compensated via the bilayer compression 
anymore.  
The successful insertion of other membrane proteins (e.g., OmpF, AqpZ, and Complex I) in 
PMOXAx-PDMSy-PMOXAx GUV membranes can be explained by similar compensation in 
thickness mismatches, whereas in these examples the functionality of the reconstituted 
membrane proteins was not studied .104,156–158 The hydrophobic mismatch of membrane 
proteins/biopores reconstituted into polymer membranes which is significantly higher 
compared to lipid membranes together with the higher mechanical stability of synthetic 
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membranes makes the design of polymer GUVs with equipped membrane proteins/biopores 
quite challenging.  
Nevertheless the insertion of biopores with preserved functionality into polymer membranes 
could be realized by choosing polymers with sufficient intrinsic flexibility regarding the 
hydrophobic domain even when the mismatch between the membrane protein/biopores and 
the thickness of the membrane was more than 3.5 times higher.  
In summary GUVs obtained by electroformation technique, proved successful insertion and 
functionality of gA in block copolymer membranes with thicknesses ≤12 nm. 
 
CONCLUSION 
GUVs with selective membrane permeability by inserting gramicidin biopores, which 
allowed proton transport could be engineered. Whilst there are numerous research studies 
showing the successful incorporation of this biopore into lipid membranes, its insertion 
intointo the membrane of polymer GUVs is more challenging due to the significant mismatch 
between the pore length and the thickness of the polymer membrane (more than 3.5 times). 
By using a small library of PMOXAx-PDMSy-PMOXAx copolymers, which self-assemble 
in giant unilamellar vesicles (GUVs) with membrane thickness ranging from 9.2 to 16.2 nm, 
the conditions in which gA can be inserted and remains functional inside the synthetic 
membrane, whilst preserving the GUV architecture could be analyzed. By the encapsulation 
of a pH-sensitive dye inside the cavities of GUVs proton gradients between the environment 
of GUVs and their inner cavity served to assess the exchange of protons across the membrane 
upon gA insertion. It could be shown that gA was successfully inserted and remained 
functional in polymer GUV membranes with thicknesses in the range of 9.2–12.1 nm. Larger 
thicknesses did not allow gA insertion, and therefore 12.1 nm represents a limit for the 
mismatch between the pore length and the membrane thickness. Our gA-GUVs are therefore 
pH self-regulating compartments, which maintain their integrity in different pH or ion 
gradient conditions. 
Our bio-mimetic approach to insert proton channels with specific selectivity into the polymer 
membranes of GUVs is an elegant strategy towards the development of micrometer-sized cell 
mimics or to design bioreactors in which biopore functionality is combined with preserved 
membrane architecture.   
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LIVE FOLLOW-UP OF ENZYMATIC REACTIONS 
INSIDE THE CAVITIES OF SYNTHETIC GIANT 
UNILAMELLAR VESICLES (GUVS) EQUIPPED WITH 
MEMBRAN PROTEINS MIMICKING CELL 
ARCHITECTURE  
 
Compartmentalization of functional biological units, cells and organelles serves as an 
inspiration for the development of biomimetic materials with unprecedented properties and 
applications in biosensing and medicine.  
Due to the complexity of cells, the design of ideal functional materials remains a challenge. 
An elegant strategy to obtain cell-like compartments as novel materials with bio-functionality 
is the combination of synthetic micrometer-sized giant unilamellar vesicles (GUVs) with 
biomolecules because it enables studying the behavior of biomolecules and processes within 
confined cavities. 
Here in this second chapter, we introduce a functional cell mimetic compartment by inserting 
the model biopore bacterial membrane protein (OmpF) in thick synthetic membranes of an 
artificial GUV compartment that encloses – as a model – the oxidative enzyme horseradish 
peroxidase. In this manner a simple and robust cell mimic is designed: the biopore serves as 
a gate, which allows substrates to enter cavities of the GUVs, where they are converted into 
products by the encapsulated enzyme, and then released in the environments of GUVs. 
Our bio-equipped GUVs facilitate the control of specific catalytic reactions in confined 
micro-scale spaces mimicking cell size and architecture and thus provide a straightforward 
approach serving to obtain deeper insights in the real-time of biological processes inside 
cells.  
 
 
 
 
 
 
 
 
 
 
This study has been published: Martina Garni, Tomaz Einfalt, Roland Goers, Cornelia G. Palivan*, Wolfgang 
Meier*. Live follow-up of enzymatic reactions inside the cavities of synthetic giant unilamellar vesicles (GUVs) 
equipped with membrane proteins mimicking cell architecture, ACS Synthetic Biology, (2018), 7 (9),          
2116-2125. 
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MOTIVATION AND PROBLEM DEFINITION 
Cells, as complex assemblies with highly defined structures based on organelles, and a 
cytoplasm with a variety of biomolecules enclosed by the cellular plasma membrane, serve as 
an inspiration for the development of new functional systems.8 In this respect, the bottom up 
approach to mimic the hierarchical organization and functionality of various cellular 
structures or even of entire cells1 is the focus for producing new functional materials with a 
large variety of applications, such as therapeutics159, catalysis160, biosensing, and surface 
technology.161 Biomimetic materials are created by combining synthetic assemblies with 
active biomolecules or complexes (proteins, enzymes, DNA).162 Self-assembly processes that 
take place in biological systems can be used to obtain biomimetic materials in which the 
biomolecule induces functionality, whilst the supramolecular assemblies (micelles, 
nanoparticles, tubes, liposomes, polymersomes, planar membranes162,163 or micrometer-sized 
giant unilamellar vesicles (GUVs)) serve as stable matrices.164 The development of functional 
biomimetic systems requires an understanding of the various reactions that occur within the 
cellular microenvironment and at cellular interfaces.165,166 In this respect, synthetic 
compartments are very appealing supramolecular assemblies, because their architecture 
offers well defined and protected reaction spaces for encapsulated catalytic compounds 
(enzymes, proteins) similar to the compartmentalization of cells or natural organelles. 
Polymer compartments (polymersomes with nanometer sizes and synthetic GUVs with 
micrometer sizes) self-assembled from amphiphilic block copolymers55,56, have become an 
elegant solution for the development of functional compartments with various advantages 
over lipid compartments (liposomes and lipid GUVs), such as an improved stability, the 
possibility to functionalize their external interface with specific molecular groups, and the 
huge variety of polymers whose chemistry can be tailored to achieve specific properties 
(stimuli-responsiveness, flexibility, crystallinity).56 Polymersomes have been developed for 
various applications, such as conventional drug delivery systems93,116, catalytic nano-
compartments named nanoreactors117, biosensors118, and even artificial organelles that act as 
simple mimics of cellular organelles.119 Interestingly, the study of enzymatic reactions taking 
place inside polymersomes as confined reaction spaces with sizes less than 300 nm indicated 
that in specific conditions it was possible to induce an increase in the bioactivity of 
encapsulated enzymes167, whilst the presence of  crowding agents (i.e. PEG) inside the cavity 
induced a decrease in bio-activity.167 Despite the use of polymersomes in various 
applications, there are still important unanswered questions, such as: How do biomolecules 
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(enzymes, proteins, substrates) behave inside confined compartments with sizes that mimic 
cells? Is there any interaction between encapsulated compounds and compartment 
membranes? Do encapsulated compounds diffuse freely inside the cavities, or are they 
attached to the membrane? If so, does this possible interaction affect the activity and stability 
of the encapsulated compounds? Development of advanced functional compartments requires 
detailed responses to such questions in order to understand the complexity and specificity of 
natural bio-compartments. 
To answer such questions, polymer GUVs can serve as a platform that allows a deeper 
insight into the molecular processes (reactions, interactions) that take place inside confined 
cavities, in their membranes, and at the interface, by real-time visualization using 
microscopic techniques. In comparison to GUVs nano-sized polymersomes can only give an 
indirect insight into membrane protein reconstitution and localization of enzyme reactions. 
GUVs can be measured directly by established microscopic techniques as their sizes match 
cell dimensions, and reactions or interactions can now be visualized. Thus, they represent a 
simple model system for studying the above mentioned processes and interactions in a cell-
like manner. In this respect, polymer GUVs are of particular interest because their higher 
mechanical stability than lipid-based GUVs allows these processes to be studied for longer 
periods of time. Unlike lipid-based GUVs, there are currently only a few examples of 
polymer GUVs being used as functional platforms.18 For example, synthetic GUVs based on 
poly(butadiene)-b-poly(ethylene oxide) (PBut2.5-b-PEO1.3) loaded with hydrophilic dyes, 
liposomes (DPPC) and polymersomes (PBut1.2-b-PEO0.6) allowed a fast selectively 
triggered release due to a light-induced increase in the osmotic pressure, which resulted in 
rupture of the GUVs.168 Despite the potential application of this system for directed delivery 
and controlled local dosing of active compounds, applications of this approach are limited by 
the fast-irreversible decomposition of the GUVs.  
PB-b-PEO polymer GUVs can mimic structural and functional eukaryotic cells by 
encapsulating enzyme-filled intrinsically porous PS-b-PIAT polymer nanoreactors with free 
enzymes and substrates to fulfil a three-enzyme cascade reaction inside the 
multicompartmentalized structures.16 However, that work provided no information about the 
localization of the enzymes, and only the fluorescence product was observed by spinning disk 
confocal microscopy. Furthermore, the transmembrane exchange of substrates and products 
occurred because of the intrinsic permeability of the membrane, and unlike in cell 
membranes was not mediated by membrane proteins.   
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Proton transport through polymer polyethylene oxide polybutadiene (PEO-PBD) GUVs 
membranes has been achieved by incorporating two different synthetic pores, self-assembled 
from either a dendritic dipeptide or a dendritic ester. However, assembly of dendrimers into 
stable helical pores was not possible in the case of poly(2-methyloxazoline)-block-
poly(dimethylsiloxane)-block-poly(2-methyloxasoline) (PMOXA-PDMS-PMOXA)-based 
GUVs, either because of the significant solubility difference between PBD and PDMS, or the 
differences between di- and triblock architectures.169  
A more challenging approach for development of cell mimics based on synthetic GUVs is to 
insert biopores and membrane proteins into their membranes to induce enhanced permeability 
to specific ions or molecules, or to support in situ reactions while preserving the 3D 
architectures of the GUVs. This approach gives the possibility of understanding the 
biological function of the biopores or membrane proteins, and the visualization of 
transmembrane processes in real-time. An example is GUVs based on the rendering of 
PMOXA-PDMS-PMOXA triblock copolymer permeable for Ca2+ ions by inserting an 
unselective ionophore, Lasalocid A, and a highly selective ionophore N,N-dicyclohexyl-
N′,N′-dioctadecyl-3-oxapentane-1,5-diamide90 whilst insertion of the channel forming 
peptide alamethicin allowed unselective transport of cations and anions.90 The insertion and 
functionality of the small pore-forming peptide gramicidin (gA) in synthetic PMOXA-
PDMS-PMOXA GUVs membranes was visualized in real-time by the fluorescence change of 
the encapsulated dye inside inner cavities.164 Interestingly, functional insertion of gA could 
be achieved in thick membranes up to 5 times greater than the size of gA.164 The ability of 
synthetic membranes, to allow insertion of biopores and membrane proteins (KcsA, OmpF 
and AqpZ) that are several times smaller than the membrane thickness is the result of its 
intrinsic fluidity, which overcomes the significant hydrophobic mismatch, if the copolymers 
are appropriately selected chemically, as in the case of diblock and triblock PMOXA-PDMS-
PMOXA copolymers.18,83,109 However, to the best of our knowledge, the proof of a functional 
reconstitution of membrane proteins in synthetic GUVs with cell-like membranes has not yet 
been established.  
Here we present the functional reconstitution of a membrane protein in thick and stable 
synthetic membranes of GUVs, in order to support cell-like functionality - an enzyme 
reaction that takes place within a GUV micro-sized cavity (Figure 21). Membrane protein 
functionality inside GUV membranes represents the key factor for enabling diffusion of the 
substrates/products of the reaction, and therefore supporting the in situ reaction in a cell-like 
manner. 
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Figure 21. Design of a natural cell (left) and a synthetic giant unilamellar vesicle (GUV) 
with encapsulated enzymes engineered for selective permeability to substrates and products 
based on reconstitution of the Outer membrane protein F (OmpF) to visualize a model 
enzymatic reaction inside the cavity (right).  
 
We selected a cysteine double mutant of the bacterial outer membrane porin F (OmpF) as the 
model membrane protein, because it has various advantages, such as well-known stability 
and a pore size, which allows diffusion of molecules up to 600 Da. The controlled labelling 
of the cysteine residues within the OmpF backbone by fluorophores allows the OmpF 
reconstitution to be monitored.115 In addition, OmpF has already been inserted into PMOXA-
PDMS-PMOXA polymersome membranes with sizes around 200 nm, either as wild type115, 
or as a mutant170, and demonstrated to allow molecular diffusion. Therefore, we chose this 
type of amphiphilic copolymer to generate GUVs. The crucial step in our approach was to 
simultaneously encapsulate an enzyme inside GUVs and insert the OmpF double mutant to 
provide the trans-membrane exchange of substrates and products for the in situ enzymatic 
reaction. The molecular cut-off of OmpF pores plays a dual role: i) it prevents the model 
enzyme horseradish peroxidase (HRP) from escaping from the cavity of the GUVs, and ii) it 
allows diffusion of the substrates (H2O2, Amplex UltraRed (AR)) and the fluorescent product 
of the enzymatic reaction (resorufin-like product). The reaction has been characterized on 
whole GUV populations by flow cytometry, whilst conversion into the fluorescent product 
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inside individual GUVs has been detected by confocal laser scanning miscroscopy (CLSM) 
in real-time by time-lapse recording. Real-time visualization allows a deep insight regarding 
the membrane protein and enzyme localization, synthetic membrane permeability, and 
calculation of the conversion rate. Membrane protein functionality in the synthetic 
membranes of GUVs together with the in situ enzymatic reaction represents a necessary step 
towards the production of more sophisticated reactions inside functional compartments. Such 
synthetic GUVs equipped with membrane proteins represent robust functional assemblies 
that benefit from the stability of the synthetic membrane and the activity of the biomolecules: 
they open the opportunity of providing detailed insight into the design of multifunctional 
systems that serve as simple models of artificial cells. 
 
INSERTION OF THE CHANNEL PROTEIN OMPF 
An essential step towards the production of synthetic GUVs with controlled membrane 
permeability and a confined space for enzymatic reactions is the reconstitution of the double 
mutant of the channel porin OmpF, OmpF-M. In order to visualize OmpF-M reconstitution in 
the PMOXA7-PDMS49-PMOXA7 polymer membrane of GUVs by CLSM, 300 mM sucrose 
was used as a default rehydration solution, since it allows GUVs to settle once they are 
dispersed in PBS (150 mM PBS). The cysteine residues replacing the native amino acids K89 
and R270 in OmpF-M were conjugated with a fluorophore (Atto 488 Maleimide)170, and non-
reacted Atto 488 Maleimide was removed by filtration and dialysis. Atto 488 modification of 
OmpF-M has been evaluated by fluorescence correlation spectroscopy (FCS) and gel 
electrophoresis. FCS allows the determination of the diffusion time for fluorescent molecules 
through the confocal volume of the confocal laser scanning microscope (CLSM), and thus 
their binding to compounds/assemblies with significantly higher molecular weights by 
measuring the respective diffusion times.171,172 By comparing the molecular brightness 
(counts per molecule, CPM in kHz) and diffusion times of Atto 488 in PBS (pH 7.4) (3.1 ± 
1.23 kHz) and Atto 488 maleimide bound to OmpF-M in 1% n-octyl-β-D-glucopyranoside 
(OG) PBS (pH 7.4) (4.5 ± 0.3 kHz), a labelling efficiency of an average of 2 Atto 488 
molecules per OmpF-M monomer was obtained. No residual fluorescence was observed 
when Atto 488 was added to wild type OmpF in 3% OG, or to 3% OG alone, thus proving 
that the maleimide fluorophore binds specifically to the cysteine residues of OmpF-M (Figure 
22A, Figure S8). 
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Figure 22. Atto 488 conjugation of OmpF-M. A: FCS autocorrelation curves of Atto 488 in 
PBS (Blue), and OmpF-Atto 488 in 3% OG (Green). Dotted line – experimental auto 
correlation curves, Full line – fit. Curves normalized to 1 to facilitate comparison. B: CLSM 
micrographs of GUVs: without labeled OmpF-M (a), and with labeled OmpF-M (Atto 488) 
reconstituted into the synthetic membrane (b). C: Flow cytometry analysis of HRP-loaded 
GUVs containing OmpF-M (green), HRP-loaded GUVs without OmpF-M (grey), and 
polystyrene latex beads with diameters 2µm, 3µm, 5µm, 7µm s, and 10µm (visualized in 
increasing size from light purple to dark purple). D: Flow cytometry analysis of PMOXA-
PDMS-PMOXA GUVs with OmpF-Atto 488 (green) or without OmpF-Atto 488 (grey). 
 
To determine whether OmpF was inserted in GUV membranes, CLSM measurements were 
carried out by using GUVs prepared in the presence of Atto 488 labeled OmpF-M (Atto 488-
OmpF-M), and compared with GUVs in the presence of unlabeled OmpF-M (Figure 22B). 
Membranes of the GUVs with unlabeled OmpF-M remained dark, whilst those of GUVs with 
Atto 488-OmpF-M presented a distinct fluorescent membrane (shown in green in Figure 
22B), which clearly indicates successful insertion of Atto 488 OmpF-M. In addition to CLSM 
measurements, insertion of Atto 488-OmpF-M was evaluated by flow cytometry, which has 
previously been used for analysis of lipid GUVs.21 First, the sizes of the GUVs were 
calibrated using the forward scattering (FSC-A) of polystyrene latex beads in the size range 
of 2-10 µm (Figure 22C). Taking into account the GUV population between 3 – 10 µm, a 
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significant shift in fluorescence was observed in the population for GUVs that contained Atto 
488-OmpF (Figure 22D, Figure S9). The GUV population smaller than 3 µm was discarded 
in line with CLSM measurements where GUVs in this size range were too small for precise 
measurements inside their cavities.   
 
ENZYME ENCAPSULATION INSIDE THE CAVITIES OF 
GUVS 
We were interested in encapsulating enzymes within the cavities of GUVs and analyzing how 
they behave inside a cell-like confined space, lacking the crowded environment of the 
cytoplasm. In addition, the enzymatic reaction was used to verify diffusion of the substrates 
through the OmpF-M pores.  
In order to follow the encapsulation of the model enzyme horseradish peroxidase (HRP) in 
GUVs, lysine residues of HRP were conjugated with Atto 488 succinimide ester, and the 
unreacted fluorophore was removed by filtration and dialysis. The conjugation and purity of 
the Atto 488-HRP conjugate was established with FCS (Figure 23A) and SDS-PAGE (Figure 
S10). Atto 488 in solution had a typical diffusion time τD = 44.3 ± 17 µs and molecular 
brightness of 4.4 ± 0.3 CPM, whereas the Atto 488-HRP presented a significantly longer 
diffusion time τD = 252 ± 43 µs with a molecular brightness of 3.4 ± 0.5 CPM. The free 
fraction of Atto 488 in the HRP-Atto 488 solution was determined with a two component fit 
of the autocorrelation curve to be 15% ± 11% (Figure 23A). 
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Figure 23. A: FCS autocorrelation curves for Atto 488 in sucrose (Blue), and HRP-Atto 488 
in sucrose (Green). Dotted line – experimental auto correlation curves, Full line – fit. Curves 
are normalized to 1 to facilitate comparison. B: a,b,c: CLSM images of polymer GUVs with 
labeled HRP (Atto 488) encapsulated. In each image: left: fluorescence channel, right: 
transmission channel. C: FCS autocorrelation curves for Atto 488 in sucrose (Blue), HRP-
Atto 488 in sucrose (Black), HRP-Atto 488 in GUV (Green). Dotted line – experimental auto 
correlation curves, Full line – fit. Curves normalized to 1 to facilitate comparison. 
 
After encapsulation of Atto 488-HRP in 300 mM sucrose solution, and settling of the GUVs 
to the imaging chamber surface (SI), most of the GUVs measured by CLSM showed 
fluorescence inside their cavities (Figure 23B), indicating successful HRP encapsulation and 
free diffusion of the enzyme. In addition, GUV membranes presented only low fluorescence 
intensity, due to the reflection of fluorescent light between the GUV membrane / cavity 
interface, and a minor enzyme-membrane interaction. No fluorescence was observed outside 
the GUVs, which demonstrates successful purification of the GUVs after enzyme 
encapsulation (purification procedure is described in material and methods, chapter 4) . Self-
assembly of the GUVs with encapsulated enzyme is a statistical process, meaning not all 
GUVs have the same amount of Atto 488-HRP present inside their cavities. To visualize in 
more detail the dynamics of enzyme encapsulation in the GUVs, we performed FCS 
measurements inside the cavites of Atto 488 labeled HRP-loaded GUVs (Figure 23C). As the 
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encapsulated HRP molecules have similar diffusion times (273 ± 144 µs) to the free HRP in 
sucrose (252 ± 43µs), it confirms a successful enzyme encapsulation (at least 10 GUVs were 
measured by FCS), and no change in the dynamics of the enzyme inside the confined space 
of the GUVs (Figure 23C). 
 
ENZYME REACTION INSIDE GUVS CAVITIES 
To address the question of enzyme functionality within GUV cavities, the rate of oxidation of 
Amplex UltraRed by HRP in the presence of H2O2 was first studied in solution by 
fluorescence spectroscopy and the enzyme activity for HRP in PBS pH=7.4 compared to that 
for HRP in 300 mM sucrose, which was used for GUV formation (Figure S11). There was no 
evident difference between the two media. Furthermore, without H2O2 as a co-substrate, there 
was barely any conversion of Amplex UltraRed into the fluorescent resorufin-like product. 
Similarly, there was no substrate conversion if no substrate Amplex UltraRed or no enzyme 
was present in solution (Figure S11). 
This model enzyme reaction has been recently studied in synthetic compartments with sizes 
in the nanometer range, namely polymersomes equipped with OmpF-M. As we modified this 
method for the formation of OmpF-M equipped polymersomes by using sucrose solution for 
GUVs preparation instead of PBS pH=7.4, and the addition of OmpF-M in bidistilled water 
instead of PBS pH=7.4 (since the presence of salts disturbed the GUV formation), we were 
interested in determining whether these modifications affect the OmpF-M reconstitution and 
further enzymatic reactions. Therefore, we compared the enzymatic reaction inside 
polymersomes under the above mentioned conditions used for GUVs with those previously 
reported for polymersomes by fluorescence spectroscopy. For this, OmpF equipped 
polymersomes loaded with HRP were prepared and characterized (Figure S12, S13). As the 
in situ enzymatic reaction was not affected, this result indicates that the sucrose solution 
together with the addition of the OmpF-M in bidistilled water used for the GUVs experiments 
(see below) does not affect the functional reconstitution of OmpF or the activity of the 
encapsulated enzyme within polymersomes (Figure S14). This information tells us that the 
OmpF-M reconstitution together with the enzyme reaction should not be hindered by the 
conditions used for preparing the GUVs. 
By monitoring the enzymatic reaction by CLSM for up to 12 min, it was demonstrated that 
the membrane protein OmpF is fully functional in the synthetic membrane of GUVs and that 
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it renders the membrane permeable to the substrates and products. We produced videos with 
an image recording time of 15.7 s/image and 1 s delay. To establish a starting point (t=0), the 
first image was recorded before addition of the substrates. Then, the enzymatic reaction was 
initiated by adding substrates (Amplex UltraRed and H2O2) to the external solution, and the 
increase in the fluorescent signal associated with the product of the reaction was visualized 
by CLSM (Figure 24). The same procedure was carried out for HRP-loaded GUVs without 
inserted OmpF-M (Figure 24).  
 
Figure 24. CLSM Fluorescence micrographs of single GUVs obtained over time, by 
recording images at certain time points after initial addition of the substrates H2O2 and 
Amplex UltraRed. Top) GUV with reconstituted OmpF-M. Bottom) GUV without OmpF-M.  
 
The increase in the fluorescence intensity within GUVs equipped with OmpF-M results from 
the formation of the fluorescent resorufin-like product, and proves the functional insertion of 
OmpF-M that permits molecular transport through the synthetic membrane of the GUVs. On 
the contrary, there was no increase in fluorescence intensity inside GUVs without inserted 
OmpF-M, since the substrates were unable to pass through the synthetic membrane. Over 
time, the fluorescence inside the cavity of the OmpF-equipped GUVs decreased slightly (see 
the change from 165s to 6 min in Figure 24), because the resorufin-like product of the 
enzyme reaction diffuses out of the GUVs through the OmpF-M pores. As expected, after a 
certain time, the fluorescence inside the cavity of OmpF-equipped GUVs becomes equal to 
the fluorescence intensity of the environment of the GUVs, which is not the case for GUVs 
without OmpF-M, where there was almost no fluorescence signal inside the GUVs (dark core 
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of GUVs). Both GUVs with OmpF-M inserted and without OmpF showed a fluorescent 
membrane over time due to small amounts of HRP interacting with GUV membranes and 
being exposed at the exterior of GUVs even after several washing steps. In addition, a second 
factor, which causes the membrane to appear fluorescent, is the scattering and reflection of 
fluorescent light between the GUV membrane / cavity interface. Note, that in the following 
data assessment, the fluorescence intensity of the membrane of the GUVs has not been taken 
into account. The passive accumulation of the fluorescent resorufin-like product in the 
background was used as a criterion to determine whether the enzyme reaction has taken place 
within the cavity of the GUVs. The reaction occurred only if the fluorescence intensity was 
higher inside the GUVs than in the background. Both phenomena were considered in the data 
assessment, and consequently the membrane fluorescence was disregarded and the 
fluorescence intensity of the background was subtracted. 
For each image of the sequences, the mean fluorescence intensity of a region of interest 
(ROI), depending on the individual size of the GUVs, both inside the cavity of each GUV 
(Figure S15) and outside the GUVs (background) was calculated using the program ImageJ. 
The mean fluorescence intensity values of the background over time were subtracted from the 
values inside GUVs cavity (Figure 25 A and C, Figure S16). Around 70% of the GUVs with 
reconstituted OmpF-M showed fluorescence higher than the background inside their cavities 
indicating that the enzyme reaction occurred, whereas the fluorescence intensity inside the 
cavity of ~ 70% of the GUVs without OmpF showed less fluorescence intensity than the 
background (Table S2).  
In order to estimate the conversion rate, k, for the GUVs with and without OmpF, a linear 
regression of the fluorescence increase within the first 120 s was performed on all the curves, 
where each curve corresponded to a single GUV with background fluorescence intensity 
subtracted. Only GUVs with fluorescence higher than the background in case of the OmpF-M 
equipped GUVs (70%) were taken into account and vice versa for the GUVs containing no 
OmpF. A conversion rate of k ≈ 0.011 s-1 was obtained for GUVs with reconstituted OmpF-M 
(Figure 25 B). In contrast, for GUVs without OmpF the negative conversion rate was an 
order of magnitude lower with k ≈ -0.0036 s-1 (Figure 25 D). The increase in the relative 
fluorescence intensity for OmpF-equipped GUVs clearly indicates successful in situ bio-
activity of HRP (Figure 25 A and B), whilst the decrease towards negative values of the 
curve for the GUVs without OmpF is due to an increase in the fluorescence intensity of the 
background that results from the HRP activity at the exterior of the GUVs (Figure 25 C and 
D).  
59 
LIVE FOLLOW-UP OF ENZYMATIC REACTIONS INSIDE THE CAVITIES OF 
SYNTHETIC GIANT UNILAMELLAR VESICLES (GUVS) 
 
Figure 25. Top: GUVs with reconstituted OmpF-M. Bottom: GUVs without reconstituted 
OmpF-M A and C: Temporal variation in the relative fluorescence intensity of the resorufin-
like product inside the cavities of single GUVs after addition of the reagents H2O2 and 
Amplex UltraRed after background subtraction. Each curve represents one GUV. B and D): 
Linear regressions of change of the fluorescence intensity over time. Shown are the mean 
values with standard error of the mean (sem). n = 18 – 25. 
 
To gain further information on the membrane permeabilization by insertion of the OmpF-M 
pore, the Amplex UltraRed enzymatic assay was applied in combination with flow cytometry 
analysis. Oxidation of Amplex UltraRed was observed inside the cavities of HRP-loaded 
GUVs equipped with OmpF-M, in agreement with the results obtained by CLSM, and the 
significant shift of the fluorescence for HRP-loaded GUVs equipped with OmpF-M 
compared to HRP-loaded GUVs without OmpF-M clearly proved that the porins allow 
substrates to efficiently diffuse into the cavities of the GUVs (Figure 26, Figure S17).  
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Figure 26. Flow cytometry analysis - Amplex UltraRed enzymatic assay of OmpF equipped 
(red) or unequipped PMOXA7-PDMS49-PMOXA7 GUVs (blue). 
 
Thus these CLSM and flow cytometry results confirm the necessity of functional membrane 
protein reconstitution inside polymer GUV membranes for production of the fluorescent 
product by the enzyme confined inside the GUV cavities. 
 
GUV SIZE DISTRIBUTION 
Next, we were interested in assessing whether the size of GUVs affects the enzymatic 
reaction that takes place within their cavities. To determine the corresponding sizes of the 
GUVs for a comparison between the dataset from GUVs with reconstituted OmpF-M and 
GUVs without OmpF-M, it was necessary to investigate whether these two populations 
showed size differences. First, the diameters of GUVs (both OmpF-equipped GUVs, and 
GUVs without OmpF) were measured using ImageJ and plotted (Figure S18); a Welch Two 
Sample t-test showed no significant difference between the OmpF-equipped GUVs and 
GUVs without OmpF (p-value = 0.27, α = 0.05) (Figure S19).  
To carry out a more detailed comparison, the fluorescence intensity of each individual vesicle 
was taken 260 seconds after the reaction was initiated to ensure a stable signal. A significant 
difference in fluorescence intensity was observed between the averages of OmpF-equipped 
GUVs and GUVs without OmpF (Figure S20 A) (p ≈ 0.024 (α = 0.05)).  
 Further details of the in situ enzymatic reaction were revealed by dividing the GUVs into 4 
groups, namely from 6 to 9 µm (A), 9 to 11 µm (B), 11 to 13 µm (C) and 13 to 16 µm (D) 
(Figure S13 B). The difference in intensity of the two GUV populations was less pronounced 
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in the range of 6 to 9 µm, but the median intensity differed clearly between OmpF equipped 
GUVs and non OmpF equipped GUVs within the size ranges 9 to 11, 11 to 13 and 13 to 16 
µm, and was most pronounced with the higher sizes. This is in good agreement with the 
expectation that larger GUVs should contain more dye molecules and thus have a higher 
overall intensity. Even though a slight decrease was observed from group C to group D, it 
was not statistically significant (p ≈ 0.344). 
 
Figure 27. A) Conversion rate, k, of two populations of GUVs with and without 
reconstituted OmpF-M. Each GUV was fitted independently. B) Variation of conversion 
rate, k, with GUV diameters. The black line = median, white square = average value, white 
points = data points. 
 
The conversion rate, was further calculated for each individual GUV. Again, there were 
significant differences between GUVs with and those without inserted OmpF (Welch Two 
Sample t-test, p-value ≈ 0.025, α = 0.05) (Figure 27A). Classification of GUVs into the same 
size clusters as above shows a similar behavior to that described in the previous paragraph 
(Figure 27B). Overall, the difference in the median conversion rate, k, is marginal for group 
A, but there is an obvious difference in group B, and this increased in groups C and D. Since 
there was a constant enzyme concentration in the rehydration solution, the number of 
enzymes present in a GUV’s cavity should depend only on its size, and therefore volume. 
Thus, with increasing GUV sizes, the volume and the number of enzymes per cavity should 
increase, and explains the lower conversion rate that was observed in group A. Furthermore, 
larger sizes have more membrane surface, which allows a higher number of OmpF pores to 
be present. This then results in increased substrate diffusion rates, and a steady stream of 
substrates and product can be achieved. It appears that the closer the physical characteristics 
(e.g. size and volume) are to a natural cell, the higher the performance of the system. 
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CONCLUSION 
This is the first time that a membrane protein (OmpF) has been reconstituted into synthetic 
polymer membranes of giant unilamellar vesicles (GUVs) with preserved functionality, and 
is instrumental in initiating an in situ enzymatic reaction by allowing diffusion of substrates 
and products. The model enzyme reaction inside the GUV cavities was monitored in real-
time and gave insight into both the substrate conversion rate by the encapsulated enzyme and 
the reconstitution of the functional membrane protein (OmpF) in synthetic GUV membranes. 
The large cavities of GUVs allowed free diffusion of the encapsulated enzyme, as proven by 
FCS. Furthermore, there appears to be a size-dependent trend in enzyme conversion rate in 
respect of GUV diameters. Also, whereas direct observation of internal reactions in 
established nano-compartment platforms, such as liposomes and polymersomes, are limited 
by the resolution barrier, GUVs provide a unique opportunity for observing the behavior of 
biomolecules within defined confined spaces.  The combination of biomolecules and 
synthetic materials found in membrane protein-equipped polymer GUVs not only offers the 
advantages of increased stability and lower membrane permeability than lipid GUVs, but 
together with an encapsulated enzyme makes the micro scale compartment platform relevant 
for various applications, as for example a research tool to study biomolecule behavior within 
these cell-like compartments or as biosensors.  
Our simultaneous encapsulation and insertion of biomolecules in GUVs allows a thorough 
understanding of biological processes in real-time, and represents a useful platform to study 
reactions inside confined spaces or interactions of biomolecules with membranes by a 
straightforward change of enzyme type. As GUVs have sizes similar to those of cells, they 
allow the relevant study of bio-processes in vitro in a simple manner.  Thinking even further 
ahead, molecular factories and advanced cell mimics could be developed by encapsulating in 
cell-sized GUVs various polymersomes loaded with different types of enzyme inside their 
cavities. 
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Chapter 5 
 
STRATEGY FOR CREATING BIOINSPIRED MOLECULAR 
FACTORIES WITH FUNCTIONALITY AS CELL MIMICS  
 
The final experimental chapter of this thesis builds on the knowledge of cell-biology in order 
to create the first cell-like molecular factory. In this respect, micro-sized giant plasma 
membrane vesicles (GPMVs) are chosen as a fundament on which the cell mimic is 
constructed. These cell-derived vesicles present an ideal material as they are produced and 
isolated in high quantities by chemical, salt or laser treatment of donor cells, presenting 
themselves as a molecular material that has a potential, which has surprisingly left 
untouched. During their formation, GPMVs acquire both the outer compartment architecture 
of the donor cell (plasma membrane) and the inner composition of cells (cytoplasm). In this 
way GPMVs composition directly mirrors the composition of cells from which they originate 
with the exception of the larger organelles like for example nuclei and Golgi apparatus - 
making them the closest cell-mimic available on the market up to now. The possibility of 
designing molecular factories by manipulating cellular material (cytoplasm and plasma 
membrane) by genetic modification together with the encapsulation of solid sphere structures 
nanoparticles / vesicular structures (liposomes, polymersomes) in the cytoplasm-like cavities 
of the GPMVs represents the basis of these molecular factories. To develop bioinspired 
molecular factories with functionality as cell mimics, we propose a new approach for the 
generation of cell mimics by the production of sophisticated hybrid molecular factories based 
on giant plasma membrane vesicles (GPMVs) equipped with the necessary molecular 
machinery inside their cavities that provides function. When encapsulated in GPMVs, solid 
sphere and vesicular structures can further be used as sensors when there are active objects 
on their surfaces (i.e. fluorophores), but can also provide a mean of spatial localization of 
molecules within the GPMVs (i.e. attached on the surface or encapsulated). Towards the first 
bioinspired molecular factory enzyme-equipped polymersomes with a reconstituted 
membrane protein (OmpF) are encapsulated inside the GPMVs as enzymatic nanoreactors 
where they retain their functionality. Successful substrate conversion was visualized by the 
fluorescent product (resorufin-like product), which could leave the polymersome and diffuse 
inside the GPMV cavity, which thus allowed the substrates to be transported to the inside and 
the product to diffuse out of these polymersomes. Finally, we demonstrate that equipped 
GPMVs can act as artificial cell mimics. 
 
 
 
 
 
 
This study has been published: T. Einfaltx, M. Garnix, D. Witzigmann, S. Sieber, N. Baltisberger, J. Huwyler, 
W. Meier*, C. G. Palivan*. Bioinspired molecular factories with architecture and in vivo functionalities as cell 
mimics, Advanced Science, (2019). (in press) 
x Both authors contributed equally. 
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MOTIVATION AND PROBLEM DEFINITION 
 
Innovative molecular concepts that closely imitate natural cellular compartmentalization 
currently appear to be in high demand as they represent first stepping stones towards the 
production of life-like micro- and nano scale biomimetic system.165,173,174 The bottom up 
approach used in designing artificial biomimics is based on the combination of specific 
molecular building units (natural or synthetic) to form a hybrid hierarchically organized 
framework with a distinct architecture and functionality.16 This modular design makes hybrid 
systems very appealing both in research and industry175, where their applications are starting 
to play a major role as biosensors176, sophisticated therapeutic or diagnostic tools177, and even 
cross over in the field of electronics.178 Especially in fundamental research, cell-like 
biomimetic compartment systems imitating cellular or subcellular structures prove 
themselves as excellent models of pro and eukaryotic cells and have previously given insight 
of the progression from non-living materials to a living organism.16,173,179 
In the game of cellular imitation, substantial advances in developing nanoscale systems 
capable of functioning within the intracellular environment of viable cells have been 
achieved by the contribution of several groups, where nanomimics mimicked subcellular 
structures (i.e. organelles) in the form of artificial organelles (AOs).119 However, despite 
advances in developing artificial cellular sub-compartments, a decade after the first notion of 
an artificial cell was introduced in synthetic biology the design of a functional stand-alone 
cell mimic, available to any laboratory in the world, continues to remain one of the most 
elusive and challenging concepts to realize. This is primarily as designing a life-like cell 
mimic requires the bottom up construction of system that possesses a confined molecular 
machinery, which can function in a highly controlled manner.62 To achieve a cell-like 
organization a complex molecular factory needs to be designed, ideally capable of adapting 
to specific tasks and environmental conditions - a microscale compartment system that is 
adept to engineering and processing molecules (i.e. proteins, RNA, DNA) in a life-like 
manner. Previously there have been several attempts to design an artificial cell. These arose 
in the form of biomolecule-loaded lipid- and polymer-based giant unilamellar vesicles 
(GUVs)5,7,16–18, lipid coated porous silica nanoparticles19, layer-by-layer capsules20, 
membrane free microdroplets, and micro-scaled proteinosomes.21 However, existing 
synthetic compartment systems predominantly fail to meet the complexity found in nature, 
especially in relation to the diverse lipid and biomolecule composition that is inherent to the 
cellular architecture. In this respect, not only compartment barriers (i.e. membranes)21 but 
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also the mainly used buffer-solutions62 encapsulated within the cell mimics are far away from 
the cellular structures. Up till now cell mimics are designed by combining few isolated 
biomacromolecules (i.e. enzymes, membrane proteins) with a certain type of synthetic 
material (i.e. coacervates, droplets, liposomes, proteinosomes, polymers, porous silica 
particles) in order to construct a cell mimic with a very specific function.18–21,180–182 The 
precisely defined composition of current “cell-mimics” makes it easier to define their 
function and characterize the role of individual building blocks, however it also represents a 
fundamental barrier, as the rudimental diversity in materials means that individual “cell-like” 
compartment systems cannot get near the complexity found in living organisms and are 
limited by the materials used in construction. This has led to the development of very group 
specific cell mimics, that cannot be easily adapted by other laboratories, due to the materials 
(i.e. polymers) used in their design. Another issue in designing cell mimics is that all 
modifications to the fundamental architecture (i.e. membrane and inner cavity) have to be 
inserted by crude self-assembly, which especially true for modifications done to the 
membrane. Membrane protein reconstitution has presented a challenging task since years, 
because the formation of membranous structures is based on spontaneous self-assembly 
processes, which can be rapidly disrupted during the process of protein reconstitution, due to 
the presence of amphiphilic molecules used in membrane protein isolation, purification and 
stabilization.45,183 There have been significant advances in controlling the self-assembly 
process of cell-mimics by means of microfluidics, however the complexity of the resulting 
systems is still minimalistic and leaves room for improvement.182 As a result of having to 
tightly control the self-assembly parameters, current synthetic systems are composed of only 
one, two, or as seen in only rare cases more types of synthetic materials, complemented by a 
narrow selection of biomolecules.184 This inadequate material diversity of present biomimics 
is a feature that makes them largely fail to imitate the structure and metabolism found in 
natural cellular structures, where complex function is supported by an array of different 
biomolecules involved in fine-tuned internal reactions. 
When designing a system that is closer to nature in terms of complexity and function 
compared to present cell-mimics, the organization and composition of the most basic 
structural and functional units found in eukaryotic organisms (i.e. cells and their subcellular 
compartments) offers inspiration as to how an archetype of a compartment-based molecular 
factory should be built. In this respect, in order to closely imitate cellular structure, molecular 
factories should be based on a versatile membranous outer compartment barrier 
complemented with different kinds of membrane proteins, which at the same time envelops 
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and holds in place an inner aqueous molecular machinery that is composed of membranous 
active sub compartments each containing biomolecules/active substances.1 
Hierarchy in compartmentalization (compartments in compartments) is essential as multi- 
and sub-compartments allow molecules (i.e. enzymes or inorganic catalysts) to function in a 
spatially controlled manner and allow exchange of substrates/products between different sub-
compartments.185,186 
When choosing the starting material to build a cell-like molecular factory giant plasma 
membrane vesicles (GPMVs) present a particularly interesting platform, whose potential has 
surprisingly been left predominantly untouched.71,187 These cell-derived micro vesicles 
(GPMVs) can be produced and isolated in high quantities by chemical, salt or laser treatment 
of donor cells71–73 and are formed by a local delamination of the plasma membrane from the 
underlying cytoskeleton, which leads to filling of the expanding area within the GPMV via a 
passive flow of cytoplasm.74 Hence, both the outer compartment architecture of GPMVs 
(membrane) and the inner composition of GPMVs directly mirror the composition of cells 
from which they originate, but without the larger cellular organelles (i.e. nuclei, Golgi 
apparatus) making measurements easier and are the closest cell-mimic available on the 
market up-to now (Figure 28).75 Previously these characteristics made GPMVs improved 
membrane models to study the lipid composition of the plasma membrane, the behavior of 
functional membrane proteins within the GPMV membrane, and membrane interaction with 
external compounds.76 Even more recently GPMV applications have been extended from 
biophysical models77,78 to bioinspired drug delivery agents by making use of the host-cell 
membrane functionality.79,80 However, up to date there are no reports of studies that take 
advantage of the complexity of the GMPVs membrane and its compartment architecture in 
order to create molecular factories that act as artificial mimics of cells.  
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Figure 28. Schematic illustration of GPMV molecular factories, presenting the different 
types of molecular cargo that can be incorporated in the GPMV structure. Small molecular 
weight molecules (i.e. salts, fluorophores, chemotherapeutics), biomacromolecules (i.e. 
proteins, DNA), solid sphere nanostructures (i.e. quantum dots and nanoparticles) and 
hollow sphere nanostructures (i.e. liposomes, polymersomes) are integrated into the 
cytoplasmic cavities of GPMVs to form a complex molecular machinery. Loading of GPMV 
cavities is achieved through transfer of material from the donor cell cytoplasm during GPMV 
formation, whilst in addition the membrane associated cargo is transferred from the cell to 
the plasma membrane of GPMVs during vesicle formation. 
 
Here, we propose a new approach for the generation of artificial cell mimics by the 
production of sophisticated hybrid molecular factories based on giant plasma membrane 
vesicles (GPMVs) equipped with the necessary molecular machinery that provides function 
(i.e. catalyst equipped nanocompartments). In our opinion, the cellular origin of GPMVs has 
an untapped potential for developing a cell mimic, because the composition of GPMVs 
membrane is not restricted by a limited library of lipidic or synthetic amphiphiles and in 
addition avoids the reconstitution of membrane proteins characteristic for lipid or polymer 
compartment systems. Transfer of the contents of cytoplasm and membranes from donor cells 
to GPMVs occurs spontaneously during GPMV formation and offers the opportunity to build 
a cell-like molecular factory by a straightforward engineering, which combines well-
established techniques of GMPVs formation, with an elegant selection of components that are 
incorporated through the cell during their formation.71,73,79,188 
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In the strategy we present here, eukaryotic cells are used to i) manufacture GPMVs (top 
down approach), and ii) simultaneously equip GPMVs with a large variety of structural and 
functional units (enzymes, proteins, nano-objects, catalytic compartments) by pre modifying 
cell composition (bottom up approach). Design of GPMV-based molecular factories through 
this combination of a bottom up and top down approach utilizes the fundamental architecture 
of GPMVs - a cytoplasm-like core that is surrounded by a versatile plasma membrane - and a 
functional unit with plasma membrane-based outer barriers and inner molecular machinery 
that is constructed during plasma membrane vesiculation of donor cells pre-loaded with a 
molecular cargo of interest (i.e. small molecular weight molecules, biomacromolecules or 
larger nano-sized assemblies) , which can be activated “on demand” (Figure 28). 
Such a molecular factory opens up the possibility to reproduce and study biological processes 
in a real cell-like environment with defined components and less crowding agents. As both, 
the compartment core and structural membrane of a GPMV unit are directly derived from the 
cell, it implies that they can both be modified on demand by modifying the cellular 
composition, either by genetic modification or integration of molecular building blocks into 
the cytoplasm / plasma membrane. In addition, GPMV-based cell mimics not only have 
similar sizes to eukaryotic cells, but they also present a spherical shape that allows exact 
surface and volume determination, and therefore access to concentration-calculations that are 
important for precise kinetic studies. 
The ability to manipulate membrane composition represents a key advantage of GPMV-based 
artificial cells, since membrane protein reconstitution in synthetic polymer / lipid GUVs is 
always a time-consuming and challenging task.45,183 Genetic modification and subsequent cell 
membrane alteration of the GPMVs represent a fast, robust and flexible alternative to current 
approaches. 
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ENGINEERING GPMV MEMBRANE AND POSSIBLE 
MODIFICATIONS 
In order to develop a functional compartment, modifications done to its fundamental 
structure, the load bearing membrane, have to be addressed first. Customization of the cell 
mimics outer barriers - the plasma membrane – is important, as both lipid and protein 
components of the membrane play essential roles in compartment permeability, functionality, 
stability. In addition, membrane composition predominantly determines how the 
compartment will interact with the environment (i.e. protein binding, immune response) – an 
important consideration for future in vivo and in vitro applications.177,191 As the GPMV 
material composition directly mirrors that of the donor cell, we have investigated the extent 
to which the GPMV membranes can be modified on demand in a streamlined approach by 
modifying the lipid, protein and polymer composition of the donor cell. In this respect, we 
were interested to determine the effect of outfitting apical membranes of cultured model 
human cells (HepG2 liver carcinoma) with highly lipophilic molecules (such as the 
membrane tracer DiD46, fluorescently-tagged amphiphilic lipids e.g. DOPE-Rhodamine and 
DOPE-FITC192 or polymers e.g. Cholesterol-PEG-5000-FITC193) on the composition of 
GPMVs. Customized integration of lipids, as reported here by integration of a combination of 
DOPE-Rhodamine and DOPE-FITC into GPMVs, is central to the design of a GPMV-based 
cell mimic, as it allows combining molecules in the GPMV membrane that can act in tandem. 
We confirm that incubation of the model HepG2 cell line with DOPE-Rhodamine and 
DOPE-FITC micelles leads to integration of the fluorescently tagged lipids in the cell, and 
once the vesiculation process is induced, the introduced lipids are transferred to the 
membranes of the GPMVs (Figure 29). Due to their fluorescent nature these types of 
modifications done to the plasma membrane not only provide a way to manipulate the 
structural properties of GPMVs but also allow following membrane fluidity, integrity and 
architecture (possible domain building) directly, through the use of fluorescence techniques. 
We further demonstrate that the customized equipment of GPMVs is not limited by 
integration of lipids by successful integration of membrane tracers, such as DiD 
(Thermofischer) (Figure 29) or polymer modified cholesterol (Cholesterol functionalized 
polyethylene glycol 5000-FITC). The latter is especially important for future in vivo 
applications of GPMVs as artificial cells, as it demonstrates that GPMV membranes can be 
equipped with polymer macromolecules such as PEG, which prevent unspecific protein 
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binding, shield the membrane charge and provide steric stability through presence of PEG 
chains on the apical surface of membranes194(Figure 29). Yet modifying GPMV membranes 
with only relatively small molecular weight molecules is not sufficient to design a functional 
cell mimic, since active processes taking place at biological compartment interfaces are 
mostly governed and regulated by numerous bio-macromolecules, such as membrane 
associated proteins188. For this purpose, we further engineered HepG2 cells to overexpress a 
plasma membrane associated protein GFP tagged leucocyte specific (Lck) tyrosine kinase 
using baculovirus gene transfer (BacMam 2.0).195 Upon inducing vesiculation in donor cells 
we demonstrate that in addition to modifying the composition of the GPMV the plasma 
membrane forming the compartment barriers can also be manipulated and equipped on 
demand with functional membrane associated proteins (Figure 29).  
 
 
Figure 29. GPMV membrane modifications Top: HepG2 cells. Middle: HepG2 cells after 
vesiculation. Bottom: Isolated GPMVs. Carboxyfluorescein (CF, FITC) (green) 
Sulforhodamine (SRB) (red). 
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Besides modifying the membrane of the cell mimic, it is also necessary to customize the 
composition of the cytosolic cavity within the GPMV and thereby introduce the crucial 
molecular machinery that will support function of the cell mimic. During the vesiculation 
process part of the donor cell cytoplasm is transferred directly into the GPMV cavity, 
therefore the cavity of GPMVs contains a cell-like composition by default, which represents 
an essential step in complexity compared to all other reported systems proposed as artificial 
cells.1 To develop a customized molecular machinery, it is necessary to enhance the inner 
composition of a cell mimic with a unique blend of small molecular weight molecules and 
proteins, which mimic the cytoplasm and support the function and performance required for a 
specific molecular machinery to work.  By preloading the model HepG2 cell line with a small 
molecular fluorophore (CellTracker™ DeepRed Dye)196 and then inducing the GPMV 
vesiculation process, we demonstrate and confirm previous findings that low molecular 
weight compounds abundantly present in the cytoplasm of donor cells are transferred into 
GPMVs during a passive flow of cytoplasm into the expanding cavity (Figure 30).79 The 
same transfer of material is also observed for GPMV formed by HepG2 cells genetically 
modified to over-expressed larger water soluble cytosolic proteins (>20 kDa), such as RFP-
Actin and water soluble e-GFP (Figure 30), confirming the high degree in which the local 
environment within individual GPMVs can be controlled in a straightforward manner by the 
manipulation of the donor cell composition. In addition to encapsulation of a single 
molecular species within GPMVs, a combination of biomolecules (water soluble RFP and 
enhanced GFP (eGFP)) can also be achieved (Figure 30), leading to an even more complex 
inner environment. This implication of co-encapsulation remarkably important, since 
existence of different types of biomolecules within a single GPMV opens a possibility of 
combining classes of biomolecules that act in tandem (i.e. enzymes) within a confined space 
and thereby designing an environment where molecular interactions within the cell mimic 
can take place and be studied in a defined manner. 
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Figure 30. Building the outer compartment architecture of molecular factories. Top: 
HepG2 cells after uptake. Middle: HepG2 cells after vesiculation. Bottom: Isolated GPMVs. 
CellTracker™ deep red dye (blue) and e-GFP tyrosin kinase (Green). Actin-RFP (Red) and 
GFP-tyrosin kinase (Green), water soluble e-GFP (green) and water-soluble e-GFP (green) 
and RFP (red).  
 
FUNCTIONAL COMPONENTS WE NEED FOR 
MOLECULAR FACTORIES 
Besides having a customizable membrane and cytoplasm filled cavities, GPMVs are required 
to contain active compounds inside their cavities in order to support the function of a cell-like 
molecular factory. In nature, processes taking place within cellular compartments show 
significantly increased turn-over and efficiency as a result of spatial localization and multi-
compartmentalization165. Prime example are enzymes involved in cellular metabolism, which 
are able to run highly efficient and complex cascade reactions due to their confinement 
within the space of specific organelles (e.g. the extensive range of respiratory enzymes that 
are confined to mitochondria Structure and function of mitochondrial membrane protein 
complexes). Accordingly, the next step in designing a molecular factory that mimics cellular 
function, herein referred to as e-GPMV, is the introduction of multi-compartmentalization. 
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The robust and solid sphere characteristics of nanoparticles (e.g. polystyrene, silica and gold 
nanoparticles) makes them valuable tool for imaging/visualization, and fluorescently-labeled 
nanoparticles encapsulated within the cavities of GPMVs can be used to study diffusion 
(Brownian motion), interaction processes inside the cytosol-filled GPMVs, or potential 
plasma membrane interactions. Further they can serve as biological sensors in the confined 
spaces of the GPMVs, if for example antibodies or enzymes are bound to particle surface. 
197,198 However, one of the most interesting aspects of nanoparticle encapsulation in GPMVs 
is that of providing a mean for spatial localization of active molecules (i.e. enzyme, catalysts) 
on particle surfaces or encapsulation of the latter within particles (e.g. porous silica 
nanoparticles), opening the way to multi compartmentalization.199 
We have attempted to mimic cellular multi-compartmentalization by introducing solid-sphere 
nanostructures in the size ranges 1-2 nm (carboxylated quantum dots), 40 nm and 0.5-1 µm 
(polystyrene beads) in GPMV cavities. Since cellular uptake of colloidal objects with sizes 
between a few nanometers and 1µm in diameter has been observed in non-phagocytotic cell 
lines200 (Figure 31), we loaded cells with solid sphere nanoparticles (carboxylated quantum 
dots, polystyrene beads) to study how nanoscale assemblies are transferred from the cytosol 
of human-derived cells into GPMVs (Figure 31).  During the process of GPMV formation, 
colloidal assemblies abundantly present in HepG2 cytoplasm are transferred to the cytosolic 
environment within GPMVs and are able to diffuse freely in GPMV cavities where, serving 
as autonomous islets. This bottom up approach of outfitting the fundamental molecular 
factory with nano-assemblies opens the way for spatial localization and sub-
compartmentalization, thereby fulfilling a crucial requirement for the construction of 
complex biomimetic molecular machinery, which would allow chemical reactions to take 
place in life-like conditions. 
We have observed that the process by which solid sphere particles are transferred from the 
HepG2 cytoplasm into GPMVs is governed by object size, and that for our model cell line a 
size-dependent cut-off into GPMVs appears around 1000 nm. However, efficient transfer of 
nanometer-sized particles was found for objects up to 500 nm in diameter, which filled about 
25% of the GPMV cavities produced by a single cell with at least 1 colloidal object per 
GPMV. The likelihood of colloidal nanoassemblies being transferred from the cytoplasm of 
donor cells to GPMVs appears to be highly size-dependent with the smaller q-dots and 40 nm 
solid spheres being more abundant in GPMVs of a single cell than the larger 500 nm 
polystyrene latex beads. This is most likely in relation with the rate of nanoparticle uptake by 
cells – smaller nanoparticles reach higher intracellular concentrations faster, and will be 
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addressed in further studies. The uptake and subsequent transfer of nanoparticles in GPMVs 
could possibly be improved by choosing a phagocytotic cell line (i.e. THP-1 macrophages). 
Objects that were transferred into the GPMV interior retained their size and fluorescent 
properties, and showed no signs of aggregation or degradation (Figure 31). Free diffusion of 
objects in sizes up to 500 nm was observed within the cytosol-filled cavities of GPMVs. 
Observed by CLSM diffusion was primarily size dependent (bigger objects diffused slower) 
in agreement with the Brownian motion of colloidal assemblies in solution. Sedimentation of 
the larger 1 µm or 2 µm polymer beads occurred rapidly after they were added to the cellular 
culture, thus limiting their uptake and transfer into GPMVs. We observed a singular 1 µm 
particle bouncing on a GPMV, which showed the robustness of the GPMV membrane 
towards rupturing.  
 
 
Figure 31. Transfer of artificial solid sphere objects from the HepG2 cytoplasm into 
GPMV. Top: HepG2 cells loaded with nano assemblies. Middle: Cells after vesiculation. 
Bottom: GPMVs after isolation. Quantum dots and e-GFP tyrosine kinase. 40 nm-sized 
polystyrene beads and e-GFP tyrosine kinase. 500 nm-sized polystyrene beads and e-GFP 
tyrosine kinase. Quantum dots and polystyrene beads:Red and  GFP:Green.  
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VESICULAR STRUCTURES INSIDE GPMVS  
The indication that 500 nm-sized solid sphere objects can be transferred from the donor cell 
cytoplasm into the GPMV interior opens a unique possibility of implementing a type of sub-
compartmentalization in which smaller hollow-sphere vesicular structures (liposomes, 
polymersomes) are confined within GPMV cavities. The successful implementation of this 
principle is important as it allows a higher degree of sub-compartmentalization of active 
molecules within nano-sized cavities of GPMVs, and thus shows the properties of a 
molecular factory. 
In order to achieve sub-compartmentalization within GPMVs, it is first necessary to have 
abundant lipid- or polymer-based vesicular compartments (i.e. liposomes or polymersomes) 
in the cytoplasm of the HepG2 cells. For this purpose, we incubated HepG2 cells with 
vesicles (liposomes and polymersomes) encapsulating sulforhodamine B (SRB) and 
carboxyfluorescein (CF) - hydrophylic trackers as markers for the integrity of aqueous 
cavities of the nano-sized compartments. SRB- and CF-loaded poly(2-methyloxazoline)-
block-poly(dimethylsiloxane)-block-poly(2-methyloxasoline) (PMOXA44-PDMS6-
PMOXA44) polymersomes and two types of SRB-loaded liposomes composed of 
DSPC:cholesterol:DSPE-PEG (48:42:10 %mol)  / DSPS:cholesterol:DSPE-PEG (53:42:5 
%mol) were prepared in the size ranges of 100 - 200 nm, as determined by DLS, TEM and 
Cryo TEM (Figure S21-S27). Efficient loading of SRB into the cavities of negatively charged 
DSPS-PEG (-3.5 +/- 0.5 mV) and net neutral-charged DSPC-PEG (0.507 +/- 0.1 mV) 
sterically stabilized liposomes and PMOXA44-PDMS6-PMOXA44 polymersomes was 
confirmed by fluorescence correlation spectroscopy (FCS) (Figure S28-29). After separation 
of polymersomes and liposomes from non-encapsulated SRB, FCS was further applied to 
determine the absence of non-encapsulated SRB, which could potentially co-diffuse into 
GPMVs (Figure S28-29). Once cells were loaded with the vesicular cargo of choice, as 
determined by CLSM, the GPMV vesiculation process was induced. 
 
Liposome-based sub-compartments  
As with solid sphere particles, we observed transfer of liposomes to the GPMV cavities, and 
the formation of spherical sub-compartment spaces within individual GPMV units (Figure 
32, Figure S32). The negative charge of DSPS liposomes and the PEG chains present on the 
surface of both DSPS and net neutrally charged DOPC liposomes were selected specifically 
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to promote free diffusion of objects within the GPMVs, since electrostatic or steric repulsions 
are known to reduce interactions with the negatively charged plasma membrane.201 
Encapsulated SRB remained confined to the liposome structure and did not distribute evenly 
through the GPMV cavities, as observed with the small molecular weight fluorophore loaded 
in GPMVs (Figure 30). Upon vesiculation, liposomes within GPMVs retained their 
fluorescence and exhibited similar free diffusion behavior to the encapsulated solid sphere 
nano-assemblies (Figure 32). Due to the negatively charged nature of DSPS liposomes and 
the PEG brushes present on the surfaces of both DSPS and DOPC liposomes, only minor 
interaction with the GPMV membrane was observed with an average of 1 – 2 liposomes per 
individual GPMV.    
 
Polymersome-based sub-compartments 
In comparison to liposomes, polymersomes are known to have a higher mechanical stability 
due to their thicker membranes, which makes them a superior and more sustainable option for 
sub-compartments within GPMVs.55,56 Transfer of SRB-loaded polymersomes from the 
cytoplasm of HepG2 cells into GPMV cavities was observed (Figure 32, Figure S30-32), and 
free diffusion of polymersomes within GPMV cavities was possible even after storage at 
20°C for 7 days. Polymersome-like structures were observed in ruptured GPMV structures in 
TEM (Figure S30-31). As with liposomes, no loss or spreading of the fluorescent signal as a 
free dye within the GPMV was observed by CLSM (Figure S34). This integrity of the sub-
compartments was confirmed by using FCS and comparing the molecular brightness (CPM) 
and diffusion times of sub-compartmentalized SRB-loaded polymersomes in GPMVs (CPM 
= 57.2 kHz) to free SRB-loaded polymersomes in solution (CPM = 140.6 kHz) (Figure S33-
34). Both molecular brightness’s of SRB-loaded polymersomes in GPMV and free 
polymersomes presented similar Gaussian distribution profiles in contrast to free SRB 
molecules in solution, which had an order of magnitude lower molecular brightness with a 
narrow distribution profile typical for a free dye (CPM = 13.0 kHz). Further FCS analysis of 
SRB-loaded polymersomes within GPMVs revealed that the diffusion of polymersomes 
shifts to longer diffusion (τd = 8459 µs) times when polymersomes are within the cytoplasm-
like environment of GPMVs (τd = 11757 µs) in agreement with the results demonstrating that 
the cytoplasm is transferred into the GPMVs during the GPMV formation (Figure 30). To 
further prove the high degree in which the inner composition of GPMVs can be controlled, 
we transferred free water-soluble e-GFP together with SRB-loaded                          
77                                                  
STRATEGY FOR CREATING BIOINSPIRED MOLECULAR FACTORIES WITH 
FUNCTIONALITY AS CELL MIMICS 
PMOXA44-PDMS6-PMOXA44 polymersomes into GPMVs strengthening the findings of sub-
compartmentalization. 
  
Figure 32. Transfer of artificial nano-sized hollow sphere objects from the HepG2 
cytoplasm into GPMV. Top: HepG2 cells after uptake. Middle: HepG2 cells after 
vesiculation. Bottom: Isolated GPMVs. Panel a) SRB-loaded DSPS liposomes. Panel b) 
SRB-loaded DSPC-PEG liposomes. Panel c) PMOXA-PDMS-PMOXA polymersomes. 
SRB:Red and GFP:Green.   
 
MOLECULAR FACTORIES BASED ON GPMVS, MF-GMPVS 
(MULTICOMPARTMENTALIZATION WITHIN GPMVS) 
Due to their biomolecule compatibility PMOXA44-PDMS6-PMOXA44 polymersomes were 
previously reported115 as biomimetic nano-compartment spaces, here referred to as catalytic 
compartments (CatCs), which allowed enzymes to function while confined to the aqueous 
cavities of polymersomes equipped with bacterial membrane proteins (OmpF). The 
confinement of enzymes inside CatCs mirrors the natural enzymatic compartmentalization in 
organelles, since the enzyme confinement within a limited space of a few nanoliters lowers 
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the enzymatic Km, and thereby increases the enzyme-substrate affinity in addition to 
protecting the enzyme from degradation.167 Due to their robust polymeric nature CatCs 
preserve their structure after cellular integration and have recently been applied as artificial-
organelles.119 
Here CatCs were prepared by loading the oxidative model enzyme, horseradish peroxidase 
(HRP) into PMOXA44-PDMS6-PMOXA44 polymersome cavities. In order to allow the 
encapsulated enzyme access to substrates through the robust polymer membrane, the 
bacterial outer membrane protein F (OmpF) was functionally reconstituted in the polymer 
membrane to form functional nano-compartment spaces.202 This type of CatCs has been 
applied recently as an artificial cell organelle with good biocompatibility and preservation of 
function and architecture upon cellular uptake and has been shown to function in an in vivo 
environment.119 The prepared CatCs were characterized by DLS and TEM in terms of 
structure, and by the fluorescent enzymatic Amplex UltraRed assay in terms of functionality 
(Figure S35-38) with HRP-loaded polymersomes with unpermeabilized membranes serving 
as a control. 
Multi-compartmentalization of CatCs within the GPMV cavities represents a design for the 
first functional hybrid cell-like molecular factory where a predominantly synthetic artificial 
organelle functions in a cell-derived artificial cell. The separate localization of the fluorescent 
signals of SRB and e-GFP indicates that sub-compartments within individual GPMV can 
exist within a distinct nano-environment that is different from the rest of the GPMVs, (Figure 
33). GPMVs loaded with CatCs were derived from HepG2 cells, as described above for SRB-
loaded polymersomes, and Amplex UltraRed was chosen as an enzymatic substrate to 
evaluate the CatCs functionality once within cavities of GPMVs, as the small molecular 
weight molecule has previously been shown to diffuse through lipid membranes and the 
plasma membrane of cells, but not through polymersome membranes (Figure 34).115,203 
Along with H2O2, HRP encapsulated within CatCs catalyzes the reaction of AR to a 
fluorescent resorufin-like product in a stoichiometric manner, with a rate limiting step 
determined by the diffusion of H2O2 through the lipid membrane. However, the oxidation of 
Amplex UltraRed by HRP and H2O2 is difficult to follow using CLSM, as the fluorescent 
resorufin-like product also diffuses out of the GPMVs as it is. In order to demonstrate that the 
reaction takes place within the GPMV cavities, we made use of local production of H2O2. 
The enzymatic substrates H2O2 and AR were added to the GPMV solution and allowed to 
diffuse into the cavities for 2 hours. At first, no significant change in fluorescence was 
observed within the GPMV cavities, due to product diffusion out of the cavities. However, 
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since the diffusion of AR into the aqueous cavities of GPMVs is faster than that of H2O2, the 
2-hour delay allowed AR to accumulate within the GPMVs.204 To visualize the reaction of 
AR to resorufin-like product, we illuminated the GPMVs with a focused 545 nm and thereby 
speeding up the reaction of AR, in presence of HRP, to the fluorescent resorufin-like 
product.204 Compared to GPMVs equipped with control CatCs, an increase in fluorescence 
was observed limited to the illumination time. The fluorescence within GPMVs subsequently 
decreased after ceasing illumination, due to product diffusion out of the GPMV cavities. 
GPMVs loaded with control nanoreactors (HRP polymersomes without OmpF) and GPMVs 
filled by only cytoplasm demonstrated only a minor or no increase in fluorescence, as the AR 
substrate cannot effectively diffuse through the polymersome membranes unless they are 
permeabilized with OmpF nor can the reaction take place efficiently without the HRP catalyst 
(Figure S38).170,204  In this way we demonstrate that by fulfilling the requisites of having a 
substrate permeable outer compartment membrane and an inner molecular machinery that 
supports multi-compartmentalization, GPMVs can be used to provide enzymatic reactions on 
demand in a cell-like manner.  
 
 
Figure 33. Functional MF-GMPVs: Schematic representation of multi-compartmentalized 
GPMVs. A) GPMVs loaded with water soluble e-GFP and SRB-loaded PMOXA-PDMS-
PMOXA polymersomes. B) GPMVs loaded with PMOXA-PDMS-PMOXA polymersomes with 
encapsulated HRP after addition of substrates H2O2 and Amplex UltraRed. C) GPMVs 
loaded with OmpF-equipped PMOXA-PDMS-PMOXA polymersomes with encapsulated HRP 
after addition of substrates H2O2 and Amplex UltraRed. 
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TOWARDS IN VIVO SYSTEMS 
Size, composition, sub-compartmentalization and the unique possibility of customization 
make e-GPMVs the closest cell mimic available up till now.  However, a crucial aspect 
necessary to be considered is their stability, toxicity and applicability in a relevant in vivo 
environment. In previous artificial-cell studies this has been neglected - micro compartment 
spaces acting as cell mimics were only shown to function in vitro where they interacted with 
their environment, among themselves21 or with other eukaryotic / prokaryotic cells79 in 
culture. In order to demonstrate that our e-GPMVs sustain their structure in an in vivo 
environment, we decided to test the artificial cell system in zebrafish embryos as an animal 
model, which has previously been used to bridge the gap between in vitro studies and studies 
in mammalian organisms (i.e. mice). Due to their optical transparency, relative 
straightforward genetic modification (i.e. eGFP tagging of immune cells or vasculature) 
zebrafish embryos have proven themselves on several occasions as great models for 
pharmacokinetic behaviors of drugs and nanoparticles205,206 and disease models.207 In order to 
promote e-GPMV stability in vivo and decrease unspecific protein absorption we choose for 
injection eGPMV, which had membranes enhanced with Cholesterol-polyethylene glycol-
5000 as described above (Figure 34). In addition, we loaded the eGPMV inner cavity with 
water soluble RFP (Figure 34) serving as a marker for the hollow sphere nature of eGPMVs. 
Once injected intravenously via the duct of cuvier of the zebrafish embryos eGPMVs in the 
size of 10 µm were observed circulating in the vasculature of zebrafish for up to 4 hours 
(Image 34). No acute toxicity, such as change in behavior i.e. mobility, seizures, heart failure 
or other toxic effects such as malformations, denaturation of tissue fluids or yolk mass was 
observed in 16 out of 18 ZFE injected with eGPMVs. 2 of the 18 ZFE died due to apparent 
heart failure or thrombus formation at the injection site. The process of GPMV integration in 
the organism set in directly after the eGPMV injection, however only smaller eGPMVs (2-5 
µm) were seen integrated in the zebrafish tissue most likely due to their size (Figure 34). 
Surprisingly eGPMVs that transferred from circulation to tissue retained their hollow sphere 
architecture even after 24h. Their hollow sphere architecture and preservation of the vesicular 
cargo was verified by photo bleaching experiments within the GPMV cavities, where RFP 
exhibited a typical exponential photo bleaching behavior (Figure 34).208,209 
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Figure 34. Towards in vivo systems. A) RFP-loaded GPMVs in ZFE circulation. B 1-2) 
Maxiumum projection image of RFP-loaded GPMVs in ZFE. C) Photobleaching of RFP-
loaded in GPMVs in ZFE after 24h. D1) RFP-loaded GPMV in ZFE before photobleaching. 
D2) RFP-loaded GPMVs after Photobleaching.  
 
 
CONCLUSION 
Life is chemistry that takes place in very defined circumstances. This work represents the first 
report of a cell-like molecular factory, MF-GMPV based on giant plasma membrane vesicles 
combined with synthetic functional compartments that allow chemical reactions to happen in 
life-like conditions. Such a hierarchical approach in compartmentalization allows the lower-
level synthetic functional compartments within the GPMV to act as independent anatomically 
discreet units that specialize in their own function, making them nanoscale versions of nature 
own organelles. The possibility of designing molecular factories by manipulating cellular 
material (cytoplasm and plasma membrane) by genetic modification together with the 
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encapsulation of solid sphere structures nanoparticles / vesicular structures (liposomes, 
polymersomes) in the cytoplasm-like cavities of the GPMVs represents the basis of these 
molecular factories.  
When encapsulated in GPMVs, solid sphere structures can further be used as sensors when 
there are active objects on their surfaces (i.e. fluoropores), and enzyme-equipped 
polymersomes with a reconstituted membrane protein (OmpF) can be encapsulated inside the 
GPMVs as enzymatic nanoreactors where they retain their functionality. When substrates 
were added to the outer solution of the GPMVs, it was shown that they could penetrate both 
the membrane of the GPMVs and the inner compartment membranes of the synthetic 
nanoreactors equipped with OmpF pores. This allowed the enzymatic reaction to take place 
in the inner cavities of the nanoreactors. Successful substrate conversion was visualized by 
the fluorescent product (resorufin-like product), which could leave the polymersome and 
diffuse inside the GPMV cavity, which thus allowed the substrates to be transported to the 
inside and the product to diffuse out of these polymersomes. Finally, we demonstrate that 
equipped GPMVs can act as artificial cell mimics – retaining their membrane and inner 
composition if they are injected into multicellular organisms. To the best of our knowledge, 
this is the first time that a molecular factory functioning as a cell-like mimic has been be 
constructed and has been tested in vivo by taking advantage of the fundamental nature of 
GPMVs.   
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CONCLUSION AND OUTLOOK 
Towards the development of cell mimics, the creation of giant unilamellar vesicles (GUVs 
and GPMVs) with inserted functional biomolecules or membrane proteins could be realized 
in this work. Due to their size in the micrometer range, which corresponds to the size of 
eucaryotic cells, GUVs and GPMVs have the unique advantage that they can be visualized 
and analysed by microscopy techniques in real-time. This allows getting a deeper insight into 
biological processes.  
We demonstrated that synthetic GUVs are suitable platforms to study the permeating 
properties of biopores. It was possible to insert the small pore-forming peptide gramicidin 
with preserved functionality into the membranes of polymer GUVs. The functional insertion 
was successful in a small library of PMOXAx-PDMSy-PMOXAx copolymers, which self-
assemble in giant unilamellar vesicles (GUVs) with membrane thickness ranging from 9.2 to 
16.2 nm. Due to the mismatch between the pore length and the polymer membrane thickness 
the functional insertion in thicker membranes was not possible. The functionality of this 
biopore which is known to allow transport of protons could be visualized by the 
encapsulation of a fluorescent pH-sensitive dye inside the GUV cavities. Proton gradients 
between the environment of GUVs and their inner cavity served to assess the exchange of 
protons across the membrane upon gA insertion. With this approach pH self-regulating 
GUVs, which maintain their integrity in different pH gradient conditions could be created.  
Further it was possible to use synthetic GUVs in order to visualize an enzymatic reaction 
inside their cavities by the functional reconstitution of the membrane protein OmpF, a next 
step towards mimicking cell architecture. This was the first time a membrane protein could 
be reconstituted into the membrane of polymer GUVs with preserved functionality which is 
shown by initiating an in situ enzymatic reaction with a fluorescent product produced inside 
GUV cavities where the enzyme was encapsulated. The pore OmpF allowed the diffusion of 
substrates and products through the membrane of GUVs. Due to the fluorescent product the 
model enzyme reaction inside the GUV cavities was monitored in real-time and gave insight 
into both the substrate conversion rate by the encapsulated enzyme and the reconstitution of 
the functional membrane protein (OmpF) in synthetic GUV membranes. The encapsulated 
enzyme could diffuse freely inside the large GUV cavities. Further there seems to be a size-
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dependent trend in enzyme conversion rate in respect of GUV diameters. Due to their micro-
sizes, GUVs provide the unique opportunity for observing the behavior of biomolecules 
within their defined confined spaces via microscopic techniques. The approach of equipping 
the synthetic membranes together with the cavities of GUVs with biomolecules opens the 
way towards cell-like compartments as novel materials. These bio-equipped GUVs not only 
offer increased stability and lower membrane permeability compared to lipid GUVs, they 
further facilitate the control of specific catalytic reaction inside confined spaces mimicking 
the size and architecture of native cells. This straightforward approach serves to obtain 
deeper insights of biological processes or interactions of biomolecules with membranes in 
real-time or as biosensors. Therefore they allow the relevant study of bio-processes in vitro in 
a simple manner.  Thinking even further ahead, molecular factories and advanced cell mimics 
could be developed by encapsulating in cell-sized GUVs various polymersomes loaded with 
different types of enzyme inside their cavities. 
Finally the first bioinspired molecular factory with functionality as a real cell mimic could be 
realized based on micrometer-sized giant plasma membrane vesicles (GPMVs).  
GPMVs are cell-derived giant vesicles consisting of an outer compartment architecture 
(membrane) and an inner composition, which both directly mirror the composition of cells 
from which they originate except the larger organelles like for example nuclei and Golgi 
apparatus making measurements easier and are the closest cell-mimic available on the market 
up to now. 
 In a step towards the development of bioinspired molecular factories with functionality as 
cell mimics, we created sophisticated hybrid molecular factories based on GPMVs, which are 
equipped with a synthetic molecular machinery inside their cavities that provides 
functionality. Such a hierarchical approach in compartmentalization allows the lower-level 
synthetic functional compartments encapsulated within the cavities of the GPMVs to act as 
independent anatomically discreet units that specialize in their own function, making them 
nanoscale versions of nature own organelles. 
The realization of the bioinspired molecular factory was achieved via the encapsulation of 
nanoreactors inside the GPMV cavities where they retained their functionality. These 
nanoreactors represented enzyme-equipped polymersomes with a reconstituted membrane 
protein (OmpF), which was essential to allow substrates and the product to pass the polymer 
membrane. Therefore, the substrates which were added to outer solution could pass the 
GPMV membranes and further the inner compartment membranes of the synthetic 
nanoreactors to reach the enzyme. The functionality of the nanoreactors when encapsulated 
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inside GPMVs could be visualized due to the generated fluorescent product of the enzymatic 
reaction which could leave the nanoreactors and diffused into the cavities of the GPMVs. As 
a result the cavity of the GPMVs showed fluorescence.   
Finally equipped GPMVs retained their architectures (membrane and inner composition) 
when injected into multicellular organisms – Zebrafish embryos. This was the first time that a 
molecular factory functioning as cell mimic has been tested in vivo by taking advantage of 
the fundamental nature of GPMVs. 
The successful creation of synthetic GUVs equipped with functional biomolecules like the 
small pore forming peptide gA and the bacterial membrane protein OmpF shows great 
promise towards the reconstitution of more sensitive membrane proteins, or further the 
reconstitution of different kinds of membrane proteins at the same time into the polymer 
membranes of GUVs. Further the realization of the first artificial molecular factory by using 
GPMVs opens the way towards the production of man-made artificial cells. The option to 
design both, their membranes by gene modification and their inner cavities by equipping 
them with any kind of biomolecules, compartments and nanoreactors could enable the 
creation towards closer cell mimics for example different functional reconstituted membrane 
proteins/receptors etc. combined with different kinds of functional compartments inside their 
cavities would give us a deeper insight into the cell metabolism of native cells.  
The creation of artificial cell-sized compartments used as biomimetic microscale platforms to 
visualize and imitate biological processes in real-time can increase our knowledge about 
understanding native cells, the smallest unit of life. A micrometer-sized artificial cell makes it 
possible to get a deeper insight into the otherwise hidden world in the nanometer range.  
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CHAPTER 3 
Materials  
Gramicidin from Bacillus aneurinolyctus (Bacillus brevis), linear polypeptide antibiotic 
complex A mixture of gramicidins A, B, C, and D, 8-hydroxypyrene-1,3,6-trisulfonic acid 
trisodium salt (pyranine), 5(6)-carboxyfluorescein, monosodium phosphate (NaH2PO4), 
potassium phosphate dibasic (K2HPO4), potassium phosphate monobasic (KH2PO4), sodium 
chloride (NaCl), sodium hydroxide (NaOH), hydrochloric acid (HCl), ethanol (EtOH), and 
dimethyl sulfoxide (DMSO), C2H6OS, were obtained from Sigma Aldrich (Buchs, 
Switzerland) and were used as received. 6-(((4,4-difluoro-5-(2-thienyl)-4-bora-3a,4a-diaza-s-
indacene-3-yl)styryloxy)acetyl) aminohexanoic acid, succinimidyl ester (BODIPY) 630/650 
fluorophore was purchased from Molecular Probes (Eugene, United States). Asante Natrium 
Green-2 (ANG-2) and Asante Potassium Green-2 (APG-2) were purchased from TEFLabs 
Inc. 
 
Preparation of giant unilamellar vesicles (GUVs) and insertion of gA  
GUVs were formed by the electroformation technique210 using a Nanion Vesicle Prep Pro 
setup (Nanion Technologies, Munich, Germany). Briefly, 50 μL of a 4 mg/mL polymer stock 
solution in EtOH was spread on an indium tin oxide (ITO) coated glass slide to form a 
smooth polymer film on the glass surface, followed by drying for 45 min in high vacuum. By 
using an O-ring, a closed chamber was formed filled with a solution containing 100 mm 
sucrose, 10 mm K2HPO4/KH2PO4, pH 5.5 and 0.05 mM 5(6)-carboxyfluorescein (Sigma). 
Electroformation was performed overnight, in dark at RT (2.0 V, 3.0 Hz). 
 
For imaging, GUVs containing gA were formed by addition of 0.7 μL 0.32 mg/mL gA (567 
nM final concentration) to GUVs solution. gA insertion was tested by changing the pH with 1 
μL of 0.4 M NaOH. The intrinsic permeability of GUVs to proton outflux was verified by 
incubating solutions of GUVs with 0.7 μL DMSO:EtOH (1:1) ratio solvent, and 1 μL 0.4 M 
of NaOH. 
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Confocal laser scanning microscopy (CLSM)  
CLSM experiments were performed on a confocal laser-scanning microscope (Zeiss LSM 
510-META/Confocor2, Carl Zeiss, Jena, Germany). An Argon/2 laser (λ = 488 nm, 30 mW, 
25% power output, 0.5% transmission) as the excitation source. A main dichromatic beam 
splitter (HFT 488/543), a secondary dichroic beam splitter (NFT 515) and a band pass filter 
(BP 505-530) were used in all experiments. In case of BODIPY, a He–Ne laser (λ = 633 nm) 
was used as the excitation source with a transmission of 15%, and main dichromatic beam 
splitter (HFT UV/488/543/633), a secondary dichroic beam splitter (NFT 545) and a band 
pass filter (LP 650). The images were recorded with a water immersion objective (C-
Apochromat 40x/1.2W). Each sample was scanned unidirectionally using an automatically 
controlled time series with a cycle delay of 5s. 
 
GUV solutions were diluted in 60 mM K2HPO4/KH2PO4 buffer and transferred to plasma-
cleaned 8-well borosilicate microscopy chambers (ThermoFischer Scientific). For 
visualization purposes, GUV membranes were stained with Bodipy 630/650. Gramicidin 
insertion in GUV membranes was observed by using a fluorescently labeled amphiphilic 
peptide (OG488-K8-gA), containing the complete gA sequence labeled with 
OregonGreen488. As both OG488 and Bodipy have different excitation and emission 
wavelengths (OG488: λex = 501/λem = 526, and Bodipy 630/650: λex = 625/λem = 640 
respectively), CLSM is suitable for their concurrent visualization. 
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CHAPTER 4 
Materials 
Reagents and materials were of the highest commercially available grade and used without 
further purification, unless indicated. Reagents were purchased from Sigma-Aldrich unless 
otherwise specified. n-octyl-β-D-glucopyranoside (OG) (Anatrace), Amplex UltraRed, 30% 
H2O2 (Sigma Aldrich), Horseradish Peroxidase Type IV (Sigma Aldrich), Atto 488 
maleimide (ATTO-TEC GmbH), Atto 488 succinimide ester, (ATTO-TEC GmbH), sucrose 
(Sigma Aldrich) and polystyrene beads (2-10 µm) (Spherotech). A 4-15% Mini-PROTEAN® 
TGX™ Precast Gels SDS (Biorad). 
 
Polymer synthesis 
PMOXA-b-PDMS-b-PMOXA (poly(2-methyl-2-oxazoline) - block - poly(dimethylsiloxane) 
– block – poly(2-methyl-2-oxazoline)) triblock copolymer (A7B49A7) was synthesized 
according to the protocol described previously.83 
 
GUV preparation 
GUVs were prepared by the film rehydration method. Briefly 0.2 mg of the polymer 
PMOXA-b-PDMS-b-PMOXA (A7B49A7), dissolved in 50 µL ETOH was dried for 1h under 
vacuum. Afterwards the film was rehydrated with 680 µL 300 mM sucrose in ddH2O. The 
sample was then held at RT overnight without stirring. 
 
OmpF expression and extraction  
The OmpF K89 R270 cysteine mutant (OmpF-M) expression and extraction was done as 
previously reported in 115,170. First under aseptic conditions, a loop full of cells from an 
ampicillin resistant Escherichia Coli strain BL21 stock culture that overexpressed the OmpF 
K89 R270 mutant was smeared onto the surface of a lysogeny broth (LB), ampicillin (100 mg 
mL-1 ampicillin) agar plate. After 16 hours of incubation at 37 °C, a single colony was 
selected and transferred from the plate to 10 mL of terrific broth (TB) liquid medium with 
100 mg mL-1 ampicillin (4 flasks in total). 5 L TB medium with 100 mg mL-1 ampicillin was 
inoculated with 15 mL of the overnight culture (OD = 0.1-0.5), and the optical density of the 
growing culture was followed by measuring the absorbance at 600 nm. When the absorbance 
reached an OD of 0.6, IPTG was added to a final concentration of 1 mM in order to start the 
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over-expression of the OmpF-M gene. The bacteria were grown for 16 more hours at 25 ºC, 
with vigorous stirring, then the E. Coli cells were pelleted at 7.000 g for 8 min at 4 ºC.  
Pellets were stored at -25 ºC, and on the following day were re-suspended in 50 mL of 25 
mM Tris-HCl pH 7.4. 10 mg DNase and 10 mg RNase were added, and the cell suspension 
French pressed five times at 1,000 bar. 1 mL of 20% SDS was added per 10 mL of cell 
suspension and incubated for 1 h at 60 ºC. The suspension was centrifuged at 50.000 g at 23 
ºC for 1 hour. The supernatant was removed and the cell pellet incubated in 0.125% OG for 1 
h at 37 ºC. The suspension was then centrifuged at 50.000 g for 1 hour at 23 ºC. Finally, the 
cell pellet was re-suspended in 3% OG in 10 mM phosphate buffer and homogenized. The 
suspension was centrifuged at 50.000 g and the protein concentration in the supernatant was 
determined by UV-Vis absorption at 280 nm. Before the reconstitution experiments were 
carried out, the protein was dialysed against 1L of 0.05 % OG in PBS for 16 hours and twice 
against PBS pH 7.4 for 2 hours. After the dialysis the protein concentration was adjusted to 
1.2 mg mL-1. 
 
Labeling of OmpF-M  
The OmpF K89 R270 double cysteine mutant in 3% OG was modified by attaching Atto 488 
maleimide (MW 1067 kDa, Atto 488 maleimide, BioReagent, suitable for fluorescence, 
≥90% from Sigma) to free thiol groups of cysteine residues. The same reaction was also 
performed in presence of either OmpF wild type (OmpF-WT) in 3% OG) or 3% octyl 
glucopyranoside. This served as a control of unspecific interactions of the fluorophore with 
other amino acid residues or OG micelles. 10 µL of 10mM Atto 488 dissolved in 5% DMSO 
in PBS buffer pH 7.4 was added to 400 µL of 0.9 mg mL-1 OmpF, and mixed. The protein 
was purified by washing 20 times with 1% OG in PBS pH 7.2 in Vivaspin-0.5 mL centrifugal 
filters for protein purification and concentration, molecular cut off: 10 kDA (10 min at 13 
000 RPM). The volume was adjusted to 475 µL PBS pH 7.2 and the protein concentration 
was determined by UV-Vis spectroscopy. 40 µL of the purified protein fraction was taken for 
FCS analysis and SDS gel electrophoresis. Before the reconstitution experiments were 
carried out, the protein was dialysed against 1L of 0.05 % OG in PBS for 16 hours and twice 
against PBS pH 7.4 for 2 hours. No residual fluorescence was observed in the OG and 
OmpF-WT controls, as determined by FCS.  The protein concentration was determined by 
UV-Vis spectroscopy (Nanodrop) and adjusted to 0.4 mg mL-1 with 0.05% OG, PBS. 
 
90 
MATERIALS AND METHODS 
Reconstitution of OmpF-M  
Before the reconstitution the media of OmpF-M (PBS) was exchanged to ddH2O by filtering 
using 10 kDa Amicons (4 x 400 µL ddH2O). For control experiments the first flowthrough 
when exchanging the OmpF-M media from PBS to ddH2O was taken and washed with 4 x 
400 µL ddH2O. The reconstitution was carried out by adding 10 µL of a solution of OmpF-M 
in water (≈1.2 mg mL-1) calculated/measured by UV-Vis spectroscopy (Nanodrop, 
Thermofischer Scientific) or 10 µL of the control solution directly to the film formation 
solution (0.2 mg polymer PMOXA-b-PDMS-b-PMOXA (A7B49A7) in 40 µL ETOH.  
 
Flow cytometry  
For flow cytometry measurements, the GUVs solution (containing GUVs in 300 mM sucrose 
solution in ddH2O with encapsulated enzyme HRP) was diluted 1:1 with PBS and 600 µL of 
this solution was used for dialysis using 300 kDa cut-off Spectrapore dialysis tubes. The 
dialysis was carried out for 24 h and 3 x buffer (PBS) was exchanged during that time period 
approximately every 24h. Afterwards the volume was adjusted again to 600 µL. A sample 
volume of 400 µL was chosen in which 50 µL of the dialysed sample solution (polymer only-
control, filtrate-control and OmpF-M sample) was added to 350 µL PBS and measured first 
without adding the reactants. Then 50 µL of the dialysed sample solution (polymer only-
control, filtrate-control and OmpF-M sample) was added into 300 µL PBS. Afterwards 70 µL 
of a solution in PBS containing the reagents Amplex UltraRed and H2O2 was added to the 
GUV solution, carefully mixed by pipetting and immediately measured by flow cytometry.  
Flow cytometry analysis was performed using a BD FACSCanto II flow cytometer (BD 
Bioscience, USA). Doublets were excluded using FSC and SSC detectors. For assessing the 
OmpF-Atto 488 reconstitution – single GUVs were excited at 488 and the emission was 
detected using FL-1 (533/30; Atto 488 channel). For assessing the Amplex UltraRed 
conversion, single giants were excited at 561 nm and the emission was detected in FL15 
(586/15; resorufin channel). A total of 4000 events for each sample were analyzed, and data 
processed using Flow Jo VX software (TreeStar, Ashland, OR). The samples were measured 
in “slow flowthrough” mode and the cytometer nozzle was kept at an appropriate distance 
from the sampling tube in order to prevent shear forces, which could influence the GUV 
integrity. 
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Labeling of the enzyme HRP                          
1 mL of HRP (0.2 mg mL-1 44 kDa, 4.5 µM) in sodium bicarbonate buffer (pH=8.2) was 
mixed with 10 µL of Atto 488 succinimide ester in DMSO (final dye concentration in this 
mixture 100 µM). The solution was placed on a shaker overnight (24 hours) at 20 ºC. 
Afterwards 500 µL of this solution was dialysed against PBS for 2 days using dialysing tubes 
with a 14 kDa cut-off Membra-CelTM (Carl Roth, Germany) and the buffer was exchanged 
twice per day approximately every 8 hours. Afterwards the volume was adjusted again to 500 
µL using PBS. By using spin-columns (Vivaspin500) with a 10 kDa cut-off the sample was 
washed 10 x with 500 µL PBS in each case. The next step was the FCS measurements to 
determine the success of the enzyme labeling. For enzyme encapsulation experiments in 
GUVs, the PBS was exchanged by 300 mM sucrose in ddH2O by using spin-columns 
(Vivaspin500) with a 10 kDa cut-off. Therefore, the solution of HRP in PBS was washed 3 x 
using 400 µL 300 mM sucrose in ddH2O. Afterwards FCS measurements were performed, 
and a SDS-PAGE gel prepared to verify the successful labeling of the enzyme. For control 
experiments the unlabeled HRP was used without further purification. To visualize the 
enzyme encapsulation by using the labeled enzyme, the same amount of enzyme was used as 
that of the unlabeled enzyme used for the reaction inside the GUVs.  
 
Enzyme encapsulation  
The enzyme HRP (0.05 µM for LSM experiments and 0.025 µM for flow cytometry 
experiments) in 680 µL sucrose solution was added to the dried polymer film with or without 
OmpF-M. The formed GUV solution was diluted 1:1 with PBS. Because of the higher 
molecular weight of the sucrose compared to the buffer components, the GUVs immediately 
drop down to the bottom/surface of the chamber, interact with the hydrophilic glass and form 
hemispheres. After 15 min, the sample (200 µL) was washed with PBS by 10 addition and 
removal steps of 50 µL PBS to remove any free enzyme. 
 
Confocal laser Scanning microscopy (CLSM) 
For LSM measurements, the solution of HRP-loaded GUVs or HRP-loaded GUVs equipped 
with OmpF-M in 300 mM sucrose solution in ddH2O was diluted 1:1 with PBS (150 mM) for 
each sample to allow the GUVs to settle on the chamber surface due to a difference in density 
between the GUV inner cavity and outer environment.  
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GUVs were adsorbed (immobilized) on the borosilicate glass surface of a plasma-treated 
microscopy chamber (Nunc™ Lab-Tek™ Chamber Slide System, Thermo Fisher Scientific) 
filled with isosmotic buffer (PBS).  
Briefly, the microscopy chamber slide was first oxygen-plasma cleaned for 5 minutes in 
order to generate hydroxyl groups on the glass surface. The microscopy chamber was then 
filled with the sample solutions (200 µL).  After 15 min, the sample was washed with PBS by 
10 addition and removal steps of 50 µL PBS to remove any free enzyme. 
Suitable GUVs were selected in the LSM (laser scanning microscopy) mode. 
Confocal laser Scanning microscopy (CLSM) measurements were performed at 20 °C using a 
confocal laser scanning microscope (ZEISS LSM 510 META-ConfoCor, inverted 
microscope ZEISS Axio Observer, Carl Zeiss, Germany) with a water immersion objective 
lens (C-Apochromate 40x/1.2W korr). For CLSM measurements, a He-Ne laser was used 
(λ = 543 nm, 5 % laser intensity) as the excitation source. A main dichromatic beam splitter 
(HFT 488/543) was used in all the experiments. The detector range was set to 560-615 nm. 
The pinhole was adjusted to 1 airy units and the gain was set to 700. Each sample was 
scanned unidirectionally using a scan time of 16.73 seconds per image and 512 x 512 pixels 
with a Bit Depth of 8 Bit. Videos were taken with an image recording time of 15.7 s/image 
and 1 s delay. Afterwards the mean fluorescence intensity of every raw image was calculated 
using the program ImageJ to calculate the fluorescence intensity.  
For CLSM measurements, only GUVs ≥ 5 µm were selected. The substrates Amplex 
UltraRed (5 µL of 0.1 mmol mL-1 in DMSO) and H2O2 (5 µL of 0.1 mmol mL-1 in ddH2O) 
were mixed and these 10 µL were added during the measurements.   
 
FCS measurements  
All FCS measurements were carried out using a ConfoCor2 instrument (Carl Zeiss, 
Germany) with a 40x, 1.2. water immersion C-Apochromat objective lens. Measurements 
were carried out at room temperature. An Argon 488 laser was used for excitation of the Atto 
488 fluorophore at 488 nm (Laser power output 20%, 2.8 mW) with the appropriate filter sets 
(HFT 488, BP 505-550). The fluorescence signal was measured in real-time and the 
autocorrelation function was calculated by a software correlator (LSM 510 META-ConfoCor 
2 System). Measurements were recorded over 3s and each measurement was repeated 30 
times for measurements done with Atto 488 labeled HRP and repeated 60 times for 
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experiments done with Atto 488 labeled OmpF-M. Correlation curves that could not be fitted 
were excluded (<10%). 
 
For determining the specific binding of Atto 488 succinimide ester to HRP and and Atto 488 
malemide to OmpF-M, experimental auto correlation curves were fitted using a two-
component model including the triplet state (Eq. 1). 
 
 
Eq. 1: 
G(τ)fit = 1 + �1 + 𝑇𝑇1− 𝑇𝑇 𝑒𝑒− 𝜏𝜏𝜏𝜏trip� 1𝑁𝑁
⎣
⎢
⎢
⎡ 𝑓𝑓11 + 𝜏𝜏𝜏𝜏D1 1�1 + 𝑅𝑅2 𝜏𝜏𝜏𝜏D1⎦⎥⎥
⎤ + �1 + 𝑇𝑇1 − 𝑇𝑇 𝑒𝑒− 𝜏𝜏𝜏𝜏trip� 1𝑁𝑁
⎣
⎢
⎢
⎡ 𝑓𝑓21 + 𝜏𝜏𝜏𝜏D2 1�1 + 𝑅𝑅2 𝜏𝜏𝜏𝜏D2⎦⎥⎥
⎤
 
 
τD represents the diffusion time, T the fraction of fluorophores in triplet state with triplet time 
τtrip, N is the number of particles and R the structural parameter.  
R and τD of free dye (Atto 488) were determined independently, experimental auto 
correlation curves were fitted using a one component model including triplet state (Eq. 2). 
 
 
Eq. 2: 
G(τ)fit = 1 + (1 + 𝑇𝑇1 − 𝑇𝑇 𝑒𝑒− 𝜏𝜏𝜏𝜏trip) 1𝑁𝑁
⎣
⎢
⎢
⎡ 11 + 𝜏𝜏𝜏𝜏D 1�1 + 𝑅𝑅2 𝜏𝜏𝜏𝜏D⎦⎥⎥
⎤
 
 
τD represents the diffusion time, T the fraction of fluorophores in triplet state with triplet time 
τtrip, N is the number of particles and R the structural parameter. R and τD of free dye (Atto 
488) were determined independently.  
R and τD of Atto 488 were subsequently fixed in the fitting procedure in order to determine 
the % of free dye fraction, which represented the unreacted fluorophore still present in the 
solution after purification of HRP or OmpF-M conjugated with Atto 488. 
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The Amplex UltraRed (AR) conversion kinetics of free HRP in solution measured via 
Spectra max (Molecular devices) 
(1) 10 µL of a mixture of AR (0.4 µmol mL-1) and H2O2 (0.4 µmol mL-1) in PBS was added 
to 200 µL of a solution of HRP (0.321 ng mL-1) in 300mM sucrose in ddH2O. (in sucrose) 
(2) For comparison 10 µL of a mixture of AR (0.4 µmol mL-1) and H2O2 (0.4µmol mL-1) in 
PBS was added to 200 µL of a solution of HRP (20.0 ng mL-1) in PBS. (in PBS) 
(3) 10 µL of a mixture of AR (0.4 µmol mL-1) and H2O2 (0.4 µmol mL-1) in PBS was added 
to 200 µL of 300mM sucrose in ddH2O. (without HRP) 
(4) 10 µL of AR (0.4 µmol mL-1) in PBS was added to 200 µL of a solution of HRP (20.0 ng 
mL-1) in 300mM sucrose in ddH2O. (without H2O2) 
(5) 10 µL of H2O2 (0.4 µmol/mL) in PBS was added to 200 µL of a solution of HRP (20.0 ng 
mL-1) in 300mM sucrose in ddH2O. (without AR) 
 
Preparation of OmpF nanoreactors with encapsulated enzyme 
Polymersome nanoreactors were prepared at 20 ºC from the ABA triblock copolymer, 
PMOXA-b-PDMS-b-PMOXA (A7B49A7) and OmpF K89 R270 as previously reported in 
115,170. The synthetic procedure and the polymer characterization are presented in 83. 
Nanoreactors were generated using the film rehydration technique in the presence of OmpF-
M, and HRP in either PBS buffer pH=7.4 or 300 mM sucrose in ddH20 at 20ºC. Thin 
polymer films were rehydrated to a final polymer concentration of 2.5 mg mL-1, HRP 
concentration of 0.2 mg mL-1, and OmpF-M concentration of 80 µg mL-1, respectively. 
Polymersomes without OmpF-M were also prepared in the absence of OmpF-M. Rehydrated 
films were stirred overnight at 20 ºC. On the following day all samples were extruded 
through an Avanti mini-extruder (Avanti Polar Lipids, Alabama, USA) using a 100 nm 
diameter pore-size polycarbonate membrane (11 times) in order to obtain size homogeneity. 
Non-encapsulated HRP was removed from the nanoreactors by dialysis against PBS at pH 
7.4 at 20 ºC for 5 days, exchanging the buffer every 8 hours, using Spectrapore dialysis tubes 
with a molecular weight cut-off of 300 kDa (from Spectrum Laboratories Inc.) All activity 
measurements were performed on the following day. 
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Functionality of the enzyme reaction in OmpF nanoreactors under the same conditions 
In order to verify if the sucrose buffer used in the rehydration solution of the polymer film 
affects OmpF-M insertion and the self-assembly of the PMOXA-b-PDMS-b-PMOXA 
(A7B49A7)  polymer, the insertion of the porin was tested on smaller polymersomes as 
previously reported115,167 with the modification of using the sucrose buffer. Sucrose did not 
appear to influence the membrane permeability or architecture (Figure S5, S6) of the 
upermeabelized HRP-loaded polymersomes, nor did it influence the OmpF-M insertion into 
the polymersomes.  
 
TEM 
0.5 mg mL-1 HRP-loaded polymersomes or HRP-loaded polymersomes equipped with 
OmpF-M solution were used for for TEM imaging studies were negatively 
stained with 1.5% uranyl acetate solution and deposited on carbon-coated copper grids. A 
transmission electron microscope (Philips Morgagni 268D) at 293 K was used (Figure S3a). 
 
Dynamic lightscattering 
The measurements of DH of polymersomes were performed on a Zetasizer Nano ZSP at 25 
°C. The measure angle is 173° and the data were analyzed by intensity distribution. 450 μL of 
0.5 mg mL-1 HRP-loaded polymersomes or HRP-loaded polymersomes equipped with 
OmpF-M solution were used for the measurements. 
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CHAPTER 5 
Isolation of GMPVs 
The supernatant from the 6-well plates was transferred to an Eppendorf tube and centrifuged 
at 100 g for 10 min to remove cells. 200 µL of the supernatant was transferred to poly-D-
lysine- or plasma-activated 8-well microscopy chamber (Nunc™ Lab-Tek™ Chamber Slide 
System, Thermo Fisher Scientific).  
 
Confocal laser Scanning microscopy (CLSM) 
CLSM measurements were performed using a confocal laser scanning microscope (ZEISS 
LSM 880, inverted microscope ZEISS Axio Observer, Carl Zeiss, Germany) equipped with a 
water immersion objective (C-Apochromate 40x/1.2W korr FCS M27). Samples containing 
GFP and Q-dots were excited with an argon laser at 488 nm by setting the detector range to 
499-521 nm for GFP and 640-714 for Q-dots. To measure the fluorescence of RFP-actin, 
SRB, resorufin, and RFP, a diode-pumped solid-state 561-10 laser (DPSS) at 561 nm was 
used as excitation source and the detector range set to 572-704 nm. A helium-neon laser 
(HeNe) at 633 nm was used to measure samples containing CellTracker™ Deep Red, and the 
fluorescent signal was collected with a detector range of 651-740 nm. Respectively, nano 
compartment beam splitters (MBS) of 488, 561 and 633 were used. Each sample was scanned 
unidirectional using 1024 x 1024 pixels with a Bit Depth of 16 Bit. Afterwards, every raw 
image was adjusted with ImageJ software. 
 
Cells were imaged either 24h after treatment with transfection agents or nano-formulations. 
Cells stained with CellTracker™ Deep Red were imaged directly after the final washing step. 
To minimize spectral crosstalk the samples were scanned using sequential mode. The laser 
settings between cells that weren't treated and cells treated by transfection or addition of 
dye/nanoformulation, the photomultiplier tube gain, and the pinhole settings were kept 
constant during the analyses.  
  
CellTracker™ Deep Red staining and GPMV packaging  
HepG2 cells were either cultured at a density of 4x104 cells per well in a µ-Slide 8 Well, 
Collagen IV: coverslip or at a density of 30x104 in a 6 Well , in 200 µL or 500 µL DMEM 
growth medium (High Glucose DMEM, supplemented with 10% fetal calf serum, penicillin 
(100 units mL-1) and streptomycin (100 µg mL-1)). 1 minute after culturing the cells 10 µL of 
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CellLight® Plasma Membrane-GFP BacMam 2.0 was added for cells cultured in 8 wells and 
25 µL for cells cultured in 6 wells. Cells were incubated for 24 h at 37 ºC, 5% CO2 to allow 
attachment on surface. After 24 h the medium was removed and CellTracker™ Deep Red 
was added according to the manufacturer’s instructions.  Cells were incubated for 30 min, 
then washed five times with DMEM growth medium.  
 
GPMV membrane modifications PEG-5000, DiI, DOPE-Rhodamine, DOPE-FITC 
HepG2 cells were either cultured at a density of 4x104 cells per well in a µ-Slide 8 Well, 
Collagen IV: coverslip or at a density of 30x104 in a 6 Well, in 200 µL or 500 µL DMEM 
growth medium (High Glucose DMEM, supplemented with 10% fetal calf serum, penicillin 
(100 units mL-1), and streptomycin (100 µg mL-1)). Cells were incubated for 24 h at 37 ºC, 
5% CO2 to allow attachment to the surface. 
 
For Cholesterol-PEG-5000 membrane modifications, Cholesterol-PEG-5000-FITC and 
Cholesterol-PEG-5000-CLS were purchased from Nanocs Inc and a 20 μg mL-1 solution was 
prepared in DMEM growth medium. Cells were treated with Cholesterol-PEG-5000-FITC for 
10 minutes before removing the medium and adding GPMV formation buffer. For in vivo 
experiments cells were treated with a Cholesterol-PEG-5000-FITC and Cholesterol-PEG-
CLS solution in a 20 μg mL-1 solution in DMEM for 1 h before removing the medium, 
washing the cells with PBS and adding the GPMV formation buffer.  
 
For DOPE-FITC and DOPE-Rhodamine membrane modifications, DOPE-FITC and DOPE-
Rhodamine were purchased from Avanti Polar lipids. 20 μg mL-1 solutions of either DOPE-
FITC and DOPE-Rhodamine were prepared in DMEM growth medium. For GPMVs 
equipped with both DOPE-FITC and DOPE-Rhodamine, the 20 μg mL-1 solutions of either 
membrane marker were mixed in a 1:1 ratio (10 μg mL-1 final concentration).  Cells were 
treated with DOPE-Rhodamine, DOPE-FITC or DOPE-FITC/DOPE-Rhodamine solutions 
for 10 minutes before removing the medium, washing the cells with PBS and adding GPMV 
formation buffer. 
 
For DiD 633 Labelling a 10 μg mL-1 DiD solution was prepared in DMEM growth medium. 
Cells were treated with the 10 μg mL-1 DiD solution in DMEM growth medium for 10 min 
before removing the medium, washing the cells with PBS and adding GPMV formation 
buffer. 
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GFP and RFP transfection and GPMV packaging  
HepG2 cells were either cultured at a density of 4x104 cells per well in a µ-Slide 8 Well, 
Collagen IV: coverslip or at a density of 30x104 in a 6 Well, in 200 µL or 500 µL DMEM 
growth medium (High Glucose DMEM, supplemented with 10% fetal calf serum, penicillin 
(100 units mL-1), and streptomycin (100 µg mL-1)). Cells were incubated for 24 h at 37 ºC, 
5% CO2 to allow attachment to the surface. After 24 h GFP or GFP and RFP transfection 
agent were added. After 24 h, the medium was removed and GPMV formation buffer was 
added.  Cells were imaged after incubation with GPMV buffer for 1 h at 37 ºC, 5% CO2. 
 
RFP actin transfection and GPMV packaging  
HepG2 cells were either cultured at a density of 4x104 cells per well in a µ-Slide 8 Well, 
Collagen IV: coverslip or at a density of 30x104 in a 6 Well , in 200µL or 500µL DMEM 
growth medium (High Glucose DMEM, supplemented with 10% fetal calf serum, penicillin 
(100 units mL-1), and streptomycin (100 µg mL-1)). 1 minute after culturing the cells, 10 µL 
of CellLight® Plasma Membrane-GFP BacMam 2.0 and CellLight® Actin-RFP, BacMam 
2.0 were added for cells cultured in 8 wells and 25 µL for cells cultured in 6 wells, 
respectively. After 24 h the medium was removed and GPMV formation buffer was added.  
Cells were imaged after incubation with GPMV buffer for 1 hour at 37 ºC, 5% CO2. 
 
Quantum dot uptake and GPMV packaging  
HepG2 cells were either cultured at a density of 4x104 cells per well in a µ-Slide 8 Well, 
Collagen IV: coverslip or at a density of 30x104 in a 6 Well, in 200 µL or 500 µL DMEM 
growth medium (High Glucose DMEM, supplemented with 10% fetal calf serum, penicillin 
(100 units mL-1), and streptomycin (100 µg mL-1)). 1 minute after culturing the cells 10 µL of 
CellLight® Plasma Membrane-GFP BacMam 2.0 was added for cells cultured in 8 wells and 
25µL for cells cultured in 6 wells. Cells were incubated for 24 h at 37 ºC, 5% CO2 to allow 
attachment on surface. After 24 h the medium was removed and of Qdot® 655 ITK™ 
Carboxyl Quantum Dots were added diluted 1:100 in DMEM growth medium as provided by 
the manufacturer.  After 24 h, cells were washed five times with DMEM growth medium. 
After the final wash step, DMEM growth medium was removed and GPMV buffer was 
added. Cells were imaged after incubation with GPMV buffer for 1 h at 37 ºC, 5% CO2.  
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Polymersome uptake and GPMV packaging  
HepG2 cells were either cultured at a density of 4x104 cells per well in a µ-Slide 8 Well, 
Collagen IV: coverslip or at a density of 30x104 in a 6 Well, in 200µL or 500 µL DMEM 
growth medium (High Glucose DMEM, supplemented with 10% fetal calf serum, penicillin 
(100 units mL-1) and streptomycin (100 µg mL-1)). 1 min after culturing the cells, 10 µL of 
CellLight® Plasma Membrane-GFP BacMam 2.0 was added for cells cultured in 8 wells and 
25 µL for cells cultured in 6 Wells. Cells were incubated for 24 h at 37 ºC, 5% CO2 to allow 
attachment on surface. After 24h the medium was removed and PMOXA-PDMS-PMOXA 
polymersomes or negatively charged PMOXA-PDMS-PMOXA was added to a final 
concentration of 1mg mL-1. After 24 h, cells were washed five times with DMEM growth 
medium. After the final wash step, DMEM growth medium was removed and GPMV buffer 
was added. Cells were imaged after incubation with GPMV buffer for 1 h at 37 ºC, 5% CO2.  
 
Liposome uptake and packaging  
HepG2 cells were either cultured at a density of 4x104 cells per well in a µ-Slide 8 Well, 
Collagen IV: coverslip or at a density of 30x104 in a 6 Well, in 200 µL or 500 µL DMEM 
growth medium (High Glucose DMEM, supplemented with 10% fetal calf serum, penicillin 
(100 units mL-1), and streptomycin (100 µg mL-1)). 1 min after culturing the cells 10 µL of 
CellLight® Plasma Membrane-GFP BacMam 2.0 was added for cells cultured in 8 wells and 
25 µL for cells cultured in 6 wells. Cells were incubated for 24 h at 37 ºC, 5% CO2 to allow 
attachment on surface. After 24 h the medium was removed and DSPS liposomes or 
PEGilated DOPC liposomes were added to a final concentration of 1 mg mL-1. Cells were 
incubated for an additional 24 h DMEM growth medium. After 24 h cells were washed five 
times with DMEM growth medium. After the final wash step, DMEM growth medium was 
removed and GPMV buffer was added. Cells were imaged after incubation with GPMV 
buffer for 1 h at 37 ºC, 5% CO2.  
 
Solid sphere particle uptake and packaging  
HepG2 cells were either cultured at a density of 4x104 cells per well in a µ-Slide 8 Well, 
Collagen IV: coverslip or at a density of 30x104 in a 6 Well, in 200 µL or 500 µL DMEM 
growth medium (High Glucose DMEM, supplemented with 10% fetal calf serum, penicillin 
(100 units mL-1), and streptomycin (100 µg mL-1)), respectively. 1 minute after culturing the 
cells 10 µL of CellLight® Plasma Membrane-GFP BacMam 2.0 was added for cells cultured 
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in 8 wells and 25 µL for cells cultured in 6 wells. Cells were incubated for 24 h at 37 ºC, 5% 
CO2 to allow attachment to the surface. After 24 h the medium was removed and 200 µL or 
500 µL of 40 nm latex beads 5% solids in DI water diluted 1:1000 into DMEM growth 
medium, or 500 nm latex beads 2% solids in 2 mM sodium azide solution diluted 1: 10 000 
into DMEM growth medium or 1 µm latex beads diluted 1: 10 000 into DMEM growth 
medium or 2 µm latex beads 2.5% solids in DI water were added to cells. Cells were 
incubated for an additional 24 h DMEM growth medium. After 24 h cells were washed five 
times with DMEM growth medium. After the final wash step, DMEM growth medium was 
removed and GPMV buffer was added. Cells were imaged after incubation with GPMV 
buffer for 1 h at 37 ºC, 5% CO2.  
 
PMOXA-PDMS-PMOXA catalytic nanocompartment uptake and GPMV packaging  
HepG2 cells were either cultured at a density of 4x104 cells per well in a µ-Slide 8 Well, 
Collagen IV: coverslip or at a density of 30x104 in a 6 Well, in 200 µL or 500 µL DMEM 
growth medium (High Glucose DMEM, supplemented with 10% fetal calf serum, penicillin 
(100 units mL-1), and streptomycin (100 µg mL-1)). 1 min after culturing the cells, 10 µL of 
CellLight® Plasma Membrane-GFP BacMam 2.0 was added for cells cultured in 8 wells and 
25 µL for cells cultured in 6 wells. Cells were incubated for 24 h at 37 ºC, 5% CO2 to allow 
attachment on surface. After 24 h the medium was removed and HRP-loaded PMOXA-
PDMS-PMOXA polymersomes equipped with OmpF were added to a final concentration of 
1 mg mL-1. After 24 h cells were washed five times with DMEM growth medium. After the 
final wash step, DMEM growth medium was removed and GPMV buffer was added. Cells 
were imaged after incubation with GPMV buffer for 1 h at 37 ºC, 5% CO2.  
 
Preparation of OmpF equipped polymersomes 
OmpF-equipped polymersomes (A6B44A6) OmpF were prepared at RT from the ABA 
triblock copolymer, PMOXA6-PDMS44-PMOXA6. The synthetic procedure and the polymer 
characterization are presented in Itel et al. 201482. Polymersomes were generated using the 
film rehydration technique where the polymer was dried in the presence of OmpF K89 R270 
cysteine mutant. Horseradish peroxidase (HRP) in PBS buffer pH=7.4 at RT was used as 
rehydration solution. Films were rehydrated to a final polymer concentration of 2.5 mg mL-1, 
HRP concentration of 0.2 mg mL-1, and OmpF concentration of 50 µg mL-1, respectively. 
Control polymersomes were also prepared in the absence of OmpF. Rehydrated films were 
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stirred overnight at RT, protected from light. All samples were extruded through an Avanti 
mini-extruder (Avanti Polar Lipids, USA) using a 100 nm diameter pore-size polycarbonate 
membrane (7 times) at RT in order to obtain size homogeneity. The non-encapsulated 
enzyme was removed from the polymersomes by dialysis against PBS at pH 7.4 at RT for 5 
days, exchanging the buffer every 3 hours during the day and leaving the buffer unchanged 
overnight, using Spectrapore dialysis tubes with a molecular weight cut-off of 300 kDa 
(Spectrum Laboratories Inc., USA).  
 
Preparation of SRB-loaded polymersomes 
SRB-loaded polymersomes were prepared at RT from the ABA triblock copolymer, 
PMOXA6-PDMS44-PMOXA6. The synthetic procedure and the polymer characterization are 
presented in Itel et al. 201482. Polymersomes were generated using the film rehydration 
technique where the polymer was dried, and 1 mM sulforhodamine B in PBS buffer pH=7.4 
at RT was used as rehydration solution. Rehydrated films were stirred overnight at RT, while 
being protected from light. All samples were extruded through an Avanti mini-extruder 
(Avanti Polar Lipids, USA) using a 100 nm diameter pore-size polycarbonate membrane (7 
times) at RT in order to obtain size homogeneity. Non-encapsulated dye was removed from 
the polymersomes by using a HiTrap Desalting ready-to-use 5 mL column, prepacked with 
Sephadex G-25 Superfine, and equilibrated with PBS.  
 
Liposome Preparation 
Liposomes were prepared using the film-rehydration-extrusion method. In brief, dry lipid 
films were rehydrated at Tm+10°C using a 1 mM sulforhodamine B solution resulting in a 
total lipid concentration of 40 mM. Finally, samples were extruded 21 times through a 100 
nm diameter pore-size polycarbonate membrane (11 times) at Tm+10°C using an Avanti 
mini-extruder (Avanti Polar Lipids, Alabama, USA).  
Non-encapsulated dye was removed from the polymersomes by using a HiTrap Desalting 
ready-to-use 5 mL column, prepacked with Sephadex G-25 Superfine, equilibrated with PBS.  
The following lipid formulations were prepared: DSPC:cholesterol:DSPE-PEG (48:42:10 
%mol) and DSPS:cholesterol:DSPE-PEG (53:42:5 %mol). 
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Transfection of HepG2 cells 
Cells were transfected using the mammalian expression plasmids pTagGFP-N and 
pTagRFP-N (Evrogen) encoding for the water-enhanced GFP or RFP under control of the 
cytomegalovirus promotor. Cells were seeded at a density of 2.5 x 104 cells/cm2 on poly-D-
lysine-coated or plasma-treated tissue culture slides and allowed to adhere for 24 h. For the 
transfection, plasmid DNA (pDNA) was complexed using Lipofectamine 3000 at a pDNA-
to-Lipofectamine reagents ratio (w/V) of 2. Cells were transfected using 2.5 µg pDNA per 
1000 mm2 surface area. GUV formation was induced 24 h post transfection. 
 
Dynamic lightscattering 
The measurements of DH of liposomes, polymersomes and catalytic nanocompartments were 
performed on a Zetasizer Nano ZSP at 25 °C. The measure angle is 173° and the data were 
analyzed by intensity distribution.  
 
Transmission electron microscopy (TEM) 
1:10 dilutions of the prepared polymersome, liposome and catalytic compartments were 
negatively stained with 1.5% uranyl acetate solution and deposited on carbon-coated copper 
grids. For GPMV TEM imaging, polymersome-loaded GPMVs were deposited on carbon-
coated copper grids and deflated vesicles imaged. Transmission electron microscope (Philips 
Morgagni 268D) at 293 K was used. 
 
Amplex UltraRed reaction in GPMVs 
After isolating GPMVs loaded with CatCs from cells, 200 µL of the GPMV solution was 
deposited in a plasma activated 8-well microscopy chamber.  The substrates Amplex 
UltraRed (5 µL of 0.1 mmol mL-1 in DMSO) and H2O2 (5 µL of 0.1 mmol mL-1 in ddH2O) 
were mixed and these 10 µL were added during the measurements. The reaction was then 
visualized 2 hours after mixing the GPMV solution with the reaction substrates in order to 
allow sufficient AR to diffuse into the GPMVs.  
 
GPMVs preparation for ZFE injection. 
HepG2 cells were cultured at a density of 30x104 in a 6 Well in 500 µL DMEM growth 
medium (High Glucose DMEM, supplemented with 10% fetal calf serum, penicillin (100 
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units mL-1), and streptomycin (100 µg mL-1)). Cells were incubated for 24 h at 37 ºC, 5% 
CO2 to allow attachment to the surface. After 24 h RFP transfection agent were added. 
Subsequently after 24 h cells were treated with 20 µM Cholesterol-PEG5000 (micelles) 
solution in PBS for 1 hour, the cells were washed with GPMV formation buffer, the medium 
was removed and GPMV formation buffer was added.  GPMVs were collected from the cells, 
sedimented overnight and injected into ZFE. ZFE CLSM measurements were performed 
using a confocal laser scanning microscope (ZEISS LSM 880, inverted microscope ZEISS 
Axio Observer, Carl Zeiss, Germany) equipped with a water immersion objective (C-
Apochromate 40x/1.2W korr FCS M27). 
 
Zebrafish injections 
Standard zebrafish embryo (ZFE) culture medium at pH 7.4 was prepared at final 
concentrations of 5 mM sodium chloride, 0.25 mM potassium chloride, 0.5 mM magnesium 
sulfate, 0.15 mM potassium dihydrogen phosphate, 0.05 mM sodium phosphate dibasic, 0.5 
mM calcium chloride, 0.71 mM sodium bicarbonate, and 0.001 % (w/v) methylene blue. 
Collected eggs from adult ABC/TU ZFE (Wildtype) and kdrl:GFP (GFP vasculature line) 
were kept in ZFE culture medium at 28°C. 1-Phenyl-2-thiourea (PTU) (0.03 mg mL-1) was 
added 1-day post fertilization (dpf) in order to avoid pigment cell formation. Equipped 
GPMVs were injected into 2-dpf ZFE according to an adapted protocol originally designed 
for microangiography. ZFE were anesthetized using 0.01% tricaine (w/v) and cast into 0.3% 
(w/v) agarose containing the same amount of tricaine. Immobilized ZFE were injected  with 3 
nL of GPMV solution.  
 
GPMVs preparation for ZFE injection 
HepG2 cells were cultured at a density of 30x104 in a 6 Well in 500 µL DMEM growth 
medium (High Glucose DMEM, supplemented with 10% fetal calf serum, penicillin (100 
units mL-1), and streptomycin (100 µg mL-1)). Cells were incubated for 24 h at 37 ºC, 5% 
CO2 to allow attachment to the surface. After 24 h RFP transfection agent were added. 
Subsequently after 24 h cells were treated with 20 µM Cholesterol-PEG5000 solution in PBS 
for 1 hour, the cells were washed with GPMV formation buffer, the medium was removed 
and GPMV formation buffer was added.  GPMVs were collected from the cells, sedimented 
overnight and injected into ZFE. ZFE CLSM measurements were performed using a confocal 
laser scanning microscope (ZEISS LSM 880, inverted microscope ZEISS Axio Observer, 
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Carl Zeiss, Germany) equipped with a water immersion objective (C-Apochromate 40x/1.2W 
korr FCS M27). 
 
FCS Measurements 
FCS Fluorescence correlation spectroscopy (FCS) measurements were carried out using a 
confocal laser scanning microscope (ZEISS LSM 880, inverted microscope ZEISS Axio 
Observer, Carl Zeiss, Germany) with a water immersion objective lens (C-Apochromate 
40x/1.2W korr FCS M27). Measurements were taken at room temperature using a sample 
volume of 20 µL on a glass cover slide or within individual GUVs using the position mode. 
A diode-pumped solid-state 561-10 laser (DPSS) at 561 nm was used for excitation of the 
SRB fluorophore (λ = 561 nm) with the appropriate filter sets. The laser intensity was kept 
constant between individual measurements. The fluorescence signal was measured in real 
time and the autocorrelation function was calculated by a software correlator provided by the 
manufacturer (ZEN 2 Blue edition). Measurements were recorded over 2 s and each 
measurement was repeated 60 times. Correlation curves that presented a lower CPM than the 
calibration fluorophore (SRB) or could not be fitted were excluded. 
For determining purification of free SRB from the formed liposomes and polymersomes, 
experimental auto correlation curves were fitted using a two-component model including the 
triplet state (Eq. 1). 
 
Eq. 1: 
G(τ)fit = 1 + �1 + 𝑇𝑇1− 𝑇𝑇 𝑒𝑒− 𝜏𝜏𝜏𝜏trip� 1𝑁𝑁
⎣
⎢
⎢
⎡ 𝑓𝑓11 + 𝜏𝜏𝜏𝜏D1 1�1 + 𝑅𝑅2 𝜏𝜏𝜏𝜏D1⎦⎥⎥
⎤ + �1 + 𝑇𝑇1 − 𝑇𝑇 𝑒𝑒− 𝜏𝜏𝜏𝜏trip� 1𝑁𝑁
⎣
⎢
⎢
⎡ 𝑓𝑓21 + 𝜏𝜏𝜏𝜏D2 1�1 + 𝑅𝑅2 𝜏𝜏𝜏𝜏D2⎦⎥⎥
⎤
 
 
 
τD represents the diffusion time, T the fraction of fluorophores in triplet state with triplet time 
τtrip, N is the number of particles and R the structural parameter.  
 
R and τD of free dye (SRB) were determined independently, experimental auto correlation 
curves were fitted using a one component model including triplet state (Eq. 2). 
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Eq. 2: 
G(τ)fit = 1 + (1 + 𝑇𝑇1 − 𝑇𝑇 𝑒𝑒− 𝜏𝜏𝜏𝜏trip) 1𝑁𝑁
⎣
⎢
⎢
⎡ 11 + 𝜏𝜏𝜏𝜏D 1�1 + 𝑅𝑅2 𝜏𝜏𝜏𝜏D⎦⎥⎥
⎤
 
 
τD represents the diffusion time, T the fraction of fluorophores in triplet state with triplet time 
τtrip, N is the number of particles and R the structural parameter. R and τD of free dye (SRB) 
were determined independently. R and τD of SRB were subsequently fixed in the fitting 
procedure in order to determine the % of free dye fraction, which represented the 
unencapsulated fluorophore still present in the solution after purification of SRB-loaded 
polymersomes / liposomes. 
 
OmpF expression and purification 
The OmpF K89 R270 cysteine mutant (OmpF-M) expression and extraction was done as 
previously reported in 112,128. First under aseptic conditions, a loop full of cells from an 
ampicillin resistant Escherichia Coli strain BL21 stock culture that overexpressed the OmpF 
K89 R270 mutant was smeared onto the surface of a lysogeny broth (LB), ampicillin (100 mg 
mL-1 ampicillin) agar plate. After 16 hours of incubation at 37 °C, a single colony was 
selected and transferred from the plate to 10 mL of terrific broth (TB) liquid medium with 
100 mg mL-1 ampicillin (4 flasks in total). 5 L TB medium with 100 mg mL-1 ampicillin was 
inoculated with 15 mL of the overnight culture (OD = 0.1-0.5), and the optical density of the 
growing culture was followed by measuring the absorbance at 600 nm. When the absorbance 
reached an OD of 0.6, IPTG was added to a final concentration of 1 mM in order to start the 
over-expression of the OmpF-M gene. The bacteria were grown for 16 more hours at 25 ºC, 
with vigorous stirring, then the E. Coli cells were pelleted at 7.000 g for 8 min at 4 ºC.  
Pellets were stored at -25 ºC, and on the following day were re-suspended in 50 mL of 25 
mM Tris-HCl pH 7.4. 10 mg DNase and 10 mg RNase were added, and the cell suspension 
French pressed five times at 1,000 bar. 1 mL of 20% SDS was added per 10 mL of cell 
suspension and incubated for 1 h at 60 ºC. The suspension was centrifuged at 50.000 g at 23 
ºC for 1 hour. The supernatant was removed and the cell pellet incubated in 0.125% OG for 1 
h at 37 ºC. The suspension was then centrifuged at 50.000 g for 1 hour at 23 ºC. Finally, the 
cell pellet was re-suspended in 3% OG in 10 mM phosphate buffer and homogenized. The 
suspension was centrifuged at 50.000 g and the protein concentration in the supernatant was 
determined by UV-Vis absorption at 280 nm. Before the reconstitution experiments were 
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carried out, the protein was dialysed against 1L of 0.05 % OG in PBS for 16 hours and twice 
against PBS pH 7.4 for 2 hours. After the dialysis the protein concentration was adjusted to 
1.2 mg mL-1. 
 
Preparation of OmpF equipped polymersomes 
OmpF equipped polymersomes were prepared as described in Einfalt et al. at RT from the 
ABA triblock copolymer, PMOXA6-PDMS44-PMOXA6, (A6B44A6) and OmpF K89 R270 
cysteine mutant. The synthetic procedure and the polymer characterization are presented in 
Itel et al. Polymersomes were generated using the film rehydration technique where the 
polymer was dried in the presence of unmodified OmpF K89 R270 cysteine. Horseradish 
peroxidase (HRP) in PBS buffer pH=7.4 at RT were used as rehydration solutions. Films 
were rehydrated to a final polymer concentration of 2.5 mg mL-1, HRP concentration of 0.2 
mg mL-1, and OmpF concentration of 80 µg mL-1, respectively. Control catalytic 
nanocompartments were also prepared in the absence of OmpF. Rehydrated films were 
stirred at RT for 24 h. All samples were extruded through an Avanti mini-extruder (Avanti 
Polar Lipids, USA) using a 100 nm diameter pore-size polycarbonate membrane (6 times) at 
RT in order to obtain size homogeneity. Non-encapsulated enzyme was removed from the 
polymersomes by dialysis against PBS at pH 7.4 at RT for 4 consequitve days using 
Spectrapore dialysis tubes, MWCO 300 kDa (Spectrum Laboratories Inc., USA); the buffer 
was exchanged every 3 hours during the day, but was left unchanged overnight.  
 
Amplex UltraRed enzymatic assay  
The increase in emission fluorescence intensity was analyzed using a LS 55 Fluorescence 
Spectrometer (Perkin Elmer). For the measurement, 10 µL of the catalytic nanocompartments 
equipped with OmpF or without OmpF were transferred to 220 µL of the reaction mixture 
(4.5 µM H202 and 3.4 µM Amplex Ultra Red) in PBS at pH 7.4. Subsequently the reaction 
mixture was excited at 530 nm and the emission intensity was monitored at 590 nm. 
Fluorescence was expressed as relative fluorescence units (RFU) and was measured at the 
same instrument setting in all experiments. 
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Chapter 8 
APENDIX – SUPPLEMENTARY INFORMATION  
CHAPTER 3 
GUV membrane staining and visualization by LSM 
 
 
Figure S1. GUVs formation identified by staining the membrane with Bodipy 633, measured 
with CLSM. 
 
Proton outflux through GUV membranes 
 
Figure S2. Fluorescence intensity change over time of 5(6)-carboxyfluorescein (CF) inside 
and outside of polymer GUVs (A7B42A7) in the presence of DMSO/EtOH. Fluorescence 
intensity inside GUVs (dotted line), and outside GUVs (solid line).  
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Below, Figures S3-7, we provide the evidence for the successful insertion and functionality 
of gA in GUVs for A6B34A6, A6B44A6, A7B49A7, A12B63A12, and A12B87A12. Left part consists 
in microscopy micrographs before and after addition of NaOH. Each image, specific for each 
polymer in part, consists of three subparts. The GUVs were monitored upon NaOH addition 
and without gA (upper part), DMSO/EtOH and NaOH without gA (middle part), and 
DMSO/EtOH with gA and NaOH (bottom part).  
Right column contains the plots of the fluorescent intensity over time inside GUVs (dotted 
line) compared with the background - the outside part of the GUVs (solid line). The steadily 
decrease of the fluorescence intensity is attributed to the CF photobleaching in time. An 
increase in the intensity occurred immediately after pH increase in the outside environment of 
GUVs. Multiple peaks represent consecutive addition of NaOH, after the system was 
equilibrated. Where the fluorescence intensity was similar in both cases (inside and outside 
GUVs), we concluded that the membrane was permeabilized due to the gA addition. It has to 
be noted that on the micrographs some polymer chunks are also visible, which are typical 
byproducts obtained when transferring the GUV solution from electroformation chamber to 
storage tubes. This phenomenon is similar as observed in the case of lipid GUVs obtained by 
electroformation.212 The polymer chunks did not have any influence on the experiments we 
performed with the polymer GUVs.  
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Figure S3. Successful proton outflux through the A6B34A6  membranes of GUVs. 
 
 
 
Figure S4. Successful proton outflux through the A6B44A6 membranes of GUVs. 
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Figure S5. Successful proton outflux through the A7B49A7 membranes of GUVs. 
 
 
 
Figure S6. No proton outflux through the A12B63A12 membranes of GUVs. 
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Figure S7. No proton outflux through the A12B87A12 membranes of GUVs. 
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CHAPTER 4  
 
Figure S8. 4-15% SDS Gel chromatograpy. Left: Coomasie Blue stain Right: 488 
Fluorescence. 1) Benchmark protein ladder, 2) Atto 488 conjugated OmpF-M, 3) OmpF-M 4) 
Benchmark protein ladder.  
 
 
 
Figure S9. A) and B) Flow cytometry gating of OmpF-Atto 488 equipped (green) or 
unequipped PMOXA-b-PDMS-b-PMOXA (A7B49A7) GUVs( grey). 
 
 
                
Figure S10. Left: 4-15% SDS-PAGE Gel with comassie stained labeled HRP-Atto 488. 
Right: Gel showing fluorescence of labeled HRP-Atto 488. 1) HRP-Atto 488, 2) Protein 
ladder. 
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Figure S11. Amplex UltraRed conversion kinetics of free HRP in solution. Red: Amplex 
UltraRed conversion in PBS pH 7.4, Blue: Amplex UltraRed conversion in 300 mM sucrose, 
Green: Amplex UltraRed conversion without the presence of H2O2 in PBS pH 7.4, Black: 
Amplex UltraRed conversion without the presence of HRP, Orange: Amplex UltraRed 
coversion without the presence of Amplex UltraRed. 
 
 
 
Figure S12. TEM micrographs of HRP- loaded polymersomes where sucrose was used as the 
rehydration solution. A) OmpF equipped polymersomes and B) polymersomes without OmpF. 
Scale bar 200 nm. 
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Figure S13. Dynamic light scattering analysis of A) OmpF-M equipped HRP-loaded 
PMOXA-b-PDMS-b-PMOXA (A7B49A7) polymersomes and B) HRP-loaded PMOXA-b-
PDMS-b-PMOXA (A7B49A7) polymersomes. 
 
 
 
Figure S14. Amplex red conversion kinetics of HRP-loaded polymersomes equipped with 
OmpF-M (red) or unequipped (blue), where PBS was used as the rehydration solution A) and 
where 300mM sucrose was used as the rehydration solution B).  
 
 
Figure S15 Temporal variation of the relative fluorescence intensity of the resorufin-like 
product inside the cavities of single GUVs after addition of the reagents H2O2 and Amplex 
UltraRed. Each curve represents one GUV. Left: GUVs with filtrate control. Right: GUVs 
with reconstituted OmpF-M.  
115 
SUPPLEMENTARY INFORMATION 
      
Figure S16. Temporal variation of the relative fluorescence intensity of the resorufin-like 
product inside the cavities of single GUVs after background subtraction and after addition of 
the reagents H2O2 and Amplex UltraRed. Each curve represents one GUV. Left: GUVs with 
reconstituted OmpF. Right: GUVs without OmpF-M.  
 
 
GUVs without OmpF (26 vesicles):  GUVs with reconstituted OmpF (22 
Vesicles):            
27% showed fluorescence activity (7) 68% showed fluorescence acticity (15) 
73% remained dark (19) 31% remained dark (7) 
 
Table 2. Fluorescence activity of GUVs after the enzyme reaction. Left: GUVs without 
OmpF. Right: GUVs with reconstituted OmpF. 
 
 
 
Figure S17. Flow cytometry analysis - Amplex UltraRed enzymatic assay. A) Flow cytometry 
gating (FSC-A, SSC-A) and B) single giant selection by FSC-H / FSC –A of OmpF equipped 
(red) or unequipped PMOXA-b-PDMS-b-PMOXA (A7B49A7) GUVs (blue). 
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Figure S18. Size distribution of GUVs, including density distribution and histogram. 
 
 
 
Figure S19. Boxplot of the size distribution of all GUVs measured. The population of GUVs 
equipped with OmpF are shown in red and the population of GUVs without OmpF are shown 
in blue. 
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Figure S20. A) Relative fluorescence intensity of the resorufin-like product inside the cavities 
of single GUVs after background subtraction over time and after addition of H2O2 and 
Amplex UltraRed. B) Relative fluorescence intensity by size of the resorufin-like product 
inside the cavities of single GUVs after background subtraction over time and after addition 
of H2O2 and Amplex UltraRed. 
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CHAPTER 5  
 
Figure S21. Transmission electron microscopy micrograph of SRB-loaded 
DSPC:Cholesterol:DSPE-PEG (48:42:10 %mol) liposomes. Scale bar: 200 nm. 
 
 
 
Figure S22. Transmission electron microscopy micrograph of SRB-loaded 
DSPS:Cholesterol:DSPE-PEG (53:42:5 %mol). Scale bar: 200 nm. 
 
 
 
Figure S23. Transmission electron microscopy of SRB-loaded PMOXA44-PDMS6-PMOXA44 
polymersomes. Scale bar: 200 nm. 
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Figure S24. Cryogenic transmission electron microscoy of PMOXA44-PDMS6-PMOXA44 
polymersomes. Scale bar left: 200nm. Scale bar right: 50 nm.  
 
 
 
Figure S25. Intensity distribution by DLS of SRB-loaded PMOXA44-PDMS6-PMOXA44 
polymersomes. (n=3).  
 
 
 
Figure S26. Intensity distribution by DLS of SRB-loaded DSPS:Cholesterol:DSPE-PEG 
(53:42:5 %mol) liposomes (n=3).  
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Figure S27. Intensity distribution by DLS of SRB-loaded DSPC:Cholesterol:DSPE-PEG 
(48:42:10 %mol) liposomes (n=3).  
 
 
 
Figure S28: FCS analysis of SRB-loaded DSPS and DSPC liposomes in PBS pH 7.4. FCS 
autocorrelation curves of free SRB in PBS pH 7.4 (Black), SRB-loaded DSPS liposomes in 
PBS pH 7.4 (Blue) SRB-loaded DSPC liposomes in PBS pH 7.4 (Red). Dotted line – 
experimental auto correlation curves, Full line – fit. Curves normalized to 1 to facilitate 
comparison.     
 
 
 
Figure S29: FCS analysis of SRB-loaded PMOXA44-PDMS6-PMOXA44 polymersomes in PBS 
pH 7.4 (Blue) and SRB-loaded PMOXA44-PDMS6-PMOXA44 polymersomes within GPMVs 
(Red). Dotted line – experimental auto correlation curves, Full line – fit. Curves normalized 
to 1 to facilitate comparison.     
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Figure S30. TEM micrograph of a PMOXA44-PDMS6-PMOXA44 polymersome-loaded 
HepG2-derived GPMV. Scale bar: 500 nm. Arrowheads: Subcompartmentalized GPMVs. 
 
 
 
Figure S31. TEM micrograph of a PMOXA-PDMS-PMOXA polymersome-loaded HepG2-
derived GPMV. Scale bar: 500 nm. Arrowheads: Subcompartmentalized GPMVs. 
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Figure S32. Left: 3D representation of GPMVs Right: Maximum projection image of 3D 
representation. Top panel: GPMVs equipped with SRB (red) and CF (green)-loaded 
PMOXA44-PDMS6-PMOXA44 polymersomes. Middle panel: Plasma membrane equipped 
with e-GFP Lck Tyrosine kinase (green) filled with SRB-loaded PMOXA-PDMS-PMOXA 
polymersomes (red). Bottom panel: GPMVs equipped with e-GFP Lck Tyrosine kinase 
(green) filled with SRB-loaded DSPC-PEG liposomes (red).  
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Figure S33: Frequency distribution of diffusion times taken from individual FCS 
measurements. SRB-loaded PMOXA44-PDMS6-PMOXA44 polymersomes in PBS pH 7.4 
(Blue) and SRB-loaded PMOXA44-PDMS6-PMOXA44 polymersomes within GPMVs (Red).  
 
 
 
 
Figure S34: Frequency distribution of molecular brightness’s taken from individual FCS 
measurements. FCS analysis of SRB-loaded PMOXA-PDMS-PMOXA polymersomes in 
GPMVs (Red) and PBS pH 7.4 (Blue). 
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Figure S35. TEM micrograph of a PMOXA44-PDMS6-PMOXA44 polymersomes loaded with 
HRP. Left: OmpF equipped HRP-loaded polymersomes. Right: HRP-loaded polymersomes. 
GPMV. Scale bar 100 nm.  
 
 
 
Figure S36. Intensity distribution by DLS of OmpF equipped HRP-loaded PMOXA44-
PDMS6-PMOXA44 polymersomes. 
 
 
 
Figure S37. Intensity distribution of DLS measurement of HRP-loaded PMOXA44-PDMS6-
PMOXA44 polymersomes (n=3).  
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Figure S38. Fluorescence intensity (Ex: 530 Em:590) resulting from the enzymatic 
conversion of Amplex UltraRed into the resorufin-like product by HRP encapsulated in 
catalytic nanocompartments, measured free in solution (PBS pH 7.4). (Red) Catalytic 
nanocompartments loaded with HRP and equipped with OmpF K89 R270, (Blue) Catalytic 
nanocompartments without OmpF.  
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